products  mylan en   en mylan worldwide close please select one of our websites from the list below africa south africa english americas brazil português brasileiro canada english français united states english asia india english japan  taiwan  europe austria deutsch belgium français nederlands bulgaria българия czech republic čeština denmark dansk finland suomi france français germany deutsch greece ελληνικά hungary magyar ireland english italy italiano netherlands nederlands norway norsk poland polski portugal português romania română serbia serbian latin slovakia slovenský slovenia slovenian spain español sweden svensk switzerland deutsch english united kingdom english pacific australia english new zealand english mylan also is proud to do business in these locations morocco luxembourg china singapore search company and product information menu products select product catalog quality our medicines and consumer products therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms generic products branded products consumer healthcare products unit dose and specialty packaging transdermal technology products mylan is a global healthcare company focused on making high quality medicines available to everyone who needs them our broad and diverse portfolio of more than  products is available to customers of all types including retail and pharmacy establishments wholesalers governments institutions and physicians mylan quality it’s everyone’s responsibility our medicines and consumer products  we make more than  high quality products that people around the world depend on therapeutic innovation our worldwide research and development group includes approximately  scientists and regulatory experts who innovate every day the distinctive mylan blue bottle uniquely designed with pharmacists and patients in mind read about the inside and out of our packing innovation packaging and delivery systems information on unitofuse and specialty packaging innovations and injectables for institutional products as well as for transdermal patches and medical device components including films liners and adhesive laminates gbr® — generic brand reference guide this easytouse guide—available as a smartphone app — offers health care professionals crossreferenced lists of brand name and generic medicines other features include color guides to mylan’s institutional pharmaceutical and specialty portfolios iphone android blackberry download the app gbr® is a registered trademark of mylan pharmaceuticals inc iphone is a registered trademark of apple inc android is a trademark of google inc find a mylan product search our generic and brand name us pharmaceuticals powered by institutional products we are committed to offering a complete line of reliable high quality products that are designed to help hospitals and other institutions reduce error increase efficiency and improve care what we offer questions get more information on our products services and mylan global center locations contact us business opportunities do you have an opportunity or a collaboration idea partner with us company about us business segments leadership global social responsibility corporate governance products product catalog quality our medicines and consumer products why generics therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms news feature stories press releases investors stock performance investment calculator stock history public filings investor faqs update on meridian’s voluntary worldwide recall of epipen® autoinjector careers life at mylan mylan benefits diversity  inclusion mylan near you resources and information to help prescribe dispense and take medicine with confidence pharmacists educational materials to help empower your customers patients what to know about our high quality products physicians details about our brandname and generic medicines health systems customers resources that meet the specific needs of your institution explore you are leaving mylancom you are now leaving mylancom for a mylan affiliate site a mylan product site a third party site that mylan may contribute content to but does not have exclusive control over or a third party site that is solely responsible for its content and may not follow guidelines applicable in certain geographies continue go back contact mylan privacy shield policy privacy statement terms and conditions site map california supply chains act copyright   mylan nv all rights reserved for us audiences only nonnon ampamplta hrefhttpwwwyoutubecomuserseeinsidemylan targetblank relnofollow datacategorysocialyoutube dataactionclicklink datalabelglobalfooterampampgtyoutubeampampltaampampgt ampamplta hrefhttptwittercommylannews targetblank relnofollow datacategorysocialtwitter dataactionclicklink datalabelglobalfooterampampgttwitterampampltaampampgt ampamplta hrefhttpfacebookcom targetblank relnofollow datacategorysocialfacebook dataactionclicklink datalabelglobalfooterampampgtfacebookampampltaampampgt quality in pharmaceutical manufacturing  mylan en   en mylan worldwide close please select one of our websites from the list below africa south africa english americas brazil português brasileiro canada english français united states english asia india english japan  taiwan  europe austria deutsch belgium français nederlands bulgaria българия czech republic čeština denmark dansk finland suomi france français germany deutsch greece ελληνικά hungary magyar ireland english italy italiano netherlands nederlands norway norsk poland polski portugal português romania română serbia serbian latin slovakia slovenský slovenia slovenian spain español sweden svensk switzerland deutsch english united kingdom english pacific australia english new zealand english mylan also is proud to do business in these locations morocco luxembourg china singapore search company and product information menu products product catalog quality our medicines and consumer products therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms generic products branded products consumer healthcare products unit dose and specialty packaging transdermal technology the mylan story play video see inside our passion innovation and commitment see inside our passion innovation and commitment play video how drugs are made play video watch how high quality tablets and capsules are made each year at one of our oral solid dose manufacturing sites watch how high quality tablets and capsules are made each year at one of our oral solid dose manufacturing sites play video mylan quality mylan applies one global quality standard across our facilities and across our product line…regardless of market at mylan whether it’s a medication for millions or for a handful of people our priorities are to meet or exceed industry standards because there’s nothing generic about our standards our internal teams conduct reviews of all products start to finish no matter where in the world they are made in fact we championed a law that empowers the fda to biennially inspect all manufacturing facilities around the world that supply the us market we have one global quality standard because we know where our priorities are it all starts and ends with you robert j coury chairman to us trust goes beyond our global quality standards it’s all about caring for the people who will be helped by what we do most of all quality is the reason we can say to  billion people that we know where our priorities are it all starts and ends with you because our mylan is your mylan therapeutic innovation our worldwide research and development group includes approximately  scientists and regulatory experts who innovate every day key categories why generics low cost and high quality our generics contributed to us health care system savings of an estimated  trillion from  to  and  billion in  alone and our global quality standard applies to all our medicines no matter where they’re made find out more find a mylan product search our generic and brand name us pharmaceuticals powered by company about us business segments leadership global social responsibility corporate governance products product catalog quality our medicines and consumer products why generics therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms news feature stories press releases investors stock performance investment calculator stock history public filings investor faqs update on meridian’s voluntary worldwide recall of epipen® autoinjector careers life at mylan mylan benefits diversity  inclusion mylan near you resources and information to help prescribe dispense and take medicine with confidence pharmacists educational materials to help empower your customers patients what to know about our high quality products physicians details about our brandname and generic medicines health systems customers resources that meet the specific needs of your institution explore you are leaving mylancom you are now leaving mylancom for a mylan affiliate site a mylan product site a third party site that mylan may contribute content to but does not have exclusive control over or a third party site that is solely responsible for its content and may not follow guidelines applicable in certain geographies continue go back contact mylan privacy shield policy privacy statement terms and conditions site map california supply chains act copyright   mylan nv all rights reserved for us audiences only non ampamplta hrefhttpwwwyoutubecomuserseeinsidemylan targetblank relnofollow datacategorysocialyoutube dataactionclicklink datalabelglobalfooterampampgtyoutubeampampltaampampgt ampamplta hrefhttptwittercommylannews targetblank relnofollow datacategorysocialtwitter dataactionclicklink datalabelglobalfooterampampgttwitterampampltaampampgt ampamplta hrefhttpfacebookcom targetblank relnofollow datacategorysocialfacebook dataactionclicklink datalabelglobalfooterampampgtfacebookampampltaampampgt what are bioequivalent generic drugs  mylan en   en mylan worldwide close please select one of our websites from the list below africa south africa english americas brazil português brasileiro canada english français united states english asia india english japan  taiwan  europe austria deutsch belgium français nederlands bulgaria българия czech republic čeština denmark dansk finland suomi france français germany deutsch greece ελληνικά hungary magyar ireland english italy italiano netherlands nederlands norway norsk poland polski portugal português romania română serbia serbian latin slovakia slovenský slovenia slovenian spain español sweden svensk switzerland deutsch english united kingdom english pacific australia english new zealand english mylan also is proud to do business in these locations morocco luxembourg china singapore search company and product information menu products product catalog quality our medicines and consumer products therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms generic products branded products consumer healthcare products unit dose and specialty packaging transdermal technology why generics at mylan we have one global quality standard in everything we do because there is nothing generic about our standards our internal teams conduct reviews of all products start to finish no matter where in the world they are made why such high standards because we truly care about the people who will be helped by the medicines we make and we believe in earning that trust from physicians pharmacists other healthcare professionals and patients every day it’s why we say “our mylan is your mylan” want to know more about generic medicines see the facts figures and bioequivalence requirements below percentage of us prescriptions filled with a generic medicine number of us prescriptions brandname or generic filled with a mylan product food and drug administration this agency must approve every generic medicine before it can be sold in the us to gain fda approval generic medicines must be proven to be “bioequivalent” to their brand name counterparts that means generic and brand name medicines are the same in the following ways active ingredient maximum amount of medicine in the blood at any given time total amount of medicine in the blood from the time it’s taken until the body eliminates it strength and dosage route of administration—tablet injection etc expected safety and efficacy fda evaluation of manufacturing facilities just because products have the same active ingredient does not mean they are bioequivalent once generic bioequivalence is proven the fda considers a generic medicine interchangeable with the brand name medicine average amount consumers can save by filling a prescription with a generic rather than a brand name medicine the price of generic medicines is usually lower when compared to brand name medicines since they are not invented from scratch generally subject to clinical trials or supported by advertising campaigns  trillion according to ims health generic medications saved the us healthcare system an estimated  trillion from  to  and  billion in  alone  main factors behind the growth of the generics industry aging population desire to reduce healthcare spending the key to mylan’s ability to bring new generics to market especially medicines that are difficulttomanufacture and difficulttoformulate find out about our therapeutic innovation find a mylan product search our generic and brandname us pharmaceuticals powered by generics information center quality discover why it’s so important to everyone at mylan learn more choosing generics with confidence find out more about the safety and bioequivalency of generic medicines learn choose act therapeutic innovation our worldwide research and development group includes approximately  scientists and regulatory experts who innovate every day key categories company about us business segments leadership global social responsibility corporate governance products product catalog quality our medicines and consumer products why generics therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms news feature stories press releases investors stock performance investment calculator stock history public filings investor faqs update on meridian’s voluntary worldwide recall of epipen® autoinjector careers life at mylan mylan benefits diversity  inclusion mylan near you resources and information to help prescribe dispense and take medicine with confidence pharmacists educational materials to help empower your customers patients what to know about our high quality products physicians details about our brandname and generic medicines health systems customers resources that meet the specific needs of your institution explore you are leaving mylancom you are now leaving mylancom for a mylan affiliate site a mylan product site a third party site that mylan may contribute content to but does not have exclusive control over or a third party site that is solely responsible for its content and may not follow guidelines applicable in certain geographies continue go back contact mylan privacy shield policy privacy statement terms and conditions site map california supply chains act copyright   mylan nv all rights reserved for us audiences only nonnon ampamplta hrefhttpwwwyoutubecomuserseeinsidemylan targetblank relnofollow datacategorysocialyoutube dataactionclicklink datalabelglobalfooterampampgtyoutubeampampltaampampgt ampamplta hrefhttptwittercommylannews targetblank relnofollow datacategorysocialtwitter dataactionclicklink datalabelglobalfooterampampgttwitterampampltaampampgt ampamplta hrefhttpfacebookcom targetblank relnofollow datacategorysocialfacebook dataactionclicklink datalabelglobalfooterampampgtfacebookampampltaampampgt therapeutic innovation en   en mylan worldwide close please select one of our websites from the list below africa south africa english americas brazil português brasileiro canada english français united states english asia india english japan  taiwan  europe austria deutsch belgium français nederlands bulgaria българия czech republic čeština denmark dansk finland suomi france français germany deutsch greece ελληνικά hungary magyar ireland english italy italiano netherlands nederlands norway norsk poland polski portugal português romania română serbia serbian latin slovakia slovenský slovenia slovenian spain español sweden svensk switzerland deutsch english united kingdom english pacific australia english new zealand english mylan also is proud to do business in these locations morocco luxembourg china singapore search company and product information menu products product catalog quality our medicines and consumer products therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms generic products branded products consumer healthcare products unit dose and specialty packaging transdermal technology therapeutic innovation would it surprise you to know that we bring innovation to the field of generic medicine or that our research and development group includes approximately  scientists and regulatory experts who innovate worldwide every day it’s true and it’s why we’ve challenged ourselves to reach higher and go farther for more than  years the science of solutions today we design bioequivalent versions of brandname medicines many of which are difficulttomanufacture and difficulttoformulate we strive to create enhanced versions of medicines to differentiate our products from the pack and we pursue innovations in oral solid dose medicines transdermals injectables creams ointments antiretrovirals and nearly a dozen other critical areas why because we believe every disease can have a treatment we believe every epidemic should come to an end medical conditions great and small should be manageable oncology from treatments for solid tumors and cancers of the blood to supportive care mylan helps healthcare professionals provide their patients with a wide variety of treatments for every stage of cancer survivorship learn more about mylans commitment to oncology anaphylaxis anaphylaxis a lifethreatening allergic reaction is a significant public health problem when anaphylaxis occurs every minute matters and immediate access to epinephrine and emergency medical care is crucial we advocate for increased anaphylaxis awareness preparedness and access to treatment because even one anaphylactic episode without access to epinephrine is one too many antiretrovirals these medicines treat hivaids often treatment regimens require a patient to take three or more medicines and may include an arv medicine that breaks down if not refrigerated many places hardest hit by the epidemic are in warm climates—africa and india for instance—where refrigeration can be scarce for such regions mylan was able to make a heatstable version of an arv medicine that doesn’t require refrigeration cardiovascular our commitment to cardiovascular medicine beats strongly using our transdermal technology we have formulated adhesive patches that deliver medicine through the skin respiratory we’re developing asthma and chronic obstructive pulmonary disease copd treatments that use a drypowder drugdelivery platform technology find out more about our other brand name respiratory products dermatology while we manufacture products in many formats—from tablets and capsules to injectables and transdermals—we also produce creams and ointments for dermatology our commitment to these medicines gained strength during the s when we acquired bertek pharmaceuticals today we have several products in clinical trials awaiting approval as well as many creams ointments sprays and dressings always moving forward innovation is a part of who we are and the reason we see the opportunity in every challenge research and development creating positive change we’re committed to setting new standards in healthcare for people living with hivaids  kb breaking down barriers taking action about  million people are currently living with hivaids  kb impact of an epidemic company about us business segments leadership global social responsibility corporate governance products product catalog quality our medicines and consumer products why generics therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms news feature stories press releases investors stock performance investment calculator stock history public filings investor faqs update on meridian’s voluntary worldwide recall of epipen® autoinjector careers life at mylan mylan benefits diversity  inclusion mylan near you resources and information to help prescribe dispense and take medicine with confidence pharmacists educational materials to help empower your customers patients what to know about our high quality products physicians details about our brandname and generic medicines health systems customers resources that meet the specific needs of your institution explore you are leaving mylancom you are now leaving mylancom for a mylan affiliate site a mylan product site a third party site that mylan may contribute content to but does not have exclusive control over or a third party site that is solely responsible for its content and may not follow guidelines applicable in certain geographies continue go back contact mylan privacy shield policy privacy statement terms and conditions site map california supply chains act copyright   mylan nv all rights reserved for us audiences only non ampamplta hrefhttpwwwyoutubecomuserseeinsidemylan targetblank relnofollow datacategorysocialyoutube dataactionclicklink datalabelglobalfooterampampgtyoutubeampampltaampampgt ampamplta hrefhttptwittercommylannews targetblank relnofollow datacategorysocialtwitter dataactionclicklink datalabelglobalfooterampampgttwitterampampltaampampgt ampamplta hrefhttpfacebookcom targetblank relnofollow datacategorysocialfacebook dataactionclicklink datalabelglobalfooterampampgtfacebookampampltaampampgt mylan pharmaceuticals inc company information  drugscom skip to content search all allconsumerprofessionalpill idinteractionsnewsfda alertsapprovalspipelineclinical trialscare notesencyclopediadictionarynatural products browse all medications a b c d e f g h i j k l m n o p q r s t u v w x y z advanced search topics  tools facebook twitter google plus sign in sign in register menu home › pharmaceutical companies › mylan pharmaceuticals inc print share mylan pharmaceuticals inc address mylan pharmaceuticals inc  mylan blvd canonsburg pa contact detailsphone  website wwwmylancomcareers wwwmylancomcareers drugs associated with mylan pharmaceuticals incmylan pharmaceuticals inc manufactures markets andor distributes more than  drugs in the united states medications listed here may also be marketed under different names in different countries nonus country and region specific information is not available on this page brandgeneric name average user rating abacavir class nucleoside reverse transcriptase inhibitors nrtis      acamprosate class drugs used in alcohol dependence      acarbose class alphaglucosidase inhibitors      acebutolol class cardioselective beta blockers group ii antiarrhythmics      acetaminophencodeine class narcotic analgesic combinations      acetaminophenoxycodone class narcotic analgesic combinations      acetaminophentramadol class narcotic analgesic combinations      acitretin class antipsoriatics      acyclovir class topical antivirals      albuterol class adrenergic bronchodilators      albuterolipratropium class bronchodilator combinations      alendronate class bisphosphonates      alfuzosin class antiadrenergic agents peripherally acting      allopurinol class antigout agents antihyperuricemic agents      almotriptan class antimigraine agents      alprazolam class benzodiazepines      amantadine class adamantane antivirals dopaminergic antiparkinsonism agents      amiodarone class group iii antiarrhythmics      amitriptyline class tricyclic antidepressants      amitriptylinechlordiazepoxide class psychotherapeutic combinations      amlodipine class calcium channel blocking agents      amlodipinetelmisartan class angiotensin ii inhibitors with calcium channel blockers      amlodipinevalsartan class angiotensin ii inhibitors with calcium channel blockers      amnesteem generic name isotretinoin class miscellaneous antineoplastics miscellaneous uncategorized agents      amoxicillinclavulanate class betalactamase inhibitors      amphetaminedextroamphetamine class cns stimulants      ampicillinsulbactam class betalactamase inhibitors      anastrozole class aromatase inhibitors hormonesantineoplastics      armodafinil class cns stimulants      ascorbic acid class vitamins      atenolol class cardioselective beta blockers      atenololchlorthalidone class beta blockers with thiazides      atorvastatin class statins      atovaquoneproguanil class antimalarial combinations      avita generic name tretinoin class topical acne agents      azathioprine class antirheumatics other immunosuppressants      baclofen class skeletal muscle relaxants      benazepril class angiotensin converting enzyme inhibitors      benazeprilhydrochlorothiazide class ace inhibitors with thiazides      bexarotene class miscellaneous antineoplastics      bicalutamide class antiandrogens hormonesantineoplastics      bisoprololhydrochlorothiazide class beta blockers with thiazides      bromocriptine class dopaminergic antiparkinsonism agents prolactin inhibitors      bumetanide class loop diuretics      buprenorphine class narcotic analgesics      bupropion class miscellaneous antidepressants smoking cessation agents      buspirone class miscellaneous anxiolytics sedatives and hypnotics      butorphanol class narcotic analgesics      cabergoline class dopaminergic antiparkinsonism agents prolactin inhibitors      calcium acetate class minerals and electrolytes phosphate binders      capecitabine class antimetabolites      captopril class angiotensin converting enzyme inhibitors      captoprilhydrochlorothiazide class ace inhibitors with thiazides na carbidopaentacaponelevodopa class dopaminergic antiparkinsonism agents      carbidopalevodopa class dopaminergic antiparkinsonism agents      carboplatin class alkylating agents      carisoprodol class skeletal muscle relaxants      carvedilol class noncardioselective beta blockers      celecoxib class cox inhibitors      cetirizine class antihistamines      chlorothiazide class thiazide diuretics      chlorpromazine class phenothiazine antiemetics phenothiazine antipsychotics      chlorpropamide class sulfonylureas      chlorthalidone class thiazide diuretics      cidofovir class purine nucleosides na cimetidine class h antagonists      cisplatin class alkylating agents      citalopram class selective serotonin reuptake inhibitors      clomipramine class tricyclic antidepressants      clonazepam class benzodiazepine anticonvulsants benzodiazepines      clonidine class antiadrenergic agents centrally acting      clorazepate class benzodiazepines      clorpres generic name chlorthalidoneclonidine class antiadrenergic agents central with thiazides na clozapine class atypical antipsychotics      cystagon generic name cysteamine class miscellaneous uncategorized agents na desloratadine class antihistamines      desogestrelethinyl estradiol class contraceptives      desvenlafaxine class serotoninnorepinephrine reuptake inhibitors      dexmethylphenidate class cns stimulants      dextroamphetamine class cns stimulants      diazepam class benzodiazepine anticonvulsants benzodiazepines      dicyclomine class anticholinergicsantispasmodics      didanosine class nucleoside reverse transcriptase inhibitors nrtis      diltiazem class calcium channel blocking agents group iv antiarrhythmics      diltiazem hydrochloride cd generic name diltiazem class calcium channel blocking agents group iv antiarrhythmics      diltiazem hydrochloride sr generic name diltiazem class calcium channel blocking agents group iv antiarrhythmics      diltiazem hydrochloride xr generic name diltiazem class calcium channel blocking agents group iv antiarrhythmics na disulfiram class drugs used in alcohol dependence      divalproex sodium class fatty acid derivative anticonvulsants      donepezil class cholinesterase inhibitors      doxazosin class antiadrenergic agents peripherally acting      dronabinol class miscellaneous antiemetics      drospirenoneethinyl estradiol class contraceptives      dutasteride class alphareductase inhibitors      efavirenz class nnrtis      enalapril class angiotensin converting enzyme inhibitors      enalaprilhydrochlorothiazide class ace inhibitors with thiazides      enlon generic name edrophonium class cholinergic muscle stimulants na enlonplus generic name atropineedrophonium class cholinergic muscle stimulants na entacapone class dopaminergic antiparkinsonism agents      eprosartan class angiotensin receptor blockers      esmolol class cardioselective beta blockers group ii antiarrhythmics na esomeprazole class proton pump inhibitors      estradiol patch generic name estradiol class estrogens      eszopiclone class miscellaneous anxiolytics sedatives and hypnotics      ethinyl estradiolethynodiol class contraceptives      ethinyl estradiollevonorgestrel class contraceptives      ethinyl estradiolnorethindrone class contraceptives sex hormone combinations      ethinyl estradiolnorgestimate class contraceptives      etomidate class general anesthetics na etoposide class mitotic inhibitors      exemestane class aromatase inhibitors hormonesantineoplastics      famciclovir class purine nucleosides      famotidine class h antagonists      felbamate class carbamate anticonvulsants      fenofibrate class fibric acid derivatives      fenofibric acid class fibric acid derivatives      fenoprofen class nonsteroidal antiinflammatory agents      fentanyl class narcotic analgesics      fexofenadine class antihistamines      finasteride class alphareductase inhibitors      fluconazole class azole antifungals      flumazenil class antidotes na fluorouracil class topical antineoplastics      fluoxetine class selective serotonin reuptake inhibitors      fluphenazine class phenothiazine antipsychotics      flurazepam class benzodiazepines      fluvastatin class statins      fluvoxamine class selective serotonin reuptake inhibitors      fondaparinux class factor xa inhibitors      fosphenytoin class hydantoin anticonvulsants na frovatriptan class antimigraine agents      furosemide class loop diuretics      gabapentin class gammaaminobutyric acid analogs      galantamine class cholinesterase inhibitors      gemcitabine class antimetabolites      gemfibrozil class fibric acid derivatives      glimepiride class sulfonylureas      glipizide class sulfonylureas      glipizidemetformin class antidiabetic combinations      guanfacine class antiadrenergic agents centrally acting      haloperidol class miscellaneous antipsychotic agents      hydrochlorothiazide class thiazide diuretics      hydrochlorothiazideirbesartan class angiotensin ii inhibitors with thiazides      hydrochlorothiazidelisinopril class ace inhibitors with thiazides      hydrochlorothiazidelosartan class angiotensin ii inhibitors with thiazides      hydrochlorothiazidemethyldopa class antiadrenergic agents central with thiazides      hydrochlorothiazidemetoprolol class beta blockers with thiazides na hydrochlorothiazideolmesartan class angiotensin ii inhibitors with thiazides      hydrochlorothiazidepropranolol class beta blockers with thiazides na hydrochlorothiazidespironolactone class potassium sparing diuretics with thiazides      hydrochlorothiazidetriamterene class potassium sparing diuretics with thiazides      hydrochlorothiazidevalsartan class angiotensin ii inhibitors with thiazides      hydroxychloroquine class antimalarial quinolines antirheumatics      hydroxyzine class antihistamines miscellaneous anxiolytics sedatives and hypnotics      ibandronate class bisphosphonates      ifosfamide class alkylating agents      iloperidone class atypical antipsychotics      indapamide class thiazide diuretics      indomethacin class nonsteroidal antiinflammatory agents      irbesartan class angiotensin receptor blockers      itraconazole class azole antifungals      ketamine class general anesthetics      ketoprofen class nonsteroidal antiinflammatory agents      labetalol class noncardioselective beta blockers      lacosamide class miscellaneous anticonvulsants      lamivudine class nucleoside reverse transcriptase inhibitors nrtis      lamivudinezidovudine class antiviral combinations      lamotrigine class triazine anticonvulsants      lansoprazole class proton pump inhibitors      latanoprost class ophthalmic glaucoma agents      letrozole class aromatase inhibitors hormonesantineoplastics      leucovorin class antidotes na levalbuterol class adrenergic bronchodilators      levetiracetam class pyrrolidine anticonvulsants      levothyroxine class thyroid drugs      linezolid class oxazolidinone antibiotics      liothyronine class thyroid drugs      lisinopril class angiotensin converting enzyme inhibitors      lithium class miscellaneous antipsychotic agents      lorazepam class benzodiazepine anticonvulsants benzodiazepines miscellaneous antiemetics      lovastatin class statins      maprotiline class tetracyclic antidepressants      maxzide generic name hydrochlorothiazidetriamterene class potassium sparing diuretics with thiazides      maxzide generic name hydrochlorothiazidetriamterene class potassium sparing diuretics with thiazides      meclizine class anticholinergic antiemetics      meclofenamate class nonsteroidal antiinflammatory agents na meloxicam class nonsteroidal antiinflammatory agents      melphalan class alkylating agents      memantine class miscellaneous central nervous system agents      mentax generic name butenafine class topical antifungals na mercaptopurine class antimetabolites      mesna class antineoplastic detoxifying agents na metformin class nonsulfonylureas      methadone class narcotic analgesics      methamphetamine class anorexiants cns stimulants      methocarbamol class skeletal muscle relaxants      methotrexate class antimetabolites antipsoriatics antirheumatics other immunosuppressants      methyclothiazide class thiazide diuretics na methyldopa class antiadrenergic agents centrally acting      methylphenidate class cns stimulants      metolazone class thiazide diuretics      metoprolol class cardioselective beta blockers      metoprolol succinate er generic name metoprolol class cardioselective beta blockers      metoprolol tartrate generic name metoprolol class cardioselective beta blockers      miacalcin nasal generic name calcitonin class calcitonin      midodrine class miscellaneous cardiovascular agents      mirtazapine class tetracyclic antidepressants      modafinil class cns stimulants      montelukast class leukotriene modifiers      moxifloxacin class quinolones      mycophenolate mofetil class selective immunosuppressants      mycophenolic acid class selective immunosuppressants      nabumetone class nonsteroidal antiinflammatory agents      nadolol class noncardioselective beta blockers      naloxone class antidotes      naratriptan class antimigraine agents      nevirapine class nnrtis      nicardipine class calcium channel blocking agents      nisoldipine class calcium channel blocking agents      nitroglycerin class antianginal agents vasodilators      nizatidine class h antagonists      norethindrone class contraceptives progestins      octreotide class somatostatin and somatostatin analogs      olanzapine class atypical antipsychotics      olmesartan class angiotensin receptor blockers      omeprazole class proton pump inhibitors      ondansetron class ht receptor antagonists      oxaliplatin class alkylating agents      oxycodone class narcotic analgesics      pantoprazole class proton pump inhibitors      paroxetine class selective serotonin reuptake inhibitors      perphenazine class phenothiazine antiemetics phenothiazine antipsychotics      phenytek generic name phenytoin class group i antiarrhythmics hydantoin anticonvulsants      phenytoin class group i antiarrhythmics hydantoin anticonvulsants      phenytoin sodium extended release generic name phenytoin class group i antiarrhythmics hydantoin anticonvulsants na pindolol class noncardioselective beta blockers      pioglitazone class thiazolidinediones      polyethylene glycol  class laxatives      potassium chloride class minerals and electrolytes      pravastatin class statins      prazosin class antiadrenergic agents peripherally acting      prednisolone class glucocorticoids      probenecid class antigout agents      prochlorperazine class phenothiazine antiemetics phenothiazine antipsychotics      proderm generic name balsam perucastor oil class miscellaneous topical agents na promethazine class antihistamines phenothiazine antiemetics      propafenone class group i antiarrhythmics      propranolol class group ii antiarrhythmics noncardioselective beta blockers      pyridoxine class vitamins      quinine class antimalarial quinolines      rabeprazole class proton pump inhibitors      rasagiline class dopaminergic antiparkinsonism agents      repaglinide class meglitinides      rifampin class rifamycin derivatives      riluzole class miscellaneous central nervous system agents      rimso generic name dimethyl sulfoxide class miscellaneous genitourinary tract agents na risedronate class bisphosphonates      risperidone class atypical antipsychotics      ropinirole class dopaminergic antiparkinsonism agents      rosuvastatin class statins      rufinamide class dibenzazepine anticonvulsants      selegiline class dopaminergic antiparkinsonism agents monoamine oxidase inhibitors      sertraline class selective serotonin reuptake inhibitors      sildenafil class agents for pulmonary hypertension impotence agents      sotalol class group iii antiarrhythmics noncardioselective beta blockers      sotalol hydrochloride af generic name sotalol class group iii antiarrhythmics noncardioselective beta blockers      sotradecol generic name sodium tetradecyl sulfate class sclerosing agents na spironolactone class aldosterone receptor antagonists potassiumsparing diuretics      stavudine class nucleoside reverse transcriptase inhibitors nrtis      sucralfate class miscellaneous gi agents      sulfamylon generic name mafenide class topical antibiotics na sulindac class nonsteroidal antiinflammatory agents      tamoxifen class hormonesantineoplastics selective estrogen receptor modulators      tamsulosin class antiadrenergic agents peripherally acting      telmisartan class angiotensin receptor blockers      temazepam class benzodiazepines      temozolomide class alkylating agents      terazosin class antiadrenergic agents peripherally acting      thiamine class vitamins na thioridazine class phenothiazine antipsychotics      thiothixene class thioxanthenes      tizanidine class skeletal muscle relaxants      tolmetin class nonsteroidal antiinflammatory agents      tolterodine class urinary antispasmodics      topiramate class carbonic anhydrase inhibitor anticonvulsants      topotecan class miscellaneous antineoplastics na tramadol class narcotic analgesics      tramadol hydrochloride er generic name tramadol class narcotic analgesics      trifluoperazine class phenothiazine antipsychotics      ultiva generic name remifentanil class narcotic analgesics na valacyclovir class purine nucleosides      valsartan class angiotensin receptor blockers      vancomycin class glycopeptide antibiotics      vecuronium class neuromuscular blocking agents na venlafaxine class serotoninnorepinephrine reuptake inhibitors      verapamil class calcium channel blocking agents group iv antiarrhythmics      vinorelbine class mitotic inhibitors na vitamin b complex  generic name multivitamin class vitamin and mineral combinations      voriconazole class azole antifungals na xulane generic name ethinyl estradiolnorelgestromin class na      zaleplon class miscellaneous anxiolytics sedatives and hypnotics      zidovudine class nucleoside reverse transcriptase inhibitors nrtis      ziprasidone class atypical antipsychotics      zoledronic acid class bisphosphonates      zolmitriptan class antimigraine agents      zolpidem class miscellaneous anxiolytics sedatives and hypnotics      zonisamide class carbonic anhydrase inhibitor anticonvulsants      zovirax generic name acyclovir class purine nucleosides      discontinued drugs brandgeneric name average user rating granulex generic name balsam perucastor oiltrypsin class topical debriding agents      tolazamide class sulfonylureas      tolbutamide class sulfonylureas na latest drug information updates vosevi vosevi sofosbuvir  velpatasvir  voxilaprevir is a singletablet regimen for the treatment of adults withnerlynx nerlynx neratinib is a tyrosine kinase inhibitor for the extended adjuvant treatment of patients with earlytremfya tremfya guselkumab is an interleukin blocker indicated for the treatment of adult patients withbevyxxa bevyxxa betrixaban is an oral oncedaily factor xa inhibitor anticoagulant for the extendeddurationrituxan hycela rituxan hycela rituximab and hyaluronidase human is a subcutaneous monoclonal antibody and hyaluronidasebaxdela baxdela delafloxacin is a fluoroquinolone antibacterial indicated for the treatment of acute bacterial skin more drug information updates drugscom mobile apps the easiest way to lookup drug information identify pills check interactions and set up your own personal medication records available for android and ios devices explore apps support help center frequent questions sitemap contact us about about drugscom advertising policy content submissions drugscom blog terms  privacy editorial policy privacy policy terms of use attribution  citations facebook twitter google plus youtube rss feed subscribe to receive email notifications whenever new articles are published drugscom provides accurate and independent information on more than  prescription drugs overthecounter medicines and natural products this material is provided for educational purposes only and is not intended for medical advice diagnosis or treatment data sources include micromedex® updated july th  cerner multum™ updated july th  wolters kluwer™ updated july th  and others to view content sources and attributions please refer to our editorial policy third party advertising we comply with the honcode standard for trustworthy health information  verify here copyright   drugscom all rights reserved share on facebook share on twitter share on googleplus email to a friend hide mylan  wikipedia mylan from wikipedia the free encyclopedia jump to navigation search mylan trading name mylan nv formerly called milan type public under dutch law traded as nasdaq myl tase myl nasdaq biotechnology component nasdaq component sp  component isin us industry pharmaceuticals founded   years ago  in white sulphur springs west virginia united states founders milan puskar don panoz headquarters canonsburg pennsylvania united states of america area served worldwide key people heather bresch ceo products generic and specialty pharmaceuticals and active pharmaceutical ingredients revenue us billion  operating income us million  net income us billion  total assets us  billion  total equity us billion  number of employees   divisions see operations subsidiaries meda famy care website wwwmylancom mylan nv is an american global generic and specialty pharmaceuticals company registered in the netherlands with principal executive offices in hatfield hertfordshire uk and global headquarters in canonsburg pennsylvania us in  mylan acquired a controlling interest in indiabased matrix laboratories limited a top producer of active pharmaceutical ingredients apis for generic drugs and the generics business of germanybased merck kgaa through these acquisitions mylan grew from the thirdlargest generic and pharmaceuticals company in the united states to the secondlargest generic and specialty pharmaceuticals company in the world in  mylans pricing of the epipen an epinephrine autoinjector became controversial and was widely referred to as price gouging as a result investigations were opened into whether mylan had misclassified the epipen under the medicaid drug rebate program a common form of pharmaceutical fraud in october  mylan settled these investigations with the us department of justice agreeing to pay  million and enter into a corporate integrity agreement concerning the rebate program in a report published on june   the institutional shareholder services criticized mylan for the outsized compensation of mylans directors former ceo robert coury received a  million  pay package in spite of the harm to the company inflicted by the epipen controversies and steep shareholder losses the report urged mylans shareholders to oust all of mylans existing directors contents  operations  location  stock  history  acquisition history  criticism  epipen pricing  execution drugs  references  external links operationsedit mylan inc operates several divisions and subsidiaries in north america and south america mylan operates mylan pharmaceuticals based in morgantown west virginia mylan pharmaceuticals ulc mylan canada mylan technologies inc mti  transdermal drug delivery systems tdds and related technologies udl laboratories inc somerset pharmaceuticals inc a research and development company in tampa florida owned by mylan somerset develops emsam manufactured by mylan technologies and marketed in the united states by dey another mylan company mylan laboratories limited campos dos goytacazes brazil in oceania and central east south and southeast asia mylan operates mylan new zealand limited  new zealand mylan laboratories limited  headquartered in hyderabad india operates nine active pharmaceutical ingredient api and intermediate manufacturing facilities located in india and china mylan seiyaku ltd  japan alphapharm  australia agila specialties pvt ltd  india oncotherapies ltd  india in europe africa and west asia mylan operates operates under the mylan name in austria belgium the czech republic denmark finland france germany hungary italy the netherlands norway poland portugal slovakia slovenia spain sweden switzerland the united kingdom also operates in south africa arcana arzneimittel gmbh  germany generics pharma hellas  greece gerard laboratories  ireland qualimed  trademark in france but will stop being marketed under the brand name docpharma  generic pharmaceutical distribution company in belgium the netherlands and luxembourg locationedit founded in  the company was first located in white sulphur springs west virginia the company moved to morgantown west virginia in  and in  it relocated its corporate headquarters to the pittsburgh suburb canonsburg pennsylvania finally in  it moved to a new office center in nearby southpointe a suburban business park located in cecil township where it is still located stockedit on february   mylan had its initial public offering ipo becoming a publicly traded company on the otc market under the ticker symbol myln in  the stock moved to nasdaq their final stock move was in  when their stock became available for trade on the new york stock exchange under the ticker symbol myl currently the stock is traded on the nasdaq historyedit mylan pharmaceuticals was founded as a drug distributor in  by milan puskar and don panoz in  mylan began manufacturing penicillin g tablets as well as vitamins and other dietary supplements panoz left mylan in  and puskar quit the company in  as it grew and experienced financial difficulties the board hired roy mcknight as board chairman who convinced puskar to return in  mylan discontinued operating as a contract manufacturing organization in  and instead chose to market their products under their own mylanlabeled brandcitation needed with the passage of the hatchwaxman act in  mylan and other small generic companies gained value in the eighteen months following passage of the law mylans earnings grew  to  million and its stock value rose  in the s one of the most prescribed drugs in the us was dyazide a diuretic that was a combination drug containing triamterene and hydrochlorothiazide it had been on the market since  and its patents had expired in  complications arose with the introductions of generics versions because the formulation of dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent some generic companies committed fraud trying to bring a generic version of dyazide bolar pharmaceutical had the first generic version approved in  but it turned out that bolar had fraudulently substituted dyazide for its own version to conduct studies that were submitted to the fda by  the fda rescinded its approval based on its suspicions and filed criminal charges against bolar to which bolar eventually pled guilty in  mylan chose to develop a new version of a triamterenehydrochlorothiazide combination drug instead of going the generic route it developed a different more stable formulation and used different dosages of each active ingredient  mg hydrochlorothiazide and  mg triamterene compared with dyazides  mg hydrochlorothiazide and  mg triamterene this drug had to get approval as a new drug as opposed to a generic their product was called maxzide and was approved in  the higher dose allowed once per day dosing which mylan and its marketing partner lederle believed would help it compete against dyazide which had m in sales in  however mylans patents on the drug were declared invalid in court and its marketing exclusivity expired in  prompting a rush of generic competition mylan had concerns about the practices of its competitors and the fda in general and also with regard to companies seeking to bring generic versions of maxzide mylan hired private investigators to examine its competitors practices and when it found evidence of corruption it submitted it to the house oversight and investigations committee which investigated and found fraud and corruption within the food and drug administrations generic drugs division and at other generic companies two of the companies that had gotten approval to market generic versions of maxzide vitarine pharmaceutical and par pharmaceutical were targets of mylans initial investigation and were found to have used mylans maxzide to obtain their bioequivalence data leading both companies to withdraw its generic competitor to mylans product the corruption in the nascent generics industry and at the office in the fda regulating it was widely covered in the media and led to widespread concern among doctors and the public in the late s and early s that generic drugs were not really the same as the branded drugs they were meant to replace in  mylan agreed to enter into a joint venture with bolar to buy somerset pharmaceuticals mylan wanted access to somersets drug discovery capabilities as well as its new drug for parkinsons selegiline the deal was completed in  but its consummation was dependent on fda approval of selegiline which came in  mylan acquired bertek inc in  for its transdermal patch technologies and kept as a subsidiary in  mylan renamed the company mylan technologies inc mti mti eventually came to be the contract manufacturer for the selegiline transdermal patch and was the first company to market generic nitroglycerin estradiol clonidine and fentanyl transdermal patches mylan acquired udl laboratories a supplier of unit dose generic medications to institutional and longterm care facilities in  in  when it was the worlds second largest generics company mylan came under investigation from the federal trade commission after it raised the prices of its products tripling them in the case of lorazepam mylan had entered into an exclusive agreement with profarmica an italian company that supplied drug ingredients after which mylans competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs before the round of price increases the price of generic drugs had been    of the price of branded drugs and afterwards it was around  the ftc filed suit at the end of  and  states filed parallel actions the case was settled in  with mylan paying a total of m  m in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid  million in attorneys fees to the state attorneys general  million plus  million in attorneys fees to settle certain class actions with insurers and managed care organizations  and mylan and three ingredient suppliers cambrex corporation profarmaco srl and gyma laboratories also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future in  mylan and king pharmaceuticals began discussing a deal in which mylan would acquire king for about b mylan wanted to expand its presence in branded pharmaceuticals and to acquire kings sales force the deal became one of the business soap operas of the year and included an sec investigation into kings accounting and carl icahn obtaining a  interest in mylan and becoming its largest stakeholder in order to kill the deal the parties called off the deal in february  icahn offered to buy mylan for b and ran a slate of board members to change the direction of mylan he won three seats in may  in june mylan bought back  of its shares in order to fend off icahn and in july icahn gave up his bid and sold his shares in august  mylan announced that it had reached agreement to buy a controlling interest in matrix laboratories an indian supplier of active pharmaceutical ingredients the deal gave mylan access to markets in india and china and was completed in january the next year in may  mylan and merck kgaa agreed that mylan would acquire mercks generics arm for b the deal was completed that october and tripled the size of mylan mylan acquired the rights to market the epipen in the transaction at that time annual sales were around  million and the epipen had about  of the market in  the company filed two lawsuits against the pittsburgh postgazette after the newspaper ran an article that was critical of the quality control procedures used at the companys morgantown plant the company had earlier quality control issues involving the fda the lawsuits were dropped in  without any damages paid by the postgazette which stated the postgazette did not find and did not intend to report that mylan had manufactured or distributed any defective drugs the postgazette regrets if any reader of the article thought otherwise also in  mylan and its subsidiary udl agreed to pay a m to settle a suit filed under the false claims act in which mylanudl and two other companies were accused of underpaying states under the medicaid drug rebate program the program requires drug companies to give rebates to states under medicaid and the rebates are higher for new drugs than for generics the suit said that the companies sold new drugs but paid rebates as if they were generics in  mylan entered into an agreement with pfizer for the exclusive worldwide rights to develop manufacture and commercialize pfizers generic equivalent to glaxosmithklines advair usseretide uk diskus incorporating pfizers proprietary dry powder inhaler delivery platform mylan launched the product in the uk in  and in february  the fda accepted its anda putting it in line behind hikma and sandoz to launch a generic version in the us in  mylan launched a program called epipenschools to sell epipens in bulk and with discounts to schools to participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year in december  the national association of state boards of education launched a policy initiative designed to help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine autoinjector access and use and advocated for state laws protecting school from legal liability for stocking and using epinephrine autoinjectors gayle manchin the mother of mylans ceo heather bresch had become president of the association in  and shortly after had discussed donations from her daughters company to the association manchin had been appointed to the west virginia state school board by her husband thengovernor of the state joe manchin in  in  mylan acquired an indian generic injectable drugs company agila specialties private for  billion in cash in  three plants acquired in that deal were issued warning letters by the fda after successful lobbying from mylan in  the school access to emergency epinephrine act became law after passing congress with broad and bipartisan support it protected anyone from liability if they administered epinephrine to a child in a school previously only trained professionals or the affected person were allowed to administer the drug and were open to liability and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them joe manchin the father of mylans ceo was a senator at that time in july  mylan and abbott laboratories announced an agreement under which mylan would buy abbotts generic drugs business in developed markets for stock valued at about  billion mylan acquired mumbaibased famy care and expand its presence in the market for womens contraceptives at about  million starting in  according to a  report in the new york times midlevel executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the epipen and raising concerns that the price increases were unethical the times reported that when these concerns were brought to robert coury the chairman of the board coury replied that he was untroubled he raised both his middle fingers and explained using colorful language that anyone criticizing mylan including its employees ought to go copulate with themselves critics in congress and on wall street he said should do the same and regulators at the food and drug administration they too deserved a round of anatomically challenging selffulfillment  the times reported that bresch provided similarly dismissive responses in april  mylan tried negotiate with the management of irish pharmaceutical firm perrigo to acquire the company and when those negotiations failed mylan attempted a hostile takeover offering to buy b in shares directly from shareholders too few shareholders agreed to sell their stock by the deadline set in november  and the effort failed two weeks after mylan made its first offer for perrigo teva pharmaceutical offered to buy mylan for b the combined companies would have been the worlds largest generic company and the th biggest drug company in the world in july teva dropped its bid for mylan and instead acquired allergans generic drug business for about the same price in june  mylan agreed to work with pulmatrix a company with a proprietary inhaled drug delivery platform to codevelop a product to treat for chronic obstructive pulmonary disease the product was pur a generic drug in a pulmatrix device in february  the company announced it would acquire meda for  billion in may of the same year the company announced it would acquire renaissance acquisition holdings dermatology division for up to  billion in  mylan had about b in sales of epipens and those sales accounted for  of mylans profit mylan had maintained about a  market share since it had acquired the product and had continually raised the price of epipens starting in  in  the wholesale price of two epipens was about  by july  the price was about  in may  it was around  and in may  the price rose again to around  around a  jump from the price in  in the summer of  as parents prepared to send their children back to school and went to pharmacies to get new epipens people began to express outrage at the cost of the epipen and mylan was widely and harshly criticized the price hikes led to investigations by congress and states attorneys general in october  mylan agreed to pay a m fine related to incorrect rebates it paid under the medicaid drug rebate program in december  the attorneys general of  states filed a civil complaint accusing mylan of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug the complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings telephone calls and text messages according to the department of health and human services office of inspector general analysis the us government may have overpaid as much as  billion between  and  to drugmaker mylan nv for the epipen emergency allergy treatment this represents three times the proposed settlement of  million announced by mylan in october  republican senator chuck grassley chair of the senate judiciary committee that launched the probe of epipen pricing probe in  released the analysis on may   on the same day a group of mylan investment funds urged shareholders to vote against the reelection of the companys directors after it paid chairman robert coury over  million last year acquisition historyedit the following is an illustration of the companys major mergers and acquisitions and historical predecessors mylan   renaissance acquisition holdings dermatology div acq    meda acq    famy care acq    abbott laboratories generics div acq    merck kgaa generics div acq  renamed mylan laboratories inc   udl laboratories acq    bertek inc acq  renamed mylan technologies inc milan pharmaceuticals founded  criticismedit epipen pricingedit see also epinephrine autoinjector § cost see also heather bresch § business executive mylan acquired the right to market and distribute the epipen line of epinephrine autoinjector devices from merck kgaa as part of their  deal that right had formerly been held by dey lp a wholly owned subsidiary of merck the devices deliver about  worth of drug at that time annual sales were around m bresch the companys ceo saw an opportunity to increase sales through marketing and advocacy and the company launched a marketing campaign to increase awareness of the dangers of anaphylaxis for people with severe allergies that made the brand epipen as identified with its product as kleenex is with facial tissue the company also successfully lobbied the fda to broaden the label to include risk of anaphylaxis and in parallel successfully lobbied congress to generate legislation making epipens available in schools and in public places like defibrillators are and hired the same people that medtronic had worked with on defibrillator legislation to do so mylans efforts to gain market dominance were aided when sanofis competing product was recalled in november  and further when tevas generic competitor was rejected by the fda in march  by the first half of  mylan had an  market share of such devices in the us and in that year sales reached around b and accounted for  of mylans profit those profits were also due in part to mylans continually raising the price of epipens starting in  in  the wholesale price of two epipens was about  the price was about the same in  by july  the price about  in may  it was around  and in may  the price rose again to around  the last price increase sparked widespread outrage including criticism from martin shkreli poster boy for grasping pharma greed letters from two senators and initiation of congressional investigations and mylans pricing of the epipen was widely referred to as price gouging the last price increase coincided with a new line of tv commercials that were described as shocking and no holds barred depicting an anaphylactic reaction from the point of view of the young woman having it at a party and ending with the young woman seeing her swollen and hivecovered face in the mirror before she collapses in response to criticism mylan increased financial assistance available for some patients to purchase epipens a gesture that was called a classic public relations move by harvard medical school professor aaron kesselheim the up to  saving cards can only be used by a small number of people who need the drug and no one on medicaid they do nothing about the high price which is still being paid by insurers who ultimately pass the cost onto consumers in september  the new york state attorney general began an investigation into mylans epipenschools program in new york to determine if the programs contracts violated antitrust law and the west virginia state attorney general opened an investigation into whether mylan had given the state the correct discount under the medicaid drug rebate program and subpoenaed the company when it refused to provide the documentation the state requested in october  the ceo of mylan testified to congress that pfizerking charged mylan about  for one device in september  a silicon valley engineering consultancy performed a teardown analysis of the epipen and estimated the manufacturing and packaging costs at about  for a twopack in october  mylan announced a settlement with the us department of justice over rebates paid by mylan to states under the medicaid drug rebate program questions had been raised by congress and others about why epipen had been classified as a generic rather a proprietary product in the program since  generic drugs have lower rebates  than proprietary drugs  and price hikes for generic drugs cannot be passed onto states and a common form of pharmaceutical fraud involves misclassifying proprietary drugs as generic under the program under the agreement mylan agreed to pay a  million payment and to a sign a corporate integrity agreement requiring it to perform better in the future the settlement also resolved cases brought by states related to the rebates simultaneously with the settlement mylan also announced it was being investigated by the securities and exchange commission related to the drug rebate program in june  the new york times published an article reporting on internal mylan discussions about price increases on the epipen between  and  in which the company chairman expressed disdain for people and agencies who might criticize the company the reporter wrote those top leaders’ responses are a far cry from the message on mylan’s website which says that we challenge every member of every team to challenge the status quo and that we put people and patients first trusting that profits will follow and also noted that the firm is a case study in the limits of what consumer and employee activism as well as government oversight can achieve  execution drugsedit mylan manufactures rocuronium bromide which is approved by the state of alabama for use in executions by lethal injection european manufacturers refuse to sell drugs which can be used for executions to the united states except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain in september  the londonbased human rights organization reprieve told mylan that they were the only fdaapproved manufacturer of rocuronium bromide without legal controls in place to prevent its use in executions and there was a very real risk that mylan may soon become the goto provider of execution drugs for states across the country the german asset manager dje kapital de divested itself of  million in mylan shares for that reason mylan said that their distribution was legally compliant referencesedit  a b public filings  form k mylan investors relations retrieved august     mylan nv k for the fiscal year ended december    mylan buys part of drug maker pittsburgh business times december     mylan laboratories to acquire generics business of merck kgaa for  billion euros medical news today may     pharmaceutical giants tracking mylans prosperity the pittsburgh tribunereview august     egan matt epipen maker faces revolt over execs  million pay package cnn money   transdermal patches  mylan mylantechcom   brand name medicines  mylan deycom   about us mylancom   a b about us mylancom   matrixlabsindiacom matrixlabsindiacom   whats new  arcana arzneimittelherstellung arcanade   httpwwwmantacomcomsdnbcompanywsklv  httpwwwidairelandcomsearchcompaniesxmlssid  httpwwwbioportfoliocomnewspdfusmylantowithdrawqualimedbrandfromfrenchmarketreportpdf  a b c dearment alaric october   milan puskar cofounder of mylan dies drug store news   mylan  years young and still making history mylan retrieved april     myl stock history  mylan retrieved august     a b c d e freudenheim milt september   exposing the fda new york times   lewis ralph a  the emerging effects of the drug price competition and patent term restoration act of  journal of contemporary health law  policy   –   a b ron wolf for the philadelphia inquirer august   smithkline loses exclusive rights to drug  a b boehm garth yao lixin han liang zheng qiang september  development of the generic drug industry in the us after the hatchwaxman act of  acta pharmaceutica sinica b   – doijapsb   a b john seaman and john t landry mylan  years of unconventional success mylan in association with university press of new england  isbn  page   a b strickland carol october   bolar a drug company under siege the new york times   shaw donna february   us charges bolar pharmaceutical with misrepresenting its products philadelphia inquirer   freudenheim milt february   bolar plans guilty plea on generics the new york times   a b c pink sheet october   mylans maxzide is approvable at fda lederle to market brand competition to smithklines no ranked dyazide final approval anticipated imminently  fda approval history nda  maxzide page accessed september    reid kenneth november   us judge to rule on drug marketing journal of commerce   andrews edmund l july   fda inquiry on generic drugs focuses on changes in ingredients the new york times   cimons marlene august   fda to lift ok of last dyazide generic version los angeles times   bolar and mylan team to purchase somerset labs pink sheet november     somerset eldepryl june  approval clears way for mylanbolar acquisition pink sheet june     a b ku mannching sherry december   recent trends in specialty pharma business model journal of food and drug analysis   – doijjfda   mylan form k annual report for the financial year ending march    filed june    a b labaton stephen december   a drug maker is said to face a suit on prices the new york times   press release ftc reaches record financial settlement to settle charges of pricefixing in generic drug market  federal trade commission ftc november     labaton stephen july   genericdrug maker agrees to settlement in pricefixing case the new york times   a b creswell julie march   icahn the spoiler fortune   pollack andrew november   icahn offers  billion for mylan drug maker the new york times   okeefe eric may   icahn slate wins seats on blockbuster board the new york times   lazo shirley a survival strategy barrons   icahn drops bid for mylan los angeles times bloomberg news july     mylan signs usmil takeover deal for indias matrix laboratories ihs august     mylans acquisition of matrix business strategy case study icrm   massey steve may   mylan buys merck generic drug unit for  billion pittsburgh postgazette   press release mylan completes acquisition of generics business of merck kgaa mylan october     a b c d e f g cynthia koons and robert langreth for bloomberg businessweek september   how marketing turned the epipen into a billiondollar business  johnson carolyn y ho catherine august   how mylan the epipen company maneuvered to create a virtual monopoly the washington post via the chicago tribune   adams russell october   mylan again sues pittsburgh postgazette wall street journal retrieved august     sabatini patricia boselovic len july   mylan workers overrode drug quality controls internal report detailed pervasive practice of ignoring safety procedures pittsburgh postgazette retrieved august     edwards jim july   its not mylans first quality control beef with fda money watch cbs news retrieved august     mylan pittsburgh postgazette settle lawsuits cbs news associated press february   retrieved august     us department of justice october   press release four pharmaceutical companies pay  million for submission of false claims to medicaid  mylan acquires rights to pfizers inhaler technology drugstorenewscom retrieved may     stanton dan june   gsk breathes freely as mylan launches seretide generic in uk inpharma technologist   helfand carly february   mylan joins the advaircopycat queue but approval could be a long slog fiercepharma   swetlitz ike silverman ed august   mylan may have violated antitrust law in its epipen sales to schools pbs newshour   a b odonnell jayne september   family matters epipens had highlevel help getting into schools usa today   thomas katie february   mylan buys drug maker of generic injectables new york times   palmer eric august   updated fda castigates three mylan sterile drug plants in warning letter fiercepharma   novak matt august   how congress the fda and sarah jessica parker helped epipen become a  billion business gizmodo   abc news business news personal finance and money news  abc news abc news retrieved july     us drugmaker mylan to acquire famy care for  million timesofindiaeconomictimes february     a b duhigg charles  june  outcry over epipen prices hasn’t made them lower the new york times   koons cynthia november   mylans hostile bid for perrigo fails bloomberg   rockoff jonathan d mattioli dana april   teva offers to buy mylan for  billion wall street journal   teva to buy allergans generic drug unit bloombergcom july     chitra somayaji july   teva snaps up allergans generics arm dumping mylan bloombergcom   mylan to codevelop pulmatrix copd candidate gen   mylan to acquire meda for b  gen news highlights  gen retrieved august     mylan snaps up dermatology biz from investors in b deal  fiercepharma retrieved august     a b c tara parkerpope and rachel rabkin peachman for the new york times august   epipen price rise sparks concern for allergy sufferers  bartolotta devin august   cost jumps nearly percent for lifesaving epipens cbs baltimore retrieved august     goldberg kenny people with food allergies say lifesaving drug too expensive kpbs public media retrieved june     walker joseph winslow ron steele anne august   mylan to launch cheaper generic epipen alternative wall street journal   a b c thomas katie october   mylan to settle epipen overpricing case for  million the new york times   thomas katie   states accuse generic drug companies of price fixing the new york times retrieved    a b erman michael may   mylan may have overcharged us for epipen by  billion hhs reuters new york retrieved may     king pharmaceuticals october   press release king pharmaceuticals to acquire meridian medical technologies  carly helfand for fiercepharma march   fda swats down tevas epipen copy putting mylan in cruise control  a b emily willingham for forbes august   why did mylan hike epipen prices  because they could  emma court for marketwatch august   mylan’s epipen price increases are valeantlike in size shkrelilike in approach  brad tuttle for time august    signs that epipen prices are completely out of control  michael hiltzik for the los angeles times august   another reason to hate mylan which jacked up the price of lifesaving epipens its a tax dodger  matt novak for gizmodo august   how congress the fda and sarah jessica parker helped epipen become a  billion business  beth snyder bulik for fiercepharma may   no holds barred in mylan’s ultrarealistic peanut allergy campaign  mylan to provide epipen cost assistance as ceo is asked to testify on price hike the guardian   a b carolyn y johnson august   why mylan’s ‘savings card’ won’t make epipen cheaper for all patients washington post washington post   larson erik hopkins jared s september   mylan’s epipen school sales trigger ny antitrust probe bloomberg retrieved september     feeley jef langreth robert september   mylan investigations mount as west virginia opens fraud probe bloomberg news   popken ben september   upgraded epipens torn apart tech firm its the same core device nbc news   tracy seipel silicon valley engineers figure real cost to make lifesaving autoinjector twopack the mercury news retrieved october     thomas katie september   is epipen a brandname or a generic drug mylan casts it both ways the new york times   mole beth october   for ripping off medicaid epipen maker mylan pays feds  million ars technica retrieved october     ztracer zachary tracer october   mylan agrees to  million epipen settlement with us bloombergcom   novak matt  june  drug company chairman to america go fuck yourself gizmodo   mole beth  june  mylan chairman drug pricing critics ought to go copulate with themselves ars technica   loew derek  june  mylan begins harvesting the crop its sown in the pipeline   a b owen dyer october   drug company is targeted for refusing to adopt ban on distribution of execution drug bmj   g doibmjg  external linksedit media related to mylan at wikimedia commons business data for mylan google finance yahoo finance reuters sec filings v t e pittsburgh history timeline culture dialect media neighborhoods notable people skyscrapers government airport conventions city hall courthouse mayor council events intergov police da sheriff fire libraries transit education port regional economy allegheny conference duquesne club chamber of commerce economic club hyp club stock exchange fortune  headquarters us steel pnc ppg heinz wesco consol dicks allegheny technologies forbes largest private companies  lumber giant eagle other headquarters american bridge american eagle ampco ansys armstrong black box calgon carbon compunetix dollar bank dqe eatn park education management corporation eqt federated gnc gurucom highmark igate iron city kennametal koppers laughlin marc usa millcraft msa nichecom oxford ptc renda rue upmc vocelli wabtec shared headquarters alcoa modcloth nova chemicals subsidiary headquarters allegheny energy bayer corporation fedex ground glaxosmithkline usa lanxess respironics vivisimo westinghouse regional operations aa bny mellon formerly mellon financial dreyfus eaton spreadshirt macys historic big wheel clark dravo fisher integra mesta murphy gulf oil jl ketchum rockwell sunbeam westinghouse sports dapper dan grand prix great race head of the ohio lore marathon mylan classic regatta wphl baseball pirates wild things panthers dukes chronicletelegraph cup allegheny burghers champions crawfords filipinos grays hardhats keystones stogies rebels basketball yellow jackets panthers m panthers w dukes m dukes w colonials m colonials w roundball classic condors ironmen loendi monticello phantoms pipers piranhas pirates rens xplosion football steelers panthers steeler nation heritage colts force passion renegades  allstars allegheny americans as duquesne gladiators homestead lyceum maulers power odds olympics quakers jp stars early pro football circuit hockey penguins colonials m colonials w three rivers classic as bankers cougars duquesne ft pitt hornets keystones lyceum panthers phantoms pirates pirates wphl pros shamrocks victorias winter garden yellow jackets soccer riverhounds beadling cannons hurricanes phantoms spirit other sledgehammers bulls harlequins pcc triangles wallabies studio wrestling dirty dozen venues ppg paints arena heinz field pnc park  lumber arena fitzgerald field house highmark stadium palumbo center petersen events center petersen sports complex rooney field sewall center trees hall central park civic arena duquesne gardens exposition park forbes field josh gibson field greenlee field motor square garden pitt stadium recreation park schenley gardens three rivers winter garden parks allegheny arsenal allegheny commons allegheny riverfront artgardens buhl community chatham university arboretum frank curto frick emerald view highland market square mellon mellon green mellon square north shore riverfront phillips point of view point state ppg place riverview roberto clemente memorial rodef shalom biblical botanical garden schenley schenley plaza south shore riverfront south side three rivers west end overlook westinghouse transportation inclines steps v t e port authority of allegheny county light rail list of stations blue line – library blue line – south hills village red line inclines historical list duquesne incline monongahela incline buses and busways list of routes martin luther king jr east busway south busway west busway former lines  drake brown line patrain skybus other north shore connector port authority  series pcc wabash tunnel v t e public transportation in greater pittsburgh bus services port authority of allegheny county list of bus routes beaver butler fayette indigo mid mon valley mountain line new castle town  country university of pittsburgh washington westmoreland bus rapid transit mlk jr east busway south busway west busway light rail red line blue line library south hills village inclines duquesne monongahela amtrak capitol limited pennsylvanian airports pittsburgh international arnold palmer allegheny county beaver butler eddie dew greensburg jeannette herron jefferson jimmy stewart joe hardy lakehill monroeville new castle rock rostraver washington wheeling zelienople discontinued broadway limited brown line list of streetcar routes in pittsburgh parkway limited patrain skybus v t e tunnels and bridges in pittsburgh tunnels allegheny river tunnel armstrong tunnel cork run tunnel corliss tunnel fort pitt tunnel jl tunnel liberty tunnel mount washington transit tunnel pittsburgh and castle shannon tunnel pittsburgh  steubenville extension railroad tunnel schenley tunnel squirrel hill tunnel wabash tunnel bridges th street bridge st street bridge rd street railroad bridge th street bridge bloomfield bridge birmingham bridge david mccullough bridge fort duquesne bridge fort pitt bridge fort wayne railroad bridge glenwood bridge glenwood bo railroad bridge highland park bridge homestead grays bridge hot metal bridge liberty bridge mckees rocks bridge panhandle bridge panther hollow bridge schenley bridge senator robert d fleming bridge smithfield street bridge south tenth street bridge three sisters roberto clemente bridge andy warhol bridge rachel carson bridge veterans bridge west end bridge attractions aviary baywood cathedral of learning chinatown conservatory dippy immaculate heart duquesne incline heinz chapel little italy mellon institute mon incline observatory pamelas penn station point of view sculpture primantis science center steps uss requin zoo kennywood luna park westinghouse sign landmarks national city national county state city phlf cultural museums art arts arts festival bible fort pitt and blockhouse clayton clemente childrens frick glass center history jazz jewish mattress factory dental miller miss pittsburgh nationality rooms national map natural history soldiers and sailors warhol wilson wsg venues heinz hall benedum byham harris kellystrayhorn new hazlett oreilly foster playhouse trib hunt stage ae syria mosque nixon theater festivals anthrocon arts blues comicon fashion film folk handmade new works tekko whiskey  fine spirits wine shopping and entertainment casino gateway clipper fleet station square strip downtown oakland south side macys market square southside works waterworks mount washington east liberty squirrel hill shadyside walnut street opera ballet symphony brass classical theatre dance ensemble caravan theatre folk light opera opera theater jewish theatre public theater playwrights musical theater stage right youth ballet youth symphony bricolage nnoc v t e shopping malls in pittsburgh enclosed beaver valley mall the block northway century iii mall the galleria of mt lebanon the mall at robinson monroeville mall pittsburgh mills ross park mall south hills village station square uniontown mall warner centre washington crown center westmoreland mall lifestyle  outdoor bakery square edgewood towne centre ellsworth avenue mccandless crossing northern lights robinson town centre settlers ridge southside works walnut street the waterfront waterworks mall outlet grove city premium outlets tanger outlets pittsburgh defunct allegheny center mall east hills shopping center eastgate commerce center eastland mall greengate mall parkway center mall village square mall washington mall colleges and universities pitt carnegie mellon duquesne robert morris chatham point park carlow art institute byzantine catholic seminary pittsburgh theological seminary saint paul seminary ccac culture of pittsburgh cookie table jewish history iron city brewing company jagoff joe magarac mister rogers neighborhood mr yuk parking chairs pittsburgh left pittsburgh toilet robot hall of fame steeler nation book category portal v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlemylanoldid categories companies in the nasdaq indexcompanies listed on nasdaqcorporate inversionspharmaceutical companies of the united statescompanies in the nasdaq biotechnology indexlife sciences industryhealth care companies based in pennsylvaniacompanies listed on tasecompanies formerly listed on the new york stock exchangehidden categories use mdy dates from october all articles with unsourced statementsarticles with unsourced statements from september interlanguage link template link number navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutschespañolفارسیfrançaisעבריתportuguêssuomi edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view mylan  wikipedia mylan from wikipedia the free encyclopedia jump to navigation search mylan trading name mylan nv formerly called milan type public under dutch law traded as nasdaq myl tase myl nasdaq biotechnology component nasdaq component sp  component isin us industry pharmaceuticals founded   years ago  in white sulphur springs west virginia united states founders milan puskar don panoz headquarters canonsburg pennsylvania united states of america area served worldwide key people heather bresch ceo products generic and specialty pharmaceuticals and active pharmaceutical ingredients revenue us billion  operating income us million  net income us billion  total assets us  billion  total equity us billion  number of employees   divisions see operations subsidiaries meda famy care website wwwmylancom mylan nv is an american global generic and specialty pharmaceuticals company registered in the netherlands with principal executive offices in hatfield hertfordshire uk and global headquarters in canonsburg pennsylvania us in  mylan acquired a controlling interest in indiabased matrix laboratories limited a top producer of active pharmaceutical ingredients apis for generic drugs and the generics business of germanybased merck kgaa through these acquisitions mylan grew from the thirdlargest generic and pharmaceuticals company in the united states to the secondlargest generic and specialty pharmaceuticals company in the world in  mylans pricing of the epipen an epinephrine autoinjector became controversial and was widely referred to as price gouging as a result investigations were opened into whether mylan had misclassified the epipen under the medicaid drug rebate program a common form of pharmaceutical fraud in october  mylan settled these investigations with the us department of justice agreeing to pay  million and enter into a corporate integrity agreement concerning the rebate program in a report published on june   the institutional shareholder services criticized mylan for the outsized compensation of mylans directors former ceo robert coury received a  million  pay package in spite of the harm to the company inflicted by the epipen controversies and steep shareholder losses the report urged mylans shareholders to oust all of mylans existing directors contents  operations  location  stock  history  acquisition history  criticism  epipen pricing  execution drugs  references  external links operationsedit mylan inc operates several divisions and subsidiaries in north america and south america mylan operates mylan pharmaceuticals based in morgantown west virginia mylan pharmaceuticals ulc mylan canada mylan technologies inc mti  transdermal drug delivery systems tdds and related technologies udl laboratories inc somerset pharmaceuticals inc a research and development company in tampa florida owned by mylan somerset develops emsam manufactured by mylan technologies and marketed in the united states by dey another mylan company mylan laboratories limited campos dos goytacazes brazil in oceania and central east south and southeast asia mylan operates mylan new zealand limited  new zealand mylan laboratories limited  headquartered in hyderabad india operates nine active pharmaceutical ingredient api and intermediate manufacturing facilities located in india and china mylan seiyaku ltd  japan alphapharm  australia agila specialties pvt ltd  india oncotherapies ltd  india in europe africa and west asia mylan operates operates under the mylan name in austria belgium the czech republic denmark finland france germany hungary italy the netherlands norway poland portugal slovakia slovenia spain sweden switzerland the united kingdom also operates in south africa arcana arzneimittel gmbh  germany generics pharma hellas  greece gerard laboratories  ireland qualimed  trademark in france but will stop being marketed under the brand name docpharma  generic pharmaceutical distribution company in belgium the netherlands and luxembourg locationedit founded in  the company was first located in white sulphur springs west virginia the company moved to morgantown west virginia in  and in  it relocated its corporate headquarters to the pittsburgh suburb canonsburg pennsylvania finally in  it moved to a new office center in nearby southpointe a suburban business park located in cecil township where it is still located stockedit on february   mylan had its initial public offering ipo becoming a publicly traded company on the otc market under the ticker symbol myln in  the stock moved to nasdaq their final stock move was in  when their stock became available for trade on the new york stock exchange under the ticker symbol myl currently the stock is traded on the nasdaq historyedit mylan pharmaceuticals was founded as a drug distributor in  by milan puskar and don panoz in  mylan began manufacturing penicillin g tablets as well as vitamins and other dietary supplements panoz left mylan in  and puskar quit the company in  as it grew and experienced financial difficulties the board hired roy mcknight as board chairman who convinced puskar to return in  mylan discontinued operating as a contract manufacturing organization in  and instead chose to market their products under their own mylanlabeled brandcitation needed with the passage of the hatchwaxman act in  mylan and other small generic companies gained value in the eighteen months following passage of the law mylans earnings grew  to  million and its stock value rose  in the s one of the most prescribed drugs in the us was dyazide a diuretic that was a combination drug containing triamterene and hydrochlorothiazide it had been on the market since  and its patents had expired in  complications arose with the introductions of generics versions because the formulation of dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent some generic companies committed fraud trying to bring a generic version of dyazide bolar pharmaceutical had the first generic version approved in  but it turned out that bolar had fraudulently substituted dyazide for its own version to conduct studies that were submitted to the fda by  the fda rescinded its approval based on its suspicions and filed criminal charges against bolar to which bolar eventually pled guilty in  mylan chose to develop a new version of a triamterenehydrochlorothiazide combination drug instead of going the generic route it developed a different more stable formulation and used different dosages of each active ingredient  mg hydrochlorothiazide and  mg triamterene compared with dyazides  mg hydrochlorothiazide and  mg triamterene this drug had to get approval as a new drug as opposed to a generic their product was called maxzide and was approved in  the higher dose allowed once per day dosing which mylan and its marketing partner lederle believed would help it compete against dyazide which had m in sales in  however mylans patents on the drug were declared invalid in court and its marketing exclusivity expired in  prompting a rush of generic competition mylan had concerns about the practices of its competitors and the fda in general and also with regard to companies seeking to bring generic versions of maxzide mylan hired private investigators to examine its competitors practices and when it found evidence of corruption it submitted it to the house oversight and investigations committee which investigated and found fraud and corruption within the food and drug administrations generic drugs division and at other generic companies two of the companies that had gotten approval to market generic versions of maxzide vitarine pharmaceutical and par pharmaceutical were targets of mylans initial investigation and were found to have used mylans maxzide to obtain their bioequivalence data leading both companies to withdraw its generic competitor to mylans product the corruption in the nascent generics industry and at the office in the fda regulating it was widely covered in the media and led to widespread concern among doctors and the public in the late s and early s that generic drugs were not really the same as the branded drugs they were meant to replace in  mylan agreed to enter into a joint venture with bolar to buy somerset pharmaceuticals mylan wanted access to somersets drug discovery capabilities as well as its new drug for parkinsons selegiline the deal was completed in  but its consummation was dependent on fda approval of selegiline which came in  mylan acquired bertek inc in  for its transdermal patch technologies and kept as a subsidiary in  mylan renamed the company mylan technologies inc mti mti eventually came to be the contract manufacturer for the selegiline transdermal patch and was the first company to market generic nitroglycerin estradiol clonidine and fentanyl transdermal patches mylan acquired udl laboratories a supplier of unit dose generic medications to institutional and longterm care facilities in  in  when it was the worlds second largest generics company mylan came under investigation from the federal trade commission after it raised the prices of its products tripling them in the case of lorazepam mylan had entered into an exclusive agreement with profarmica an italian company that supplied drug ingredients after which mylans competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs before the round of price increases the price of generic drugs had been    of the price of branded drugs and afterwards it was around  the ftc filed suit at the end of  and  states filed parallel actions the case was settled in  with mylan paying a total of m  m in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid  million in attorneys fees to the state attorneys general  million plus  million in attorneys fees to settle certain class actions with insurers and managed care organizations  and mylan and three ingredient suppliers cambrex corporation profarmaco srl and gyma laboratories also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future in  mylan and king pharmaceuticals began discussing a deal in which mylan would acquire king for about b mylan wanted to expand its presence in branded pharmaceuticals and to acquire kings sales force the deal became one of the business soap operas of the year and included an sec investigation into kings accounting and carl icahn obtaining a  interest in mylan and becoming its largest stakeholder in order to kill the deal the parties called off the deal in february  icahn offered to buy mylan for b and ran a slate of board members to change the direction of mylan he won three seats in may  in june mylan bought back  of its shares in order to fend off icahn and in july icahn gave up his bid and sold his shares in august  mylan announced that it had reached agreement to buy a controlling interest in matrix laboratories an indian supplier of active pharmaceutical ingredients the deal gave mylan access to markets in india and china and was completed in january the next year in may  mylan and merck kgaa agreed that mylan would acquire mercks generics arm for b the deal was completed that october and tripled the size of mylan mylan acquired the rights to market the epipen in the transaction at that time annual sales were around  million and the epipen had about  of the market in  the company filed two lawsuits against the pittsburgh postgazette after the newspaper ran an article that was critical of the quality control procedures used at the companys morgantown plant the company had earlier quality control issues involving the fda the lawsuits were dropped in  without any damages paid by the postgazette which stated the postgazette did not find and did not intend to report that mylan had manufactured or distributed any defective drugs the postgazette regrets if any reader of the article thought otherwise also in  mylan and its subsidiary udl agreed to pay a m to settle a suit filed under the false claims act in which mylanudl and two other companies were accused of underpaying states under the medicaid drug rebate program the program requires drug companies to give rebates to states under medicaid and the rebates are higher for new drugs than for generics the suit said that the companies sold new drugs but paid rebates as if they were generics in  mylan entered into an agreement with pfizer for the exclusive worldwide rights to develop manufacture and commercialize pfizers generic equivalent to glaxosmithklines advair usseretide uk diskus incorporating pfizers proprietary dry powder inhaler delivery platform mylan launched the product in the uk in  and in february  the fda accepted its anda putting it in line behind hikma and sandoz to launch a generic version in the us in  mylan launched a program called epipenschools to sell epipens in bulk and with discounts to schools to participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year in december  the national association of state boards of education launched a policy initiative designed to help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine autoinjector access and use and advocated for state laws protecting school from legal liability for stocking and using epinephrine autoinjectors gayle manchin the mother of mylans ceo heather bresch had become president of the association in  and shortly after had discussed donations from her daughters company to the association manchin had been appointed to the west virginia state school board by her husband thengovernor of the state joe manchin in  in  mylan acquired an indian generic injectable drugs company agila specialties private for  billion in cash in  three plants acquired in that deal were issued warning letters by the fda after successful lobbying from mylan in  the school access to emergency epinephrine act became law after passing congress with broad and bipartisan support it protected anyone from liability if they administered epinephrine to a child in a school previously only trained professionals or the affected person were allowed to administer the drug and were open to liability and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them joe manchin the father of mylans ceo was a senator at that time in july  mylan and abbott laboratories announced an agreement under which mylan would buy abbotts generic drugs business in developed markets for stock valued at about  billion mylan acquired mumbaibased famy care and expand its presence in the market for womens contraceptives at about  million starting in  according to a  report in the new york times midlevel executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the epipen and raising concerns that the price increases were unethical the times reported that when these concerns were brought to robert coury the chairman of the board coury replied that he was untroubled he raised both his middle fingers and explained using colorful language that anyone criticizing mylan including its employees ought to go copulate with themselves critics in congress and on wall street he said should do the same and regulators at the food and drug administration they too deserved a round of anatomically challenging selffulfillment  the times reported that bresch provided similarly dismissive responses in april  mylan tried negotiate with the management of irish pharmaceutical firm perrigo to acquire the company and when those negotiations failed mylan attempted a hostile takeover offering to buy b in shares directly from shareholders too few shareholders agreed to sell their stock by the deadline set in november  and the effort failed two weeks after mylan made its first offer for perrigo teva pharmaceutical offered to buy mylan for b the combined companies would have been the worlds largest generic company and the th biggest drug company in the world in july teva dropped its bid for mylan and instead acquired allergans generic drug business for about the same price in june  mylan agreed to work with pulmatrix a company with a proprietary inhaled drug delivery platform to codevelop a product to treat for chronic obstructive pulmonary disease the product was pur a generic drug in a pulmatrix device in february  the company announced it would acquire meda for  billion in may of the same year the company announced it would acquire renaissance acquisition holdings dermatology division for up to  billion in  mylan had about b in sales of epipens and those sales accounted for  of mylans profit mylan had maintained about a  market share since it had acquired the product and had continually raised the price of epipens starting in  in  the wholesale price of two epipens was about  by july  the price was about  in may  it was around  and in may  the price rose again to around  around a  jump from the price in  in the summer of  as parents prepared to send their children back to school and went to pharmacies to get new epipens people began to express outrage at the cost of the epipen and mylan was widely and harshly criticized the price hikes led to investigations by congress and states attorneys general in october  mylan agreed to pay a m fine related to incorrect rebates it paid under the medicaid drug rebate program in december  the attorneys general of  states filed a civil complaint accusing mylan of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug the complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings telephone calls and text messages according to the department of health and human services office of inspector general analysis the us government may have overpaid as much as  billion between  and  to drugmaker mylan nv for the epipen emergency allergy treatment this represents three times the proposed settlement of  million announced by mylan in october  republican senator chuck grassley chair of the senate judiciary committee that launched the probe of epipen pricing probe in  released the analysis on may   on the same day a group of mylan investment funds urged shareholders to vote against the reelection of the companys directors after it paid chairman robert coury over  million last year acquisition historyedit the following is an illustration of the companys major mergers and acquisitions and historical predecessors mylan   renaissance acquisition holdings dermatology div acq    meda acq    famy care acq    abbott laboratories generics div acq    merck kgaa generics div acq  renamed mylan laboratories inc   udl laboratories acq    bertek inc acq  renamed mylan technologies inc milan pharmaceuticals founded  criticismedit epipen pricingedit see also epinephrine autoinjector § cost see also heather bresch § business executive mylan acquired the right to market and distribute the epipen line of epinephrine autoinjector devices from merck kgaa as part of their  deal that right had formerly been held by dey lp a wholly owned subsidiary of merck the devices deliver about  worth of drug at that time annual sales were around m bresch the companys ceo saw an opportunity to increase sales through marketing and advocacy and the company launched a marketing campaign to increase awareness of the dangers of anaphylaxis for people with severe allergies that made the brand epipen as identified with its product as kleenex is with facial tissue the company also successfully lobbied the fda to broaden the label to include risk of anaphylaxis and in parallel successfully lobbied congress to generate legislation making epipens available in schools and in public places like defibrillators are and hired the same people that medtronic had worked with on defibrillator legislation to do so mylans efforts to gain market dominance were aided when sanofis competing product was recalled in november  and further when tevas generic competitor was rejected by the fda in march  by the first half of  mylan had an  market share of such devices in the us and in that year sales reached around b and accounted for  of mylans profit those profits were also due in part to mylans continually raising the price of epipens starting in  in  the wholesale price of two epipens was about  the price was about the same in  by july  the price about  in may  it was around  and in may  the price rose again to around  the last price increase sparked widespread outrage including criticism from martin shkreli poster boy for grasping pharma greed letters from two senators and initiation of congressional investigations and mylans pricing of the epipen was widely referred to as price gouging the last price increase coincided with a new line of tv commercials that were described as shocking and no holds barred depicting an anaphylactic reaction from the point of view of the young woman having it at a party and ending with the young woman seeing her swollen and hivecovered face in the mirror before she collapses in response to criticism mylan increased financial assistance available for some patients to purchase epipens a gesture that was called a classic public relations move by harvard medical school professor aaron kesselheim the up to  saving cards can only be used by a small number of people who need the drug and no one on medicaid they do nothing about the high price which is still being paid by insurers who ultimately pass the cost onto consumers in september  the new york state attorney general began an investigation into mylans epipenschools program in new york to determine if the programs contracts violated antitrust law and the west virginia state attorney general opened an investigation into whether mylan had given the state the correct discount under the medicaid drug rebate program and subpoenaed the company when it refused to provide the documentation the state requested in october  the ceo of mylan testified to congress that pfizerking charged mylan about  for one device in september  a silicon valley engineering consultancy performed a teardown analysis of the epipen and estimated the manufacturing and packaging costs at about  for a twopack in october  mylan announced a settlement with the us department of justice over rebates paid by mylan to states under the medicaid drug rebate program questions had been raised by congress and others about why epipen had been classified as a generic rather a proprietary product in the program since  generic drugs have lower rebates  than proprietary drugs  and price hikes for generic drugs cannot be passed onto states and a common form of pharmaceutical fraud involves misclassifying proprietary drugs as generic under the program under the agreement mylan agreed to pay a  million payment and to a sign a corporate integrity agreement requiring it to perform better in the future the settlement also resolved cases brought by states related to the rebates simultaneously with the settlement mylan also announced it was being investigated by the securities and exchange commission related to the drug rebate program in june  the new york times published an article reporting on internal mylan discussions about price increases on the epipen between  and  in which the company chairman expressed disdain for people and agencies who might criticize the company the reporter wrote those top leaders’ responses are a far cry from the message on mylan’s website which says that we challenge every member of every team to challenge the status quo and that we put people and patients first trusting that profits will follow and also noted that the firm is a case study in the limits of what consumer and employee activism as well as government oversight can achieve  execution drugsedit mylan manufactures rocuronium bromide which is approved by the state of alabama for use in executions by lethal injection european manufacturers refuse to sell drugs which can be used for executions to the united states except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain in september  the londonbased human rights organization reprieve told mylan that they were the only fdaapproved manufacturer of rocuronium bromide without legal controls in place to prevent its use in executions and there was a very real risk that mylan may soon become the goto provider of execution drugs for states across the country the german asset manager dje kapital de divested itself of  million in mylan shares for that reason mylan said that their distribution was legally compliant referencesedit  a b public filings  form k mylan investors relations retrieved august     mylan nv k for the fiscal year ended december    mylan buys part of drug maker pittsburgh business times december     mylan laboratories to acquire generics business of merck kgaa for  billion euros medical news today may     pharmaceutical giants tracking mylans prosperity the pittsburgh tribunereview august     egan matt epipen maker faces revolt over execs  million pay package cnn money   transdermal patches  mylan mylantechcom   brand name medicines  mylan deycom   about us mylancom   a b about us mylancom   matrixlabsindiacom matrixlabsindiacom   whats new  arcana arzneimittelherstellung arcanade   httpwwwmantacomcomsdnbcompanywsklv  httpwwwidairelandcomsearchcompaniesxmlssid  httpwwwbioportfoliocomnewspdfusmylantowithdrawqualimedbrandfromfrenchmarketreportpdf  a b c dearment alaric october   milan puskar cofounder of mylan dies drug store news   mylan  years young and still making history mylan retrieved april     myl stock history  mylan retrieved august     a b c d e freudenheim milt september   exposing the fda new york times   lewis ralph a  the emerging effects of the drug price competition and patent term restoration act of  journal of contemporary health law  policy   –   a b ron wolf for the philadelphia inquirer august   smithkline loses exclusive rights to drug  a b boehm garth yao lixin han liang zheng qiang september  development of the generic drug industry in the us after the hatchwaxman act of  acta pharmaceutica sinica b   – doijapsb   a b john seaman and john t landry mylan  years of unconventional success mylan in association with university press of new england  isbn  page   a b strickland carol october   bolar a drug company under siege the new york times   shaw donna february   us charges bolar pharmaceutical with misrepresenting its products philadelphia inquirer   freudenheim milt february   bolar plans guilty plea on generics the new york times   a b c pink sheet october   mylans maxzide is approvable at fda lederle to market brand competition to smithklines no ranked dyazide final approval anticipated imminently  fda approval history nda  maxzide page accessed september    reid kenneth november   us judge to rule on drug marketing journal of commerce   andrews edmund l july   fda inquiry on generic drugs focuses on changes in ingredients the new york times   cimons marlene august   fda to lift ok of last dyazide generic version los angeles times   bolar and mylan team to purchase somerset labs pink sheet november     somerset eldepryl june  approval clears way for mylanbolar acquisition pink sheet june     a b ku mannching sherry december   recent trends in specialty pharma business model journal of food and drug analysis   – doijjfda   mylan form k annual report for the financial year ending march    filed june    a b labaton stephen december   a drug maker is said to face a suit on prices the new york times   press release ftc reaches record financial settlement to settle charges of pricefixing in generic drug market  federal trade commission ftc november     labaton stephen july   genericdrug maker agrees to settlement in pricefixing case the new york times   a b creswell julie march   icahn the spoiler fortune   pollack andrew november   icahn offers  billion for mylan drug maker the new york times   okeefe eric may   icahn slate wins seats on blockbuster board the new york times   lazo shirley a survival strategy barrons   icahn drops bid for mylan los angeles times bloomberg news july     mylan signs usmil takeover deal for indias matrix laboratories ihs august     mylans acquisition of matrix business strategy case study icrm   massey steve may   mylan buys merck generic drug unit for  billion pittsburgh postgazette   press release mylan completes acquisition of generics business of merck kgaa mylan october     a b c d e f g cynthia koons and robert langreth for bloomberg businessweek september   how marketing turned the epipen into a billiondollar business  johnson carolyn y ho catherine august   how mylan the epipen company maneuvered to create a virtual monopoly the washington post via the chicago tribune   adams russell october   mylan again sues pittsburgh postgazette wall street journal retrieved august     sabatini patricia boselovic len july   mylan workers overrode drug quality controls internal report detailed pervasive practice of ignoring safety procedures pittsburgh postgazette retrieved august     edwards jim july   its not mylans first quality control beef with fda money watch cbs news retrieved august     mylan pittsburgh postgazette settle lawsuits cbs news associated press february   retrieved august     us department of justice october   press release four pharmaceutical companies pay  million for submission of false claims to medicaid  mylan acquires rights to pfizers inhaler technology drugstorenewscom retrieved may     stanton dan june   gsk breathes freely as mylan launches seretide generic in uk inpharma technologist   helfand carly february   mylan joins the advaircopycat queue but approval could be a long slog fiercepharma   swetlitz ike silverman ed august   mylan may have violated antitrust law in its epipen sales to schools pbs newshour   a b odonnell jayne september   family matters epipens had highlevel help getting into schools usa today   thomas katie february   mylan buys drug maker of generic injectables new york times   palmer eric august   updated fda castigates three mylan sterile drug plants in warning letter fiercepharma   novak matt august   how congress the fda and sarah jessica parker helped epipen become a  billion business gizmodo   abc news business news personal finance and money news  abc news abc news retrieved july     us drugmaker mylan to acquire famy care for  million timesofindiaeconomictimes february     a b duhigg charles  june  outcry over epipen prices hasn’t made them lower the new york times   koons cynthia november   mylans hostile bid for perrigo fails bloomberg   rockoff jonathan d mattioli dana april   teva offers to buy mylan for  billion wall street journal   teva to buy allergans generic drug unit bloombergcom july     chitra somayaji july   teva snaps up allergans generics arm dumping mylan bloombergcom   mylan to codevelop pulmatrix copd candidate gen   mylan to acquire meda for b  gen news highlights  gen retrieved august     mylan snaps up dermatology biz from investors in b deal  fiercepharma retrieved august     a b c tara parkerpope and rachel rabkin peachman for the new york times august   epipen price rise sparks concern for allergy sufferers  bartolotta devin august   cost jumps nearly percent for lifesaving epipens cbs baltimore retrieved august     goldberg kenny people with food allergies say lifesaving drug too expensive kpbs public media retrieved june     walker joseph winslow ron steele anne august   mylan to launch cheaper generic epipen alternative wall street journal   a b c thomas katie october   mylan to settle epipen overpricing case for  million the new york times   thomas katie   states accuse generic drug companies of price fixing the new york times retrieved    a b erman michael may   mylan may have overcharged us for epipen by  billion hhs reuters new york retrieved may     king pharmaceuticals october   press release king pharmaceuticals to acquire meridian medical technologies  carly helfand for fiercepharma march   fda swats down tevas epipen copy putting mylan in cruise control  a b emily willingham for forbes august   why did mylan hike epipen prices  because they could  emma court for marketwatch august   mylan’s epipen price increases are valeantlike in size shkrelilike in approach  brad tuttle for time august    signs that epipen prices are completely out of control  michael hiltzik for the los angeles times august   another reason to hate mylan which jacked up the price of lifesaving epipens its a tax dodger  matt novak for gizmodo august   how congress the fda and sarah jessica parker helped epipen become a  billion business  beth snyder bulik for fiercepharma may   no holds barred in mylan’s ultrarealistic peanut allergy campaign  mylan to provide epipen cost assistance as ceo is asked to testify on price hike the guardian   a b carolyn y johnson august   why mylan’s ‘savings card’ won’t make epipen cheaper for all patients washington post washington post   larson erik hopkins jared s september   mylan’s epipen school sales trigger ny antitrust probe bloomberg retrieved september     feeley jef langreth robert september   mylan investigations mount as west virginia opens fraud probe bloomberg news   popken ben september   upgraded epipens torn apart tech firm its the same core device nbc news   tracy seipel silicon valley engineers figure real cost to make lifesaving autoinjector twopack the mercury news retrieved october     thomas katie september   is epipen a brandname or a generic drug mylan casts it both ways the new york times   mole beth october   for ripping off medicaid epipen maker mylan pays feds  million ars technica retrieved october     ztracer zachary tracer october   mylan agrees to  million epipen settlement with us bloombergcom   novak matt  june  drug company chairman to america go fuck yourself gizmodo   mole beth  june  mylan chairman drug pricing critics ought to go copulate with themselves ars technica   loew derek  june  mylan begins harvesting the crop its sown in the pipeline   a b owen dyer october   drug company is targeted for refusing to adopt ban on distribution of execution drug bmj   g doibmjg  external linksedit media related to mylan at wikimedia commons business data for mylan google finance yahoo finance reuters sec filings v t e pittsburgh history timeline culture dialect media neighborhoods notable people skyscrapers government airport conventions city hall courthouse mayor council events intergov police da sheriff fire libraries transit education port regional economy allegheny conference duquesne club chamber of commerce economic club hyp club stock exchange fortune  headquarters us steel pnc ppg heinz wesco consol dicks allegheny technologies forbes largest private companies  lumber giant eagle other headquarters american bridge american eagle ampco ansys armstrong black box calgon carbon compunetix dollar bank dqe eatn park education management corporation eqt federated gnc gurucom highmark igate iron city kennametal koppers laughlin marc usa millcraft msa nichecom oxford ptc renda rue upmc vocelli wabtec shared headquarters alcoa modcloth nova chemicals subsidiary headquarters allegheny energy bayer corporation fedex ground glaxosmithkline usa lanxess respironics vivisimo westinghouse regional operations aa bny mellon formerly mellon financial dreyfus eaton spreadshirt macys historic big wheel clark dravo fisher integra mesta murphy gulf oil jl ketchum rockwell sunbeam westinghouse sports dapper dan grand prix great race head of the ohio lore marathon mylan classic regatta wphl baseball pirates wild things panthers dukes chronicletelegraph cup allegheny burghers champions crawfords filipinos grays hardhats keystones stogies rebels basketball yellow jackets panthers m panthers w dukes m dukes w colonials m colonials w roundball classic condors ironmen loendi monticello phantoms pipers piranhas pirates rens xplosion football steelers panthers steeler nation heritage colts force passion renegades  allstars allegheny americans as duquesne gladiators homestead lyceum maulers power odds olympics quakers jp stars early pro football circuit hockey penguins colonials m colonials w three rivers classic as bankers cougars duquesne ft pitt hornets keystones lyceum panthers phantoms pirates pirates wphl pros shamrocks victorias winter garden yellow jackets soccer riverhounds beadling cannons hurricanes phantoms spirit other sledgehammers bulls harlequins pcc triangles wallabies studio wrestling dirty dozen venues ppg paints arena heinz field pnc park  lumber arena fitzgerald field house highmark stadium palumbo center petersen events center petersen sports complex rooney field sewall center trees hall central park civic arena duquesne gardens exposition park forbes field josh gibson field greenlee field motor square garden pitt stadium recreation park schenley gardens three rivers winter garden parks allegheny arsenal allegheny commons allegheny riverfront artgardens buhl community chatham university arboretum frank curto frick emerald view highland market square mellon mellon green mellon square north shore riverfront phillips point of view point state ppg place riverview roberto clemente memorial rodef shalom biblical botanical garden schenley schenley plaza south shore riverfront south side three rivers west end overlook westinghouse transportation inclines steps v t e port authority of allegheny county light rail list of stations blue line – library blue line – south hills village red line inclines historical list duquesne incline monongahela incline buses and busways list of routes martin luther king jr east busway south busway west busway former lines  drake brown line patrain skybus other north shore connector port authority  series pcc wabash tunnel v t e public transportation in greater pittsburgh bus services port authority of allegheny county list of bus routes beaver butler fayette indigo mid mon valley mountain line new castle town  country university of pittsburgh washington westmoreland bus rapid transit mlk jr east busway south busway west busway light rail red line blue line library south hills village inclines duquesne monongahela amtrak capitol limited pennsylvanian airports pittsburgh international arnold palmer allegheny county beaver butler eddie dew greensburg jeannette herron jefferson jimmy stewart joe hardy lakehill monroeville new castle rock rostraver washington wheeling zelienople discontinued broadway limited brown line list of streetcar routes in pittsburgh parkway limited patrain skybus v t e tunnels and bridges in pittsburgh tunnels allegheny river tunnel armstrong tunnel cork run tunnel corliss tunnel fort pitt tunnel jl tunnel liberty tunnel mount washington transit tunnel pittsburgh and castle shannon tunnel pittsburgh  steubenville extension railroad tunnel schenley tunnel squirrel hill tunnel wabash tunnel bridges th street bridge st street bridge rd street railroad bridge th street bridge bloomfield bridge birmingham bridge david mccullough bridge fort duquesne bridge fort pitt bridge fort wayne railroad bridge glenwood bridge glenwood bo railroad bridge highland park bridge homestead grays bridge hot metal bridge liberty bridge mckees rocks bridge panhandle bridge panther hollow bridge schenley bridge senator robert d fleming bridge smithfield street bridge south tenth street bridge three sisters roberto clemente bridge andy warhol bridge rachel carson bridge veterans bridge west end bridge attractions aviary baywood cathedral of learning chinatown conservatory dippy immaculate heart duquesne incline heinz chapel little italy mellon institute mon incline observatory pamelas penn station point of view sculpture primantis science center steps uss requin zoo kennywood luna park westinghouse sign landmarks national city national county state city phlf cultural museums art arts arts festival bible fort pitt and blockhouse clayton clemente childrens frick glass center history jazz jewish mattress factory dental miller miss pittsburgh nationality rooms national map natural history soldiers and sailors warhol wilson wsg venues heinz hall benedum byham harris kellystrayhorn new hazlett oreilly foster playhouse trib hunt stage ae syria mosque nixon theater festivals anthrocon arts blues comicon fashion film folk handmade new works tekko whiskey  fine spirits wine shopping and entertainment casino gateway clipper fleet station square strip downtown oakland south side macys market square southside works waterworks mount washington east liberty squirrel hill shadyside walnut street opera ballet symphony brass classical theatre dance ensemble caravan theatre folk light opera opera theater jewish theatre public theater playwrights musical theater stage right youth ballet youth symphony bricolage nnoc v t e shopping malls in pittsburgh enclosed beaver valley mall the block northway century iii mall the galleria of mt lebanon the mall at robinson monroeville mall pittsburgh mills ross park mall south hills village station square uniontown mall warner centre washington crown center westmoreland mall lifestyle  outdoor bakery square edgewood towne centre ellsworth avenue mccandless crossing northern lights robinson town centre settlers ridge southside works walnut street the waterfront waterworks mall outlet grove city premium outlets tanger outlets pittsburgh defunct allegheny center mall east hills shopping center eastgate commerce center eastland mall greengate mall parkway center mall village square mall washington mall colleges and universities pitt carnegie mellon duquesne robert morris chatham point park carlow art institute byzantine catholic seminary pittsburgh theological seminary saint paul seminary ccac culture of pittsburgh cookie table jewish history iron city brewing company jagoff joe magarac mister rogers neighborhood mr yuk parking chairs pittsburgh left pittsburgh toilet robot hall of fame steeler nation book category portal v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlemylanoldid categories companies in the nasdaq indexcompanies listed on nasdaqcorporate inversionspharmaceutical companies of the united statescompanies in the nasdaq biotechnology indexlife sciences industryhealth care companies based in pennsylvaniacompanies listed on tasecompanies formerly listed on the new york stock exchangehidden categories use mdy dates from october all articles with unsourced statementsarticles with unsourced statements from september interlanguage link template link number navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutschespañolفارسیfrançaisעבריתportuguêssuomi edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view mylan  wikipedia mylan from wikipedia the free encyclopedia jump to navigation search mylan trading name mylan nv formerly called milan type public under dutch law traded as nasdaq myl tase myl nasdaq biotechnology component nasdaq component sp  component isin us industry pharmaceuticals founded   years ago  in white sulphur springs west virginia united states founders milan puskar don panoz headquarters canonsburg pennsylvania united states of america area served worldwide key people heather bresch ceo products generic and specialty pharmaceuticals and active pharmaceutical ingredients revenue us billion  operating income us million  net income us billion  total assets us  billion  total equity us billion  number of employees   divisions see operations subsidiaries meda famy care website wwwmylancom mylan nv is an american global generic and specialty pharmaceuticals company registered in the netherlands with principal executive offices in hatfield hertfordshire uk and global headquarters in canonsburg pennsylvania us in  mylan acquired a controlling interest in indiabased matrix laboratories limited a top producer of active pharmaceutical ingredients apis for generic drugs and the generics business of germanybased merck kgaa through these acquisitions mylan grew from the thirdlargest generic and pharmaceuticals company in the united states to the secondlargest generic and specialty pharmaceuticals company in the world in  mylans pricing of the epipen an epinephrine autoinjector became controversial and was widely referred to as price gouging as a result investigations were opened into whether mylan had misclassified the epipen under the medicaid drug rebate program a common form of pharmaceutical fraud in october  mylan settled these investigations with the us department of justice agreeing to pay  million and enter into a corporate integrity agreement concerning the rebate program in a report published on june   the institutional shareholder services criticized mylan for the outsized compensation of mylans directors former ceo robert coury received a  million  pay package in spite of the harm to the company inflicted by the epipen controversies and steep shareholder losses the report urged mylans shareholders to oust all of mylans existing directors contents  operations  location  stock  history  acquisition history  criticism  epipen pricing  execution drugs  references  external links operationsedit mylan inc operates several divisions and subsidiaries in north america and south america mylan operates mylan pharmaceuticals based in morgantown west virginia mylan pharmaceuticals ulc mylan canada mylan technologies inc mti  transdermal drug delivery systems tdds and related technologies udl laboratories inc somerset pharmaceuticals inc a research and development company in tampa florida owned by mylan somerset develops emsam manufactured by mylan technologies and marketed in the united states by dey another mylan company mylan laboratories limited campos dos goytacazes brazil in oceania and central east south and southeast asia mylan operates mylan new zealand limited  new zealand mylan laboratories limited  headquartered in hyderabad india operates nine active pharmaceutical ingredient api and intermediate manufacturing facilities located in india and china mylan seiyaku ltd  japan alphapharm  australia agila specialties pvt ltd  india oncotherapies ltd  india in europe africa and west asia mylan operates operates under the mylan name in austria belgium the czech republic denmark finland france germany hungary italy the netherlands norway poland portugal slovakia slovenia spain sweden switzerland the united kingdom also operates in south africa arcana arzneimittel gmbh  germany generics pharma hellas  greece gerard laboratories  ireland qualimed  trademark in france but will stop being marketed under the brand name docpharma  generic pharmaceutical distribution company in belgium the netherlands and luxembourg locationedit founded in  the company was first located in white sulphur springs west virginia the company moved to morgantown west virginia in  and in  it relocated its corporate headquarters to the pittsburgh suburb canonsburg pennsylvania finally in  it moved to a new office center in nearby southpointe a suburban business park located in cecil township where it is still located stockedit on february   mylan had its initial public offering ipo becoming a publicly traded company on the otc market under the ticker symbol myln in  the stock moved to nasdaq their final stock move was in  when their stock became available for trade on the new york stock exchange under the ticker symbol myl currently the stock is traded on the nasdaq historyedit mylan pharmaceuticals was founded as a drug distributor in  by milan puskar and don panoz in  mylan began manufacturing penicillin g tablets as well as vitamins and other dietary supplements panoz left mylan in  and puskar quit the company in  as it grew and experienced financial difficulties the board hired roy mcknight as board chairman who convinced puskar to return in  mylan discontinued operating as a contract manufacturing organization in  and instead chose to market their products under their own mylanlabeled brandcitation needed with the passage of the hatchwaxman act in  mylan and other small generic companies gained value in the eighteen months following passage of the law mylans earnings grew  to  million and its stock value rose  in the s one of the most prescribed drugs in the us was dyazide a diuretic that was a combination drug containing triamterene and hydrochlorothiazide it had been on the market since  and its patents had expired in  complications arose with the introductions of generics versions because the formulation of dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent some generic companies committed fraud trying to bring a generic version of dyazide bolar pharmaceutical had the first generic version approved in  but it turned out that bolar had fraudulently substituted dyazide for its own version to conduct studies that were submitted to the fda by  the fda rescinded its approval based on its suspicions and filed criminal charges against bolar to which bolar eventually pled guilty in  mylan chose to develop a new version of a triamterenehydrochlorothiazide combination drug instead of going the generic route it developed a different more stable formulation and used different dosages of each active ingredient  mg hydrochlorothiazide and  mg triamterene compared with dyazides  mg hydrochlorothiazide and  mg triamterene this drug had to get approval as a new drug as opposed to a generic their product was called maxzide and was approved in  the higher dose allowed once per day dosing which mylan and its marketing partner lederle believed would help it compete against dyazide which had m in sales in  however mylans patents on the drug were declared invalid in court and its marketing exclusivity expired in  prompting a rush of generic competition mylan had concerns about the practices of its competitors and the fda in general and also with regard to companies seeking to bring generic versions of maxzide mylan hired private investigators to examine its competitors practices and when it found evidence of corruption it submitted it to the house oversight and investigations committee which investigated and found fraud and corruption within the food and drug administrations generic drugs division and at other generic companies two of the companies that had gotten approval to market generic versions of maxzide vitarine pharmaceutical and par pharmaceutical were targets of mylans initial investigation and were found to have used mylans maxzide to obtain their bioequivalence data leading both companies to withdraw its generic competitor to mylans product the corruption in the nascent generics industry and at the office in the fda regulating it was widely covered in the media and led to widespread concern among doctors and the public in the late s and early s that generic drugs were not really the same as the branded drugs they were meant to replace in  mylan agreed to enter into a joint venture with bolar to buy somerset pharmaceuticals mylan wanted access to somersets drug discovery capabilities as well as its new drug for parkinsons selegiline the deal was completed in  but its consummation was dependent on fda approval of selegiline which came in  mylan acquired bertek inc in  for its transdermal patch technologies and kept as a subsidiary in  mylan renamed the company mylan technologies inc mti mti eventually came to be the contract manufacturer for the selegiline transdermal patch and was the first company to market generic nitroglycerin estradiol clonidine and fentanyl transdermal patches mylan acquired udl laboratories a supplier of unit dose generic medications to institutional and longterm care facilities in  in  when it was the worlds second largest generics company mylan came under investigation from the federal trade commission after it raised the prices of its products tripling them in the case of lorazepam mylan had entered into an exclusive agreement with profarmica an italian company that supplied drug ingredients after which mylans competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs before the round of price increases the price of generic drugs had been    of the price of branded drugs and afterwards it was around  the ftc filed suit at the end of  and  states filed parallel actions the case was settled in  with mylan paying a total of m  m in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid  million in attorneys fees to the state attorneys general  million plus  million in attorneys fees to settle certain class actions with insurers and managed care organizations  and mylan and three ingredient suppliers cambrex corporation profarmaco srl and gyma laboratories also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future in  mylan and king pharmaceuticals began discussing a deal in which mylan would acquire king for about b mylan wanted to expand its presence in branded pharmaceuticals and to acquire kings sales force the deal became one of the business soap operas of the year and included an sec investigation into kings accounting and carl icahn obtaining a  interest in mylan and becoming its largest stakeholder in order to kill the deal the parties called off the deal in february  icahn offered to buy mylan for b and ran a slate of board members to change the direction of mylan he won three seats in may  in june mylan bought back  of its shares in order to fend off icahn and in july icahn gave up his bid and sold his shares in august  mylan announced that it had reached agreement to buy a controlling interest in matrix laboratories an indian supplier of active pharmaceutical ingredients the deal gave mylan access to markets in india and china and was completed in january the next year in may  mylan and merck kgaa agreed that mylan would acquire mercks generics arm for b the deal was completed that october and tripled the size of mylan mylan acquired the rights to market the epipen in the transaction at that time annual sales were around  million and the epipen had about  of the market in  the company filed two lawsuits against the pittsburgh postgazette after the newspaper ran an article that was critical of the quality control procedures used at the companys morgantown plant the company had earlier quality control issues involving the fda the lawsuits were dropped in  without any damages paid by the postgazette which stated the postgazette did not find and did not intend to report that mylan had manufactured or distributed any defective drugs the postgazette regrets if any reader of the article thought otherwise also in  mylan and its subsidiary udl agreed to pay a m to settle a suit filed under the false claims act in which mylanudl and two other companies were accused of underpaying states under the medicaid drug rebate program the program requires drug companies to give rebates to states under medicaid and the rebates are higher for new drugs than for generics the suit said that the companies sold new drugs but paid rebates as if they were generics in  mylan entered into an agreement with pfizer for the exclusive worldwide rights to develop manufacture and commercialize pfizers generic equivalent to glaxosmithklines advair usseretide uk diskus incorporating pfizers proprietary dry powder inhaler delivery platform mylan launched the product in the uk in  and in february  the fda accepted its anda putting it in line behind hikma and sandoz to launch a generic version in the us in  mylan launched a program called epipenschools to sell epipens in bulk and with discounts to schools to participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year in december  the national association of state boards of education launched a policy initiative designed to help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine autoinjector access and use and advocated for state laws protecting school from legal liability for stocking and using epinephrine autoinjectors gayle manchin the mother of mylans ceo heather bresch had become president of the association in  and shortly after had discussed donations from her daughters company to the association manchin had been appointed to the west virginia state school board by her husband thengovernor of the state joe manchin in  in  mylan acquired an indian generic injectable drugs company agila specialties private for  billion in cash in  three plants acquired in that deal were issued warning letters by the fda after successful lobbying from mylan in  the school access to emergency epinephrine act became law after passing congress with broad and bipartisan support it protected anyone from liability if they administered epinephrine to a child in a school previously only trained professionals or the affected person were allowed to administer the drug and were open to liability and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them joe manchin the father of mylans ceo was a senator at that time in july  mylan and abbott laboratories announced an agreement under which mylan would buy abbotts generic drugs business in developed markets for stock valued at about  billion mylan acquired mumbaibased famy care and expand its presence in the market for womens contraceptives at about  million starting in  according to a  report in the new york times midlevel executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the epipen and raising concerns that the price increases were unethical the times reported that when these concerns were brought to robert coury the chairman of the board coury replied that he was untroubled he raised both his middle fingers and explained using colorful language that anyone criticizing mylan including its employees ought to go copulate with themselves critics in congress and on wall street he said should do the same and regulators at the food and drug administration they too deserved a round of anatomically challenging selffulfillment  the times reported that bresch provided similarly dismissive responses in april  mylan tried negotiate with the management of irish pharmaceutical firm perrigo to acquire the company and when those negotiations failed mylan attempted a hostile takeover offering to buy b in shares directly from shareholders too few shareholders agreed to sell their stock by the deadline set in november  and the effort failed two weeks after mylan made its first offer for perrigo teva pharmaceutical offered to buy mylan for b the combined companies would have been the worlds largest generic company and the th biggest drug company in the world in july teva dropped its bid for mylan and instead acquired allergans generic drug business for about the same price in june  mylan agreed to work with pulmatrix a company with a proprietary inhaled drug delivery platform to codevelop a product to treat for chronic obstructive pulmonary disease the product was pur a generic drug in a pulmatrix device in february  the company announced it would acquire meda for  billion in may of the same year the company announced it would acquire renaissance acquisition holdings dermatology division for up to  billion in  mylan had about b in sales of epipens and those sales accounted for  of mylans profit mylan had maintained about a  market share since it had acquired the product and had continually raised the price of epipens starting in  in  the wholesale price of two epipens was about  by july  the price was about  in may  it was around  and in may  the price rose again to around  around a  jump from the price in  in the summer of  as parents prepared to send their children back to school and went to pharmacies to get new epipens people began to express outrage at the cost of the epipen and mylan was widely and harshly criticized the price hikes led to investigations by congress and states attorneys general in october  mylan agreed to pay a m fine related to incorrect rebates it paid under the medicaid drug rebate program in december  the attorneys general of  states filed a civil complaint accusing mylan of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug the complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings telephone calls and text messages according to the department of health and human services office of inspector general analysis the us government may have overpaid as much as  billion between  and  to drugmaker mylan nv for the epipen emergency allergy treatment this represents three times the proposed settlement of  million announced by mylan in october  republican senator chuck grassley chair of the senate judiciary committee that launched the probe of epipen pricing probe in  released the analysis on may   on the same day a group of mylan investment funds urged shareholders to vote against the reelection of the companys directors after it paid chairman robert coury over  million last year acquisition historyedit the following is an illustration of the companys major mergers and acquisitions and historical predecessors mylan   renaissance acquisition holdings dermatology div acq    meda acq    famy care acq    abbott laboratories generics div acq    merck kgaa generics div acq  renamed mylan laboratories inc   udl laboratories acq    bertek inc acq  renamed mylan technologies inc milan pharmaceuticals founded  criticismedit epipen pricingedit see also epinephrine autoinjector § cost see also heather bresch § business executive mylan acquired the right to market and distribute the epipen line of epinephrine autoinjector devices from merck kgaa as part of their  deal that right had formerly been held by dey lp a wholly owned subsidiary of merck the devices deliver about  worth of drug at that time annual sales were around m bresch the companys ceo saw an opportunity to increase sales through marketing and advocacy and the company launched a marketing campaign to increase awareness of the dangers of anaphylaxis for people with severe allergies that made the brand epipen as identified with its product as kleenex is with facial tissue the company also successfully lobbied the fda to broaden the label to include risk of anaphylaxis and in parallel successfully lobbied congress to generate legislation making epipens available in schools and in public places like defibrillators are and hired the same people that medtronic had worked with on defibrillator legislation to do so mylans efforts to gain market dominance were aided when sanofis competing product was recalled in november  and further when tevas generic competitor was rejected by the fda in march  by the first half of  mylan had an  market share of such devices in the us and in that year sales reached around b and accounted for  of mylans profit those profits were also due in part to mylans continually raising the price of epipens starting in  in  the wholesale price of two epipens was about  the price was about the same in  by july  the price about  in may  it was around  and in may  the price rose again to around  the last price increase sparked widespread outrage including criticism from martin shkreli poster boy for grasping pharma greed letters from two senators and initiation of congressional investigations and mylans pricing of the epipen was widely referred to as price gouging the last price increase coincided with a new line of tv commercials that were described as shocking and no holds barred depicting an anaphylactic reaction from the point of view of the young woman having it at a party and ending with the young woman seeing her swollen and hivecovered face in the mirror before she collapses in response to criticism mylan increased financial assistance available for some patients to purchase epipens a gesture that was called a classic public relations move by harvard medical school professor aaron kesselheim the up to  saving cards can only be used by a small number of people who need the drug and no one on medicaid they do nothing about the high price which is still being paid by insurers who ultimately pass the cost onto consumers in september  the new york state attorney general began an investigation into mylans epipenschools program in new york to determine if the programs contracts violated antitrust law and the west virginia state attorney general opened an investigation into whether mylan had given the state the correct discount under the medicaid drug rebate program and subpoenaed the company when it refused to provide the documentation the state requested in october  the ceo of mylan testified to congress that pfizerking charged mylan about  for one device in september  a silicon valley engineering consultancy performed a teardown analysis of the epipen and estimated the manufacturing and packaging costs at about  for a twopack in october  mylan announced a settlement with the us department of justice over rebates paid by mylan to states under the medicaid drug rebate program questions had been raised by congress and others about why epipen had been classified as a generic rather a proprietary product in the program since  generic drugs have lower rebates  than proprietary drugs  and price hikes for generic drugs cannot be passed onto states and a common form of pharmaceutical fraud involves misclassifying proprietary drugs as generic under the program under the agreement mylan agreed to pay a  million payment and to a sign a corporate integrity agreement requiring it to perform better in the future the settlement also resolved cases brought by states related to the rebates simultaneously with the settlement mylan also announced it was being investigated by the securities and exchange commission related to the drug rebate program in june  the new york times published an article reporting on internal mylan discussions about price increases on the epipen between  and  in which the company chairman expressed disdain for people and agencies who might criticize the company the reporter wrote those top leaders’ responses are a far cry from the message on mylan’s website which says that we challenge every member of every team to challenge the status quo and that we put people and patients first trusting that profits will follow and also noted that the firm is a case study in the limits of what consumer and employee activism as well as government oversight can achieve  execution drugsedit mylan manufactures rocuronium bromide which is approved by the state of alabama for use in executions by lethal injection european manufacturers refuse to sell drugs which can be used for executions to the united states except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain in september  the londonbased human rights organization reprieve told mylan that they were the only fdaapproved manufacturer of rocuronium bromide without legal controls in place to prevent its use in executions and there was a very real risk that mylan may soon become the goto provider of execution drugs for states across the country the german asset manager dje kapital de divested itself of  million in mylan shares for that reason mylan said that their distribution was legally compliant referencesedit  a b public filings  form k mylan investors relations retrieved august     mylan nv k for the fiscal year ended december    mylan buys part of drug maker pittsburgh business times december     mylan laboratories to acquire generics business of merck kgaa for  billion euros medical news today may     pharmaceutical giants tracking mylans prosperity the pittsburgh tribunereview august     egan matt epipen maker faces revolt over execs  million pay package cnn money   transdermal patches  mylan mylantechcom   brand name medicines  mylan deycom   about us mylancom   a b about us mylancom   matrixlabsindiacom matrixlabsindiacom   whats new  arcana arzneimittelherstellung arcanade   httpwwwmantacomcomsdnbcompanywsklv  httpwwwidairelandcomsearchcompaniesxmlssid  httpwwwbioportfoliocomnewspdfusmylantowithdrawqualimedbrandfromfrenchmarketreportpdf  a b c dearment alaric october   milan puskar cofounder of mylan dies drug store news   mylan  years young and still making history mylan retrieved april     myl stock history  mylan retrieved august     a b c d e freudenheim milt september   exposing the fda new york times   lewis ralph a  the emerging effects of the drug price competition and patent term restoration act of  journal of contemporary health law  policy   –   a b ron wolf for the philadelphia inquirer august   smithkline loses exclusive rights to drug  a b boehm garth yao lixin han liang zheng qiang september  development of the generic drug industry in the us after the hatchwaxman act of  acta pharmaceutica sinica b   – doijapsb   a b john seaman and john t landry mylan  years of unconventional success mylan in association with university press of new england  isbn  page   a b strickland carol october   bolar a drug company under siege the new york times   shaw donna february   us charges bolar pharmaceutical with misrepresenting its products philadelphia inquirer   freudenheim milt february   bolar plans guilty plea on generics the new york times   a b c pink sheet october   mylans maxzide is approvable at fda lederle to market brand competition to smithklines no ranked dyazide final approval anticipated imminently  fda approval history nda  maxzide page accessed september    reid kenneth november   us judge to rule on drug marketing journal of commerce   andrews edmund l july   fda inquiry on generic drugs focuses on changes in ingredients the new york times   cimons marlene august   fda to lift ok of last dyazide generic version los angeles times   bolar and mylan team to purchase somerset labs pink sheet november     somerset eldepryl june  approval clears way for mylanbolar acquisition pink sheet june     a b ku mannching sherry december   recent trends in specialty pharma business model journal of food and drug analysis   – doijjfda   mylan form k annual report for the financial year ending march    filed june    a b labaton stephen december   a drug maker is said to face a suit on prices the new york times   press release ftc reaches record financial settlement to settle charges of pricefixing in generic drug market  federal trade commission ftc november     labaton stephen july   genericdrug maker agrees to settlement in pricefixing case the new york times   a b creswell julie march   icahn the spoiler fortune   pollack andrew november   icahn offers  billion for mylan drug maker the new york times   okeefe eric may   icahn slate wins seats on blockbuster board the new york times   lazo shirley a survival strategy barrons   icahn drops bid for mylan los angeles times bloomberg news july     mylan signs usmil takeover deal for indias matrix laboratories ihs august     mylans acquisition of matrix business strategy case study icrm   massey steve may   mylan buys merck generic drug unit for  billion pittsburgh postgazette   press release mylan completes acquisition of generics business of merck kgaa mylan october     a b c d e f g cynthia koons and robert langreth for bloomberg businessweek september   how marketing turned the epipen into a billiondollar business  johnson carolyn y ho catherine august   how mylan the epipen company maneuvered to create a virtual monopoly the washington post via the chicago tribune   adams russell october   mylan again sues pittsburgh postgazette wall street journal retrieved august     sabatini patricia boselovic len july   mylan workers overrode drug quality controls internal report detailed pervasive practice of ignoring safety procedures pittsburgh postgazette retrieved august     edwards jim july   its not mylans first quality control beef with fda money watch cbs news retrieved august     mylan pittsburgh postgazette settle lawsuits cbs news associated press february   retrieved august     us department of justice october   press release four pharmaceutical companies pay  million for submission of false claims to medicaid  mylan acquires rights to pfizers inhaler technology drugstorenewscom retrieved may     stanton dan june   gsk breathes freely as mylan launches seretide generic in uk inpharma technologist   helfand carly february   mylan joins the advaircopycat queue but approval could be a long slog fiercepharma   swetlitz ike silverman ed august   mylan may have violated antitrust law in its epipen sales to schools pbs newshour   a b odonnell jayne september   family matters epipens had highlevel help getting into schools usa today   thomas katie february   mylan buys drug maker of generic injectables new york times   palmer eric august   updated fda castigates three mylan sterile drug plants in warning letter fiercepharma   novak matt august   how congress the fda and sarah jessica parker helped epipen become a  billion business gizmodo   abc news business news personal finance and money news  abc news abc news retrieved july     us drugmaker mylan to acquire famy care for  million timesofindiaeconomictimes february     a b duhigg charles  june  outcry over epipen prices hasn’t made them lower the new york times   koons cynthia november   mylans hostile bid for perrigo fails bloomberg   rockoff jonathan d mattioli dana april   teva offers to buy mylan for  billion wall street journal   teva to buy allergans generic drug unit bloombergcom july     chitra somayaji july   teva snaps up allergans generics arm dumping mylan bloombergcom   mylan to codevelop pulmatrix copd candidate gen   mylan to acquire meda for b  gen news highlights  gen retrieved august     mylan snaps up dermatology biz from investors in b deal  fiercepharma retrieved august     a b c tara parkerpope and rachel rabkin peachman for the new york times august   epipen price rise sparks concern for allergy sufferers  bartolotta devin august   cost jumps nearly percent for lifesaving epipens cbs baltimore retrieved august     goldberg kenny people with food allergies say lifesaving drug too expensive kpbs public media retrieved june     walker joseph winslow ron steele anne august   mylan to launch cheaper generic epipen alternative wall street journal   a b c thomas katie october   mylan to settle epipen overpricing case for  million the new york times   thomas katie   states accuse generic drug companies of price fixing the new york times retrieved    a b erman michael may   mylan may have overcharged us for epipen by  billion hhs reuters new york retrieved may     king pharmaceuticals october   press release king pharmaceuticals to acquire meridian medical technologies  carly helfand for fiercepharma march   fda swats down tevas epipen copy putting mylan in cruise control  a b emily willingham for forbes august   why did mylan hike epipen prices  because they could  emma court for marketwatch august   mylan’s epipen price increases are valeantlike in size shkrelilike in approach  brad tuttle for time august    signs that epipen prices are completely out of control  michael hiltzik for the los angeles times august   another reason to hate mylan which jacked up the price of lifesaving epipens its a tax dodger  matt novak for gizmodo august   how congress the fda and sarah jessica parker helped epipen become a  billion business  beth snyder bulik for fiercepharma may   no holds barred in mylan’s ultrarealistic peanut allergy campaign  mylan to provide epipen cost assistance as ceo is asked to testify on price hike the guardian   a b carolyn y johnson august   why mylan’s ‘savings card’ won’t make epipen cheaper for all patients washington post washington post   larson erik hopkins jared s september   mylan’s epipen school sales trigger ny antitrust probe bloomberg retrieved september     feeley jef langreth robert september   mylan investigations mount as west virginia opens fraud probe bloomberg news   popken ben september   upgraded epipens torn apart tech firm its the same core device nbc news   tracy seipel silicon valley engineers figure real cost to make lifesaving autoinjector twopack the mercury news retrieved october     thomas katie september   is epipen a brandname or a generic drug mylan casts it both ways the new york times   mole beth october   for ripping off medicaid epipen maker mylan pays feds  million ars technica retrieved october     ztracer zachary tracer october   mylan agrees to  million epipen settlement with us bloombergcom   novak matt  june  drug company chairman to america go fuck yourself gizmodo   mole beth  june  mylan chairman drug pricing critics ought to go copulate with themselves ars technica   loew derek  june  mylan begins harvesting the crop its sown in the pipeline   a b owen dyer october   drug company is targeted for refusing to adopt ban on distribution of execution drug bmj   g doibmjg  external linksedit media related to mylan at wikimedia commons business data for mylan google finance yahoo finance reuters sec filings v t e pittsburgh history timeline culture dialect media neighborhoods notable people skyscrapers government airport conventions city hall courthouse mayor council events intergov police da sheriff fire libraries transit education port regional economy allegheny conference duquesne club chamber of commerce economic club hyp club stock exchange fortune  headquarters us steel pnc ppg heinz wesco consol dicks allegheny technologies forbes largest private companies  lumber giant eagle other headquarters american bridge american eagle ampco ansys armstrong black box calgon carbon compunetix dollar bank dqe eatn park education management corporation eqt federated gnc gurucom highmark igate iron city kennametal koppers laughlin marc usa millcraft msa nichecom oxford ptc renda rue upmc vocelli wabtec shared headquarters alcoa modcloth nova chemicals subsidiary headquarters allegheny energy bayer corporation fedex ground glaxosmithkline usa lanxess respironics vivisimo westinghouse regional operations aa bny mellon formerly mellon financial dreyfus eaton spreadshirt macys historic big wheel clark dravo fisher integra mesta murphy gulf oil jl ketchum rockwell sunbeam westinghouse sports dapper dan grand prix great race head of the ohio lore marathon mylan classic regatta wphl baseball pirates wild things panthers dukes chronicletelegraph cup allegheny burghers champions crawfords filipinos grays hardhats keystones stogies rebels basketball yellow jackets panthers m panthers w dukes m dukes w colonials m colonials w roundball classic condors ironmen loendi monticello phantoms pipers piranhas pirates rens xplosion football steelers panthers steeler nation heritage colts force passion renegades  allstars allegheny americans as duquesne gladiators homestead lyceum maulers power odds olympics quakers jp stars early pro football circuit hockey penguins colonials m colonials w three rivers classic as bankers cougars duquesne ft pitt hornets keystones lyceum panthers phantoms pirates pirates wphl pros shamrocks victorias winter garden yellow jackets soccer riverhounds beadling cannons hurricanes phantoms spirit other sledgehammers bulls harlequins pcc triangles wallabies studio wrestling dirty dozen venues ppg paints arena heinz field pnc park  lumber arena fitzgerald field house highmark stadium palumbo center petersen events center petersen sports complex rooney field sewall center trees hall central park civic arena duquesne gardens exposition park forbes field josh gibson field greenlee field motor square garden pitt stadium recreation park schenley gardens three rivers winter garden parks allegheny arsenal allegheny commons allegheny riverfront artgardens buhl community chatham university arboretum frank curto frick emerald view highland market square mellon mellon green mellon square north shore riverfront phillips point of view point state ppg place riverview roberto clemente memorial rodef shalom biblical botanical garden schenley schenley plaza south shore riverfront south side three rivers west end overlook westinghouse transportation inclines steps v t e port authority of allegheny county light rail list of stations blue line – library blue line – south hills village red line inclines historical list duquesne incline monongahela incline buses and busways list of routes martin luther king jr east busway south busway west busway former lines  drake brown line patrain skybus other north shore connector port authority  series pcc wabash tunnel v t e public transportation in greater pittsburgh bus services port authority of allegheny county list of bus routes beaver butler fayette indigo mid mon valley mountain line new castle town  country university of pittsburgh washington westmoreland bus rapid transit mlk jr east busway south busway west busway light rail red line blue line library south hills village inclines duquesne monongahela amtrak capitol limited pennsylvanian airports pittsburgh international arnold palmer allegheny county beaver butler eddie dew greensburg jeannette herron jefferson jimmy stewart joe hardy lakehill monroeville new castle rock rostraver washington wheeling zelienople discontinued broadway limited brown line list of streetcar routes in pittsburgh parkway limited patrain skybus v t e tunnels and bridges in pittsburgh tunnels allegheny river tunnel armstrong tunnel cork run tunnel corliss tunnel fort pitt tunnel jl tunnel liberty tunnel mount washington transit tunnel pittsburgh and castle shannon tunnel pittsburgh  steubenville extension railroad tunnel schenley tunnel squirrel hill tunnel wabash tunnel bridges th street bridge st street bridge rd street railroad bridge th street bridge bloomfield bridge birmingham bridge david mccullough bridge fort duquesne bridge fort pitt bridge fort wayne railroad bridge glenwood bridge glenwood bo railroad bridge highland park bridge homestead grays bridge hot metal bridge liberty bridge mckees rocks bridge panhandle bridge panther hollow bridge schenley bridge senator robert d fleming bridge smithfield street bridge south tenth street bridge three sisters roberto clemente bridge andy warhol bridge rachel carson bridge veterans bridge west end bridge attractions aviary baywood cathedral of learning chinatown conservatory dippy immaculate heart duquesne incline heinz chapel little italy mellon institute mon incline observatory pamelas penn station point of view sculpture primantis science center steps uss requin zoo kennywood luna park westinghouse sign landmarks national city national county state city phlf cultural museums art arts arts festival bible fort pitt and blockhouse clayton clemente childrens frick glass center history jazz jewish mattress factory dental miller miss pittsburgh nationality rooms national map natural history soldiers and sailors warhol wilson wsg venues heinz hall benedum byham harris kellystrayhorn new hazlett oreilly foster playhouse trib hunt stage ae syria mosque nixon theater festivals anthrocon arts blues comicon fashion film folk handmade new works tekko whiskey  fine spirits wine shopping and entertainment casino gateway clipper fleet station square strip downtown oakland south side macys market square southside works waterworks mount washington east liberty squirrel hill shadyside walnut street opera ballet symphony brass classical theatre dance ensemble caravan theatre folk light opera opera theater jewish theatre public theater playwrights musical theater stage right youth ballet youth symphony bricolage nnoc v t e shopping malls in pittsburgh enclosed beaver valley mall the block northway century iii mall the galleria of mt lebanon the mall at robinson monroeville mall pittsburgh mills ross park mall south hills village station square uniontown mall warner centre washington crown center westmoreland mall lifestyle  outdoor bakery square edgewood towne centre ellsworth avenue mccandless crossing northern lights robinson town centre settlers ridge southside works walnut street the waterfront waterworks mall outlet grove city premium outlets tanger outlets pittsburgh defunct allegheny center mall east hills shopping center eastgate commerce center eastland mall greengate mall parkway center mall village square mall washington mall colleges and universities pitt carnegie mellon duquesne robert morris chatham point park carlow art institute byzantine catholic seminary pittsburgh theological seminary saint paul seminary ccac culture of pittsburgh cookie table jewish history iron city brewing company jagoff joe magarac mister rogers neighborhood mr yuk parking chairs pittsburgh left pittsburgh toilet robot hall of fame steeler nation book category portal v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlemylanoldid categories companies in the nasdaq indexcompanies listed on nasdaqcorporate inversionspharmaceutical companies of the united statescompanies in the nasdaq biotechnology indexlife sciences industryhealth care companies based in pennsylvaniacompanies listed on tasecompanies formerly listed on the new york stock exchangehidden categories use mdy dates from october all articles with unsourced statementsarticles with unsourced statements from september interlanguage link template link number navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutschespañolفارسیfrançaisעבריתportuguêssuomi edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view mylan  wikipedia mylan from wikipedia the free encyclopedia jump to navigation search mylan trading name mylan nv formerly called milan type public under dutch law traded as nasdaq myl tase myl nasdaq biotechnology component nasdaq component sp  component isin us industry pharmaceuticals founded   years ago  in white sulphur springs west virginia united states founders milan puskar don panoz headquarters canonsburg pennsylvania united states of america area served worldwide key people heather bresch ceo products generic and specialty pharmaceuticals and active pharmaceutical ingredients revenue us billion  operating income us million  net income us billion  total assets us  billion  total equity us billion  number of employees   divisions see operations subsidiaries meda famy care website wwwmylancom mylan nv is an american global generic and specialty pharmaceuticals company registered in the netherlands with principal executive offices in hatfield hertfordshire uk and global headquarters in canonsburg pennsylvania us in  mylan acquired a controlling interest in indiabased matrix laboratories limited a top producer of active pharmaceutical ingredients apis for generic drugs and the generics business of germanybased merck kgaa through these acquisitions mylan grew from the thirdlargest generic and pharmaceuticals company in the united states to the secondlargest generic and specialty pharmaceuticals company in the world in  mylans pricing of the epipen an epinephrine autoinjector became controversial and was widely referred to as price gouging as a result investigations were opened into whether mylan had misclassified the epipen under the medicaid drug rebate program a common form of pharmaceutical fraud in october  mylan settled these investigations with the us department of justice agreeing to pay  million and enter into a corporate integrity agreement concerning the rebate program in a report published on june   the institutional shareholder services criticized mylan for the outsized compensation of mylans directors former ceo robert coury received a  million  pay package in spite of the harm to the company inflicted by the epipen controversies and steep shareholder losses the report urged mylans shareholders to oust all of mylans existing directors contents  operations  location  stock  history  acquisition history  criticism  epipen pricing  execution drugs  references  external links operationsedit mylan inc operates several divisions and subsidiaries in north america and south america mylan operates mylan pharmaceuticals based in morgantown west virginia mylan pharmaceuticals ulc mylan canada mylan technologies inc mti  transdermal drug delivery systems tdds and related technologies udl laboratories inc somerset pharmaceuticals inc a research and development company in tampa florida owned by mylan somerset develops emsam manufactured by mylan technologies and marketed in the united states by dey another mylan company mylan laboratories limited campos dos goytacazes brazil in oceania and central east south and southeast asia mylan operates mylan new zealand limited  new zealand mylan laboratories limited  headquartered in hyderabad india operates nine active pharmaceutical ingredient api and intermediate manufacturing facilities located in india and china mylan seiyaku ltd  japan alphapharm  australia agila specialties pvt ltd  india oncotherapies ltd  india in europe africa and west asia mylan operates operates under the mylan name in austria belgium the czech republic denmark finland france germany hungary italy the netherlands norway poland portugal slovakia slovenia spain sweden switzerland the united kingdom also operates in south africa arcana arzneimittel gmbh  germany generics pharma hellas  greece gerard laboratories  ireland qualimed  trademark in france but will stop being marketed under the brand name docpharma  generic pharmaceutical distribution company in belgium the netherlands and luxembourg locationedit founded in  the company was first located in white sulphur springs west virginia the company moved to morgantown west virginia in  and in  it relocated its corporate headquarters to the pittsburgh suburb canonsburg pennsylvania finally in  it moved to a new office center in nearby southpointe a suburban business park located in cecil township where it is still located stockedit on february   mylan had its initial public offering ipo becoming a publicly traded company on the otc market under the ticker symbol myln in  the stock moved to nasdaq their final stock move was in  when their stock became available for trade on the new york stock exchange under the ticker symbol myl currently the stock is traded on the nasdaq historyedit mylan pharmaceuticals was founded as a drug distributor in  by milan puskar and don panoz in  mylan began manufacturing penicillin g tablets as well as vitamins and other dietary supplements panoz left mylan in  and puskar quit the company in  as it grew and experienced financial difficulties the board hired roy mcknight as board chairman who convinced puskar to return in  mylan discontinued operating as a contract manufacturing organization in  and instead chose to market their products under their own mylanlabeled brandcitation needed with the passage of the hatchwaxman act in  mylan and other small generic companies gained value in the eighteen months following passage of the law mylans earnings grew  to  million and its stock value rose  in the s one of the most prescribed drugs in the us was dyazide a diuretic that was a combination drug containing triamterene and hydrochlorothiazide it had been on the market since  and its patents had expired in  complications arose with the introductions of generics versions because the formulation of dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent some generic companies committed fraud trying to bring a generic version of dyazide bolar pharmaceutical had the first generic version approved in  but it turned out that bolar had fraudulently substituted dyazide for its own version to conduct studies that were submitted to the fda by  the fda rescinded its approval based on its suspicions and filed criminal charges against bolar to which bolar eventually pled guilty in  mylan chose to develop a new version of a triamterenehydrochlorothiazide combination drug instead of going the generic route it developed a different more stable formulation and used different dosages of each active ingredient  mg hydrochlorothiazide and  mg triamterene compared with dyazides  mg hydrochlorothiazide and  mg triamterene this drug had to get approval as a new drug as opposed to a generic their product was called maxzide and was approved in  the higher dose allowed once per day dosing which mylan and its marketing partner lederle believed would help it compete against dyazide which had m in sales in  however mylans patents on the drug were declared invalid in court and its marketing exclusivity expired in  prompting a rush of generic competition mylan had concerns about the practices of its competitors and the fda in general and also with regard to companies seeking to bring generic versions of maxzide mylan hired private investigators to examine its competitors practices and when it found evidence of corruption it submitted it to the house oversight and investigations committee which investigated and found fraud and corruption within the food and drug administrations generic drugs division and at other generic companies two of the companies that had gotten approval to market generic versions of maxzide vitarine pharmaceutical and par pharmaceutical were targets of mylans initial investigation and were found to have used mylans maxzide to obtain their bioequivalence data leading both companies to withdraw its generic competitor to mylans product the corruption in the nascent generics industry and at the office in the fda regulating it was widely covered in the media and led to widespread concern among doctors and the public in the late s and early s that generic drugs were not really the same as the branded drugs they were meant to replace in  mylan agreed to enter into a joint venture with bolar to buy somerset pharmaceuticals mylan wanted access to somersets drug discovery capabilities as well as its new drug for parkinsons selegiline the deal was completed in  but its consummation was dependent on fda approval of selegiline which came in  mylan acquired bertek inc in  for its transdermal patch technologies and kept as a subsidiary in  mylan renamed the company mylan technologies inc mti mti eventually came to be the contract manufacturer for the selegiline transdermal patch and was the first company to market generic nitroglycerin estradiol clonidine and fentanyl transdermal patches mylan acquired udl laboratories a supplier of unit dose generic medications to institutional and longterm care facilities in  in  when it was the worlds second largest generics company mylan came under investigation from the federal trade commission after it raised the prices of its products tripling them in the case of lorazepam mylan had entered into an exclusive agreement with profarmica an italian company that supplied drug ingredients after which mylans competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs before the round of price increases the price of generic drugs had been    of the price of branded drugs and afterwards it was around  the ftc filed suit at the end of  and  states filed parallel actions the case was settled in  with mylan paying a total of m  m in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid  million in attorneys fees to the state attorneys general  million plus  million in attorneys fees to settle certain class actions with insurers and managed care organizations  and mylan and three ingredient suppliers cambrex corporation profarmaco srl and gyma laboratories also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future in  mylan and king pharmaceuticals began discussing a deal in which mylan would acquire king for about b mylan wanted to expand its presence in branded pharmaceuticals and to acquire kings sales force the deal became one of the business soap operas of the year and included an sec investigation into kings accounting and carl icahn obtaining a  interest in mylan and becoming its largest stakeholder in order to kill the deal the parties called off the deal in february  icahn offered to buy mylan for b and ran a slate of board members to change the direction of mylan he won three seats in may  in june mylan bought back  of its shares in order to fend off icahn and in july icahn gave up his bid and sold his shares in august  mylan announced that it had reached agreement to buy a controlling interest in matrix laboratories an indian supplier of active pharmaceutical ingredients the deal gave mylan access to markets in india and china and was completed in january the next year in may  mylan and merck kgaa agreed that mylan would acquire mercks generics arm for b the deal was completed that october and tripled the size of mylan mylan acquired the rights to market the epipen in the transaction at that time annual sales were around  million and the epipen had about  of the market in  the company filed two lawsuits against the pittsburgh postgazette after the newspaper ran an article that was critical of the quality control procedures used at the companys morgantown plant the company had earlier quality control issues involving the fda the lawsuits were dropped in  without any damages paid by the postgazette which stated the postgazette did not find and did not intend to report that mylan had manufactured or distributed any defective drugs the postgazette regrets if any reader of the article thought otherwise also in  mylan and its subsidiary udl agreed to pay a m to settle a suit filed under the false claims act in which mylanudl and two other companies were accused of underpaying states under the medicaid drug rebate program the program requires drug companies to give rebates to states under medicaid and the rebates are higher for new drugs than for generics the suit said that the companies sold new drugs but paid rebates as if they were generics in  mylan entered into an agreement with pfizer for the exclusive worldwide rights to develop manufacture and commercialize pfizers generic equivalent to glaxosmithklines advair usseretide uk diskus incorporating pfizers proprietary dry powder inhaler delivery platform mylan launched the product in the uk in  and in february  the fda accepted its anda putting it in line behind hikma and sandoz to launch a generic version in the us in  mylan launched a program called epipenschools to sell epipens in bulk and with discounts to schools to participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year in december  the national association of state boards of education launched a policy initiative designed to help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine autoinjector access and use and advocated for state laws protecting school from legal liability for stocking and using epinephrine autoinjectors gayle manchin the mother of mylans ceo heather bresch had become president of the association in  and shortly after had discussed donations from her daughters company to the association manchin had been appointed to the west virginia state school board by her husband thengovernor of the state joe manchin in  in  mylan acquired an indian generic injectable drugs company agila specialties private for  billion in cash in  three plants acquired in that deal were issued warning letters by the fda after successful lobbying from mylan in  the school access to emergency epinephrine act became law after passing congress with broad and bipartisan support it protected anyone from liability if they administered epinephrine to a child in a school previously only trained professionals or the affected person were allowed to administer the drug and were open to liability and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them joe manchin the father of mylans ceo was a senator at that time in july  mylan and abbott laboratories announced an agreement under which mylan would buy abbotts generic drugs business in developed markets for stock valued at about  billion mylan acquired mumbaibased famy care and expand its presence in the market for womens contraceptives at about  million starting in  according to a  report in the new york times midlevel executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the epipen and raising concerns that the price increases were unethical the times reported that when these concerns were brought to robert coury the chairman of the board coury replied that he was untroubled he raised both his middle fingers and explained using colorful language that anyone criticizing mylan including its employees ought to go copulate with themselves critics in congress and on wall street he said should do the same and regulators at the food and drug administration they too deserved a round of anatomically challenging selffulfillment  the times reported that bresch provided similarly dismissive responses in april  mylan tried negotiate with the management of irish pharmaceutical firm perrigo to acquire the company and when those negotiations failed mylan attempted a hostile takeover offering to buy b in shares directly from shareholders too few shareholders agreed to sell their stock by the deadline set in november  and the effort failed two weeks after mylan made its first offer for perrigo teva pharmaceutical offered to buy mylan for b the combined companies would have been the worlds largest generic company and the th biggest drug company in the world in july teva dropped its bid for mylan and instead acquired allergans generic drug business for about the same price in june  mylan agreed to work with pulmatrix a company with a proprietary inhaled drug delivery platform to codevelop a product to treat for chronic obstructive pulmonary disease the product was pur a generic drug in a pulmatrix device in february  the company announced it would acquire meda for  billion in may of the same year the company announced it would acquire renaissance acquisition holdings dermatology division for up to  billion in  mylan had about b in sales of epipens and those sales accounted for  of mylans profit mylan had maintained about a  market share since it had acquired the product and had continually raised the price of epipens starting in  in  the wholesale price of two epipens was about  by july  the price was about  in may  it was around  and in may  the price rose again to around  around a  jump from the price in  in the summer of  as parents prepared to send their children back to school and went to pharmacies to get new epipens people began to express outrage at the cost of the epipen and mylan was widely and harshly criticized the price hikes led to investigations by congress and states attorneys general in october  mylan agreed to pay a m fine related to incorrect rebates it paid under the medicaid drug rebate program in december  the attorneys general of  states filed a civil complaint accusing mylan of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug the complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings telephone calls and text messages according to the department of health and human services office of inspector general analysis the us government may have overpaid as much as  billion between  and  to drugmaker mylan nv for the epipen emergency allergy treatment this represents three times the proposed settlement of  million announced by mylan in october  republican senator chuck grassley chair of the senate judiciary committee that launched the probe of epipen pricing probe in  released the analysis on may   on the same day a group of mylan investment funds urged shareholders to vote against the reelection of the companys directors after it paid chairman robert coury over  million last year acquisition historyedit the following is an illustration of the companys major mergers and acquisitions and historical predecessors mylan   renaissance acquisition holdings dermatology div acq    meda acq    famy care acq    abbott laboratories generics div acq    merck kgaa generics div acq  renamed mylan laboratories inc   udl laboratories acq    bertek inc acq  renamed mylan technologies inc milan pharmaceuticals founded  criticismedit epipen pricingedit see also epinephrine autoinjector § cost see also heather bresch § business executive mylan acquired the right to market and distribute the epipen line of epinephrine autoinjector devices from merck kgaa as part of their  deal that right had formerly been held by dey lp a wholly owned subsidiary of merck the devices deliver about  worth of drug at that time annual sales were around m bresch the companys ceo saw an opportunity to increase sales through marketing and advocacy and the company launched a marketing campaign to increase awareness of the dangers of anaphylaxis for people with severe allergies that made the brand epipen as identified with its product as kleenex is with facial tissue the company also successfully lobbied the fda to broaden the label to include risk of anaphylaxis and in parallel successfully lobbied congress to generate legislation making epipens available in schools and in public places like defibrillators are and hired the same people that medtronic had worked with on defibrillator legislation to do so mylans efforts to gain market dominance were aided when sanofis competing product was recalled in november  and further when tevas generic competitor was rejected by the fda in march  by the first half of  mylan had an  market share of such devices in the us and in that year sales reached around b and accounted for  of mylans profit those profits were also due in part to mylans continually raising the price of epipens starting in  in  the wholesale price of two epipens was about  the price was about the same in  by july  the price about  in may  it was around  and in may  the price rose again to around  the last price increase sparked widespread outrage including criticism from martin shkreli poster boy for grasping pharma greed letters from two senators and initiation of congressional investigations and mylans pricing of the epipen was widely referred to as price gouging the last price increase coincided with a new line of tv commercials that were described as shocking and no holds barred depicting an anaphylactic reaction from the point of view of the young woman having it at a party and ending with the young woman seeing her swollen and hivecovered face in the mirror before she collapses in response to criticism mylan increased financial assistance available for some patients to purchase epipens a gesture that was called a classic public relations move by harvard medical school professor aaron kesselheim the up to  saving cards can only be used by a small number of people who need the drug and no one on medicaid they do nothing about the high price which is still being paid by insurers who ultimately pass the cost onto consumers in september  the new york state attorney general began an investigation into mylans epipenschools program in new york to determine if the programs contracts violated antitrust law and the west virginia state attorney general opened an investigation into whether mylan had given the state the correct discount under the medicaid drug rebate program and subpoenaed the company when it refused to provide the documentation the state requested in october  the ceo of mylan testified to congress that pfizerking charged mylan about  for one device in september  a silicon valley engineering consultancy performed a teardown analysis of the epipen and estimated the manufacturing and packaging costs at about  for a twopack in october  mylan announced a settlement with the us department of justice over rebates paid by mylan to states under the medicaid drug rebate program questions had been raised by congress and others about why epipen had been classified as a generic rather a proprietary product in the program since  generic drugs have lower rebates  than proprietary drugs  and price hikes for generic drugs cannot be passed onto states and a common form of pharmaceutical fraud involves misclassifying proprietary drugs as generic under the program under the agreement mylan agreed to pay a  million payment and to a sign a corporate integrity agreement requiring it to perform better in the future the settlement also resolved cases brought by states related to the rebates simultaneously with the settlement mylan also announced it was being investigated by the securities and exchange commission related to the drug rebate program in june  the new york times published an article reporting on internal mylan discussions about price increases on the epipen between  and  in which the company chairman expressed disdain for people and agencies who might criticize the company the reporter wrote those top leaders’ responses are a far cry from the message on mylan’s website which says that we challenge every member of every team to challenge the status quo and that we put people and patients first trusting that profits will follow and also noted that the firm is a case study in the limits of what consumer and employee activism as well as government oversight can achieve  execution drugsedit mylan manufactures rocuronium bromide which is approved by the state of alabama for use in executions by lethal injection european manufacturers refuse to sell drugs which can be used for executions to the united states except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain in september  the londonbased human rights organization reprieve told mylan that they were the only fdaapproved manufacturer of rocuronium bromide without legal controls in place to prevent its use in executions and there was a very real risk that mylan may soon become the goto provider of execution drugs for states across the country the german asset manager dje kapital de divested itself of  million in mylan shares for that reason mylan said that their distribution was legally compliant referencesedit  a b public filings  form k mylan investors relations retrieved august     mylan nv k for the fiscal year ended december    mylan buys part of drug maker pittsburgh business times december     mylan laboratories to acquire generics business of merck kgaa for  billion euros medical news today may     pharmaceutical giants tracking mylans prosperity the pittsburgh tribunereview august     egan matt epipen maker faces revolt over execs  million pay package cnn money   transdermal patches  mylan mylantechcom   brand name medicines  mylan deycom   about us mylancom   a b about us mylancom   matrixlabsindiacom matrixlabsindiacom   whats new  arcana arzneimittelherstellung arcanade   httpwwwmantacomcomsdnbcompanywsklv  httpwwwidairelandcomsearchcompaniesxmlssid  httpwwwbioportfoliocomnewspdfusmylantowithdrawqualimedbrandfromfrenchmarketreportpdf  a b c dearment alaric october   milan puskar cofounder of mylan dies drug store news   mylan  years young and still making history mylan retrieved april     myl stock history  mylan retrieved august     a b c d e freudenheim milt september   exposing the fda new york times   lewis ralph a  the emerging effects of the drug price competition and patent term restoration act of  journal of contemporary health law  policy   –   a b ron wolf for the philadelphia inquirer august   smithkline loses exclusive rights to drug  a b boehm garth yao lixin han liang zheng qiang september  development of the generic drug industry in the us after the hatchwaxman act of  acta pharmaceutica sinica b   – doijapsb   a b john seaman and john t landry mylan  years of unconventional success mylan in association with university press of new england  isbn  page   a b strickland carol october   bolar a drug company under siege the new york times   shaw donna february   us charges bolar pharmaceutical with misrepresenting its products philadelphia inquirer   freudenheim milt february   bolar plans guilty plea on generics the new york times   a b c pink sheet october   mylans maxzide is approvable at fda lederle to market brand competition to smithklines no ranked dyazide final approval anticipated imminently  fda approval history nda  maxzide page accessed september    reid kenneth november   us judge to rule on drug marketing journal of commerce   andrews edmund l july   fda inquiry on generic drugs focuses on changes in ingredients the new york times   cimons marlene august   fda to lift ok of last dyazide generic version los angeles times   bolar and mylan team to purchase somerset labs pink sheet november     somerset eldepryl june  approval clears way for mylanbolar acquisition pink sheet june     a b ku mannching sherry december   recent trends in specialty pharma business model journal of food and drug analysis   – doijjfda   mylan form k annual report for the financial year ending march    filed june    a b labaton stephen december   a drug maker is said to face a suit on prices the new york times   press release ftc reaches record financial settlement to settle charges of pricefixing in generic drug market  federal trade commission ftc november     labaton stephen july   genericdrug maker agrees to settlement in pricefixing case the new york times   a b creswell julie march   icahn the spoiler fortune   pollack andrew november   icahn offers  billion for mylan drug maker the new york times   okeefe eric may   icahn slate wins seats on blockbuster board the new york times   lazo shirley a survival strategy barrons   icahn drops bid for mylan los angeles times bloomberg news july     mylan signs usmil takeover deal for indias matrix laboratories ihs august     mylans acquisition of matrix business strategy case study icrm   massey steve may   mylan buys merck generic drug unit for  billion pittsburgh postgazette   press release mylan completes acquisition of generics business of merck kgaa mylan october     a b c d e f g cynthia koons and robert langreth for bloomberg businessweek september   how marketing turned the epipen into a billiondollar business  johnson carolyn y ho catherine august   how mylan the epipen company maneuvered to create a virtual monopoly the washington post via the chicago tribune   adams russell october   mylan again sues pittsburgh postgazette wall street journal retrieved august     sabatini patricia boselovic len july   mylan workers overrode drug quality controls internal report detailed pervasive practice of ignoring safety procedures pittsburgh postgazette retrieved august     edwards jim july   its not mylans first quality control beef with fda money watch cbs news retrieved august     mylan pittsburgh postgazette settle lawsuits cbs news associated press february   retrieved august     us department of justice october   press release four pharmaceutical companies pay  million for submission of false claims to medicaid  mylan acquires rights to pfizers inhaler technology drugstorenewscom retrieved may     stanton dan june   gsk breathes freely as mylan launches seretide generic in uk inpharma technologist   helfand carly february   mylan joins the advaircopycat queue but approval could be a long slog fiercepharma   swetlitz ike silverman ed august   mylan may have violated antitrust law in its epipen sales to schools pbs newshour   a b odonnell jayne september   family matters epipens had highlevel help getting into schools usa today   thomas katie february   mylan buys drug maker of generic injectables new york times   palmer eric august   updated fda castigates three mylan sterile drug plants in warning letter fiercepharma   novak matt august   how congress the fda and sarah jessica parker helped epipen become a  billion business gizmodo   abc news business news personal finance and money news  abc news abc news retrieved july     us drugmaker mylan to acquire famy care for  million timesofindiaeconomictimes february     a b duhigg charles  june  outcry over epipen prices hasn’t made them lower the new york times   koons cynthia november   mylans hostile bid for perrigo fails bloomberg   rockoff jonathan d mattioli dana april   teva offers to buy mylan for  billion wall street journal   teva to buy allergans generic drug unit bloombergcom july     chitra somayaji july   teva snaps up allergans generics arm dumping mylan bloombergcom   mylan to codevelop pulmatrix copd candidate gen   mylan to acquire meda for b  gen news highlights  gen retrieved august     mylan snaps up dermatology biz from investors in b deal  fiercepharma retrieved august     a b c tara parkerpope and rachel rabkin peachman for the new york times august   epipen price rise sparks concern for allergy sufferers  bartolotta devin august   cost jumps nearly percent for lifesaving epipens cbs baltimore retrieved august     goldberg kenny people with food allergies say lifesaving drug too expensive kpbs public media retrieved june     walker joseph winslow ron steele anne august   mylan to launch cheaper generic epipen alternative wall street journal   a b c thomas katie october   mylan to settle epipen overpricing case for  million the new york times   thomas katie   states accuse generic drug companies of price fixing the new york times retrieved    a b erman michael may   mylan may have overcharged us for epipen by  billion hhs reuters new york retrieved may     king pharmaceuticals october   press release king pharmaceuticals to acquire meridian medical technologies  carly helfand for fiercepharma march   fda swats down tevas epipen copy putting mylan in cruise control  a b emily willingham for forbes august   why did mylan hike epipen prices  because they could  emma court for marketwatch august   mylan’s epipen price increases are valeantlike in size shkrelilike in approach  brad tuttle for time august    signs that epipen prices are completely out of control  michael hiltzik for the los angeles times august   another reason to hate mylan which jacked up the price of lifesaving epipens its a tax dodger  matt novak for gizmodo august   how congress the fda and sarah jessica parker helped epipen become a  billion business  beth snyder bulik for fiercepharma may   no holds barred in mylan’s ultrarealistic peanut allergy campaign  mylan to provide epipen cost assistance as ceo is asked to testify on price hike the guardian   a b carolyn y johnson august   why mylan’s ‘savings card’ won’t make epipen cheaper for all patients washington post washington post   larson erik hopkins jared s september   mylan’s epipen school sales trigger ny antitrust probe bloomberg retrieved september     feeley jef langreth robert september   mylan investigations mount as west virginia opens fraud probe bloomberg news   popken ben september   upgraded epipens torn apart tech firm its the same core device nbc news   tracy seipel silicon valley engineers figure real cost to make lifesaving autoinjector twopack the mercury news retrieved october     thomas katie september   is epipen a brandname or a generic drug mylan casts it both ways the new york times   mole beth october   for ripping off medicaid epipen maker mylan pays feds  million ars technica retrieved october     ztracer zachary tracer october   mylan agrees to  million epipen settlement with us bloombergcom   novak matt  june  drug company chairman to america go fuck yourself gizmodo   mole beth  june  mylan chairman drug pricing critics ought to go copulate with themselves ars technica   loew derek  june  mylan begins harvesting the crop its sown in the pipeline   a b owen dyer october   drug company is targeted for refusing to adopt ban on distribution of execution drug bmj   g doibmjg  external linksedit media related to mylan at wikimedia commons business data for mylan google finance yahoo finance reuters sec filings v t e pittsburgh history timeline culture dialect media neighborhoods notable people skyscrapers government airport conventions city hall courthouse mayor council events intergov police da sheriff fire libraries transit education port regional economy allegheny conference duquesne club chamber of commerce economic club hyp club stock exchange fortune  headquarters us steel pnc ppg heinz wesco consol dicks allegheny technologies forbes largest private companies  lumber giant eagle other headquarters american bridge american eagle ampco ansys armstrong black box calgon carbon compunetix dollar bank dqe eatn park education management corporation eqt federated gnc gurucom highmark igate iron city kennametal koppers laughlin marc usa millcraft msa nichecom oxford ptc renda rue upmc vocelli wabtec shared headquarters alcoa modcloth nova chemicals subsidiary headquarters allegheny energy bayer corporation fedex ground glaxosmithkline usa lanxess respironics vivisimo westinghouse regional operations aa bny mellon formerly mellon financial dreyfus eaton spreadshirt macys historic big wheel clark dravo fisher integra mesta murphy gulf oil jl ketchum rockwell sunbeam westinghouse sports dapper dan grand prix great race head of the ohio lore marathon mylan classic regatta wphl baseball pirates wild things panthers dukes chronicletelegraph cup allegheny burghers champions crawfords filipinos grays hardhats keystones stogies rebels basketball yellow jackets panthers m panthers w dukes m dukes w colonials m colonials w roundball classic condors ironmen loendi monticello phantoms pipers piranhas pirates rens xplosion football steelers panthers steeler nation heritage colts force passion renegades  allstars allegheny americans as duquesne gladiators homestead lyceum maulers power odds olympics quakers jp stars early pro football circuit hockey penguins colonials m colonials w three rivers classic as bankers cougars duquesne ft pitt hornets keystones lyceum panthers phantoms pirates pirates wphl pros shamrocks victorias winter garden yellow jackets soccer riverhounds beadling cannons hurricanes phantoms spirit other sledgehammers bulls harlequins pcc triangles wallabies studio wrestling dirty dozen venues ppg paints arena heinz field pnc park  lumber arena fitzgerald field house highmark stadium palumbo center petersen events center petersen sports complex rooney field sewall center trees hall central park civic arena duquesne gardens exposition park forbes field josh gibson field greenlee field motor square garden pitt stadium recreation park schenley gardens three rivers winter garden parks allegheny arsenal allegheny commons allegheny riverfront artgardens buhl community chatham university arboretum frank curto frick emerald view highland market square mellon mellon green mellon square north shore riverfront phillips point of view point state ppg place riverview roberto clemente memorial rodef shalom biblical botanical garden schenley schenley plaza south shore riverfront south side three rivers west end overlook westinghouse transportation inclines steps v t e port authority of allegheny county light rail list of stations blue line – library blue line – south hills village red line inclines historical list duquesne incline monongahela incline buses and busways list of routes martin luther king jr east busway south busway west busway former lines  drake brown line patrain skybus other north shore connector port authority  series pcc wabash tunnel v t e public transportation in greater pittsburgh bus services port authority of allegheny county list of bus routes beaver butler fayette indigo mid mon valley mountain line new castle town  country university of pittsburgh washington westmoreland bus rapid transit mlk jr east busway south busway west busway light rail red line blue line library south hills village inclines duquesne monongahela amtrak capitol limited pennsylvanian airports pittsburgh international arnold palmer allegheny county beaver butler eddie dew greensburg jeannette herron jefferson jimmy stewart joe hardy lakehill monroeville new castle rock rostraver washington wheeling zelienople discontinued broadway limited brown line list of streetcar routes in pittsburgh parkway limited patrain skybus v t e tunnels and bridges in pittsburgh tunnels allegheny river tunnel armstrong tunnel cork run tunnel corliss tunnel fort pitt tunnel jl tunnel liberty tunnel mount washington transit tunnel pittsburgh and castle shannon tunnel pittsburgh  steubenville extension railroad tunnel schenley tunnel squirrel hill tunnel wabash tunnel bridges th street bridge st street bridge rd street railroad bridge th street bridge bloomfield bridge birmingham bridge david mccullough bridge fort duquesne bridge fort pitt bridge fort wayne railroad bridge glenwood bridge glenwood bo railroad bridge highland park bridge homestead grays bridge hot metal bridge liberty bridge mckees rocks bridge panhandle bridge panther hollow bridge schenley bridge senator robert d fleming bridge smithfield street bridge south tenth street bridge three sisters roberto clemente bridge andy warhol bridge rachel carson bridge veterans bridge west end bridge attractions aviary baywood cathedral of learning chinatown conservatory dippy immaculate heart duquesne incline heinz chapel little italy mellon institute mon incline observatory pamelas penn station point of view sculpture primantis science center steps uss requin zoo kennywood luna park westinghouse sign landmarks national city national county state city phlf cultural museums art arts arts festival bible fort pitt and blockhouse clayton clemente childrens frick glass center history jazz jewish mattress factory dental miller miss pittsburgh nationality rooms national map natural history soldiers and sailors warhol wilson wsg venues heinz hall benedum byham harris kellystrayhorn new hazlett oreilly foster playhouse trib hunt stage ae syria mosque nixon theater festivals anthrocon arts blues comicon fashion film folk handmade new works tekko whiskey  fine spirits wine shopping and entertainment casino gateway clipper fleet station square strip downtown oakland south side macys market square southside works waterworks mount washington east liberty squirrel hill shadyside walnut street opera ballet symphony brass classical theatre dance ensemble caravan theatre folk light opera opera theater jewish theatre public theater playwrights musical theater stage right youth ballet youth symphony bricolage nnoc v t e shopping malls in pittsburgh enclosed beaver valley mall the block northway century iii mall the galleria of mt lebanon the mall at robinson monroeville mall pittsburgh mills ross park mall south hills village station square uniontown mall warner centre washington crown center westmoreland mall lifestyle  outdoor bakery square edgewood towne centre ellsworth avenue mccandless crossing northern lights robinson town centre settlers ridge southside works walnut street the waterfront waterworks mall outlet grove city premium outlets tanger outlets pittsburgh defunct allegheny center mall east hills shopping center eastgate commerce center eastland mall greengate mall parkway center mall village square mall washington mall colleges and universities pitt carnegie mellon duquesne robert morris chatham point park carlow art institute byzantine catholic seminary pittsburgh theological seminary saint paul seminary ccac culture of pittsburgh cookie table jewish history iron city brewing company jagoff joe magarac mister rogers neighborhood mr yuk parking chairs pittsburgh left pittsburgh toilet robot hall of fame steeler nation book category portal v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlemylanoldid categories companies in the nasdaq indexcompanies listed on nasdaqcorporate inversionspharmaceutical companies of the united statescompanies in the nasdaq biotechnology indexlife sciences industryhealth care companies based in pennsylvaniacompanies listed on tasecompanies formerly listed on the new york stock exchangehidden categories use mdy dates from october all articles with unsourced statementsarticles with unsourced statements from september interlanguage link template link number navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutschespañolفارسیfrançaisעבריתportuguêssuomi edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view mylan  wikipedia mylan from wikipedia the free encyclopedia jump to navigation search mylan trading name mylan nv formerly called milan type public under dutch law traded as nasdaq myl tase myl nasdaq biotechnology component nasdaq component sp  component isin us industry pharmaceuticals founded   years ago  in white sulphur springs west virginia united states founders milan puskar don panoz headquarters canonsburg pennsylvania united states of america area served worldwide key people heather bresch ceo products generic and specialty pharmaceuticals and active pharmaceutical ingredients revenue us billion  operating income us million  net income us billion  total assets us  billion  total equity us billion  number of employees   divisions see operations subsidiaries meda famy care website wwwmylancom mylan nv is an american global generic and specialty pharmaceuticals company registered in the netherlands with principal executive offices in hatfield hertfordshire uk and global headquarters in canonsburg pennsylvania us in  mylan acquired a controlling interest in indiabased matrix laboratories limited a top producer of active pharmaceutical ingredients apis for generic drugs and the generics business of germanybased merck kgaa through these acquisitions mylan grew from the thirdlargest generic and pharmaceuticals company in the united states to the secondlargest generic and specialty pharmaceuticals company in the world in  mylans pricing of the epipen an epinephrine autoinjector became controversial and was widely referred to as price gouging as a result investigations were opened into whether mylan had misclassified the epipen under the medicaid drug rebate program a common form of pharmaceutical fraud in october  mylan settled these investigations with the us department of justice agreeing to pay  million and enter into a corporate integrity agreement concerning the rebate program in a report published on june   the institutional shareholder services criticized mylan for the outsized compensation of mylans directors former ceo robert coury received a  million  pay package in spite of the harm to the company inflicted by the epipen controversies and steep shareholder losses the report urged mylans shareholders to oust all of mylans existing directors contents  operations  location  stock  history  acquisition history  criticism  epipen pricing  execution drugs  references  external links operationsedit mylan inc operates several divisions and subsidiaries in north america and south america mylan operates mylan pharmaceuticals based in morgantown west virginia mylan pharmaceuticals ulc mylan canada mylan technologies inc mti  transdermal drug delivery systems tdds and related technologies udl laboratories inc somerset pharmaceuticals inc a research and development company in tampa florida owned by mylan somerset develops emsam manufactured by mylan technologies and marketed in the united states by dey another mylan company mylan laboratories limited campos dos goytacazes brazil in oceania and central east south and southeast asia mylan operates mylan new zealand limited  new zealand mylan laboratories limited  headquartered in hyderabad india operates nine active pharmaceutical ingredient api and intermediate manufacturing facilities located in india and china mylan seiyaku ltd  japan alphapharm  australia agila specialties pvt ltd  india oncotherapies ltd  india in europe africa and west asia mylan operates operates under the mylan name in austria belgium the czech republic denmark finland france germany hungary italy the netherlands norway poland portugal slovakia slovenia spain sweden switzerland the united kingdom also operates in south africa arcana arzneimittel gmbh  germany generics pharma hellas  greece gerard laboratories  ireland qualimed  trademark in france but will stop being marketed under the brand name docpharma  generic pharmaceutical distribution company in belgium the netherlands and luxembourg locationedit founded in  the company was first located in white sulphur springs west virginia the company moved to morgantown west virginia in  and in  it relocated its corporate headquarters to the pittsburgh suburb canonsburg pennsylvania finally in  it moved to a new office center in nearby southpointe a suburban business park located in cecil township where it is still located stockedit on february   mylan had its initial public offering ipo becoming a publicly traded company on the otc market under the ticker symbol myln in  the stock moved to nasdaq their final stock move was in  when their stock became available for trade on the new york stock exchange under the ticker symbol myl currently the stock is traded on the nasdaq historyedit mylan pharmaceuticals was founded as a drug distributor in  by milan puskar and don panoz in  mylan began manufacturing penicillin g tablets as well as vitamins and other dietary supplements panoz left mylan in  and puskar quit the company in  as it grew and experienced financial difficulties the board hired roy mcknight as board chairman who convinced puskar to return in  mylan discontinued operating as a contract manufacturing organization in  and instead chose to market their products under their own mylanlabeled brandcitation needed with the passage of the hatchwaxman act in  mylan and other small generic companies gained value in the eighteen months following passage of the law mylans earnings grew  to  million and its stock value rose  in the s one of the most prescribed drugs in the us was dyazide a diuretic that was a combination drug containing triamterene and hydrochlorothiazide it had been on the market since  and its patents had expired in  complications arose with the introductions of generics versions because the formulation of dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent some generic companies committed fraud trying to bring a generic version of dyazide bolar pharmaceutical had the first generic version approved in  but it turned out that bolar had fraudulently substituted dyazide for its own version to conduct studies that were submitted to the fda by  the fda rescinded its approval based on its suspicions and filed criminal charges against bolar to which bolar eventually pled guilty in  mylan chose to develop a new version of a triamterenehydrochlorothiazide combination drug instead of going the generic route it developed a different more stable formulation and used different dosages of each active ingredient  mg hydrochlorothiazide and  mg triamterene compared with dyazides  mg hydrochlorothiazide and  mg triamterene this drug had to get approval as a new drug as opposed to a generic their product was called maxzide and was approved in  the higher dose allowed once per day dosing which mylan and its marketing partner lederle believed would help it compete against dyazide which had m in sales in  however mylans patents on the drug were declared invalid in court and its marketing exclusivity expired in  prompting a rush of generic competition mylan had concerns about the practices of its competitors and the fda in general and also with regard to companies seeking to bring generic versions of maxzide mylan hired private investigators to examine its competitors practices and when it found evidence of corruption it submitted it to the house oversight and investigations committee which investigated and found fraud and corruption within the food and drug administrations generic drugs division and at other generic companies two of the companies that had gotten approval to market generic versions of maxzide vitarine pharmaceutical and par pharmaceutical were targets of mylans initial investigation and were found to have used mylans maxzide to obtain their bioequivalence data leading both companies to withdraw its generic competitor to mylans product the corruption in the nascent generics industry and at the office in the fda regulating it was widely covered in the media and led to widespread concern among doctors and the public in the late s and early s that generic drugs were not really the same as the branded drugs they were meant to replace in  mylan agreed to enter into a joint venture with bolar to buy somerset pharmaceuticals mylan wanted access to somersets drug discovery capabilities as well as its new drug for parkinsons selegiline the deal was completed in  but its consummation was dependent on fda approval of selegiline which came in  mylan acquired bertek inc in  for its transdermal patch technologies and kept as a subsidiary in  mylan renamed the company mylan technologies inc mti mti eventually came to be the contract manufacturer for the selegiline transdermal patch and was the first company to market generic nitroglycerin estradiol clonidine and fentanyl transdermal patches mylan acquired udl laboratories a supplier of unit dose generic medications to institutional and longterm care facilities in  in  when it was the worlds second largest generics company mylan came under investigation from the federal trade commission after it raised the prices of its products tripling them in the case of lorazepam mylan had entered into an exclusive agreement with profarmica an italian company that supplied drug ingredients after which mylans competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs before the round of price increases the price of generic drugs had been    of the price of branded drugs and afterwards it was around  the ftc filed suit at the end of  and  states filed parallel actions the case was settled in  with mylan paying a total of m  m in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid  million in attorneys fees to the state attorneys general  million plus  million in attorneys fees to settle certain class actions with insurers and managed care organizations  and mylan and three ingredient suppliers cambrex corporation profarmaco srl and gyma laboratories also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future in  mylan and king pharmaceuticals began discussing a deal in which mylan would acquire king for about b mylan wanted to expand its presence in branded pharmaceuticals and to acquire kings sales force the deal became one of the business soap operas of the year and included an sec investigation into kings accounting and carl icahn obtaining a  interest in mylan and becoming its largest stakeholder in order to kill the deal the parties called off the deal in february  icahn offered to buy mylan for b and ran a slate of board members to change the direction of mylan he won three seats in may  in june mylan bought back  of its shares in order to fend off icahn and in july icahn gave up his bid and sold his shares in august  mylan announced that it had reached agreement to buy a controlling interest in matrix laboratories an indian supplier of active pharmaceutical ingredients the deal gave mylan access to markets in india and china and was completed in january the next year in may  mylan and merck kgaa agreed that mylan would acquire mercks generics arm for b the deal was completed that october and tripled the size of mylan mylan acquired the rights to market the epipen in the transaction at that time annual sales were around  million and the epipen had about  of the market in  the company filed two lawsuits against the pittsburgh postgazette after the newspaper ran an article that was critical of the quality control procedures used at the companys morgantown plant the company had earlier quality control issues involving the fda the lawsuits were dropped in  without any damages paid by the postgazette which stated the postgazette did not find and did not intend to report that mylan had manufactured or distributed any defective drugs the postgazette regrets if any reader of the article thought otherwise also in  mylan and its subsidiary udl agreed to pay a m to settle a suit filed under the false claims act in which mylanudl and two other companies were accused of underpaying states under the medicaid drug rebate program the program requires drug companies to give rebates to states under medicaid and the rebates are higher for new drugs than for generics the suit said that the companies sold new drugs but paid rebates as if they were generics in  mylan entered into an agreement with pfizer for the exclusive worldwide rights to develop manufacture and commercialize pfizers generic equivalent to glaxosmithklines advair usseretide uk diskus incorporating pfizers proprietary dry powder inhaler delivery platform mylan launched the product in the uk in  and in february  the fda accepted its anda putting it in line behind hikma and sandoz to launch a generic version in the us in  mylan launched a program called epipenschools to sell epipens in bulk and with discounts to schools to participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year in december  the national association of state boards of education launched a policy initiative designed to help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine autoinjector access and use and advocated for state laws protecting school from legal liability for stocking and using epinephrine autoinjectors gayle manchin the mother of mylans ceo heather bresch had become president of the association in  and shortly after had discussed donations from her daughters company to the association manchin had been appointed to the west virginia state school board by her husband thengovernor of the state joe manchin in  in  mylan acquired an indian generic injectable drugs company agila specialties private for  billion in cash in  three plants acquired in that deal were issued warning letters by the fda after successful lobbying from mylan in  the school access to emergency epinephrine act became law after passing congress with broad and bipartisan support it protected anyone from liability if they administered epinephrine to a child in a school previously only trained professionals or the affected person were allowed to administer the drug and were open to liability and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them joe manchin the father of mylans ceo was a senator at that time in july  mylan and abbott laboratories announced an agreement under which mylan would buy abbotts generic drugs business in developed markets for stock valued at about  billion mylan acquired mumbaibased famy care and expand its presence in the market for womens contraceptives at about  million starting in  according to a  report in the new york times midlevel executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the epipen and raising concerns that the price increases were unethical the times reported that when these concerns were brought to robert coury the chairman of the board coury replied that he was untroubled he raised both his middle fingers and explained using colorful language that anyone criticizing mylan including its employees ought to go copulate with themselves critics in congress and on wall street he said should do the same and regulators at the food and drug administration they too deserved a round of anatomically challenging selffulfillment  the times reported that bresch provided similarly dismissive responses in april  mylan tried negotiate with the management of irish pharmaceutical firm perrigo to acquire the company and when those negotiations failed mylan attempted a hostile takeover offering to buy b in shares directly from shareholders too few shareholders agreed to sell their stock by the deadline set in november  and the effort failed two weeks after mylan made its first offer for perrigo teva pharmaceutical offered to buy mylan for b the combined companies would have been the worlds largest generic company and the th biggest drug company in the world in july teva dropped its bid for mylan and instead acquired allergans generic drug business for about the same price in june  mylan agreed to work with pulmatrix a company with a proprietary inhaled drug delivery platform to codevelop a product to treat for chronic obstructive pulmonary disease the product was pur a generic drug in a pulmatrix device in february  the company announced it would acquire meda for  billion in may of the same year the company announced it would acquire renaissance acquisition holdings dermatology division for up to  billion in  mylan had about b in sales of epipens and those sales accounted for  of mylans profit mylan had maintained about a  market share since it had acquired the product and had continually raised the price of epipens starting in  in  the wholesale price of two epipens was about  by july  the price was about  in may  it was around  and in may  the price rose again to around  around a  jump from the price in  in the summer of  as parents prepared to send their children back to school and went to pharmacies to get new epipens people began to express outrage at the cost of the epipen and mylan was widely and harshly criticized the price hikes led to investigations by congress and states attorneys general in october  mylan agreed to pay a m fine related to incorrect rebates it paid under the medicaid drug rebate program in december  the attorneys general of  states filed a civil complaint accusing mylan of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug the complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings telephone calls and text messages according to the department of health and human services office of inspector general analysis the us government may have overpaid as much as  billion between  and  to drugmaker mylan nv for the epipen emergency allergy treatment this represents three times the proposed settlement of  million announced by mylan in october  republican senator chuck grassley chair of the senate judiciary committee that launched the probe of epipen pricing probe in  released the analysis on may   on the same day a group of mylan investment funds urged shareholders to vote against the reelection of the companys directors after it paid chairman robert coury over  million last year acquisition historyedit the following is an illustration of the companys major mergers and acquisitions and historical predecessors mylan   renaissance acquisition holdings dermatology div acq    meda acq    famy care acq    abbott laboratories generics div acq    merck kgaa generics div acq  renamed mylan laboratories inc   udl laboratories acq    bertek inc acq  renamed mylan technologies inc milan pharmaceuticals founded  criticismedit epipen pricingedit see also epinephrine autoinjector § cost see also heather bresch § business executive mylan acquired the right to market and distribute the epipen line of epinephrine autoinjector devices from merck kgaa as part of their  deal that right had formerly been held by dey lp a wholly owned subsidiary of merck the devices deliver about  worth of drug at that time annual sales were around m bresch the companys ceo saw an opportunity to increase sales through marketing and advocacy and the company launched a marketing campaign to increase awareness of the dangers of anaphylaxis for people with severe allergies that made the brand epipen as identified with its product as kleenex is with facial tissue the company also successfully lobbied the fda to broaden the label to include risk of anaphylaxis and in parallel successfully lobbied congress to generate legislation making epipens available in schools and in public places like defibrillators are and hired the same people that medtronic had worked with on defibrillator legislation to do so mylans efforts to gain market dominance were aided when sanofis competing product was recalled in november  and further when tevas generic competitor was rejected by the fda in march  by the first half of  mylan had an  market share of such devices in the us and in that year sales reached around b and accounted for  of mylans profit those profits were also due in part to mylans continually raising the price of epipens starting in  in  the wholesale price of two epipens was about  the price was about the same in  by july  the price about  in may  it was around  and in may  the price rose again to around  the last price increase sparked widespread outrage including criticism from martin shkreli poster boy for grasping pharma greed letters from two senators and initiation of congressional investigations and mylans pricing of the epipen was widely referred to as price gouging the last price increase coincided with a new line of tv commercials that were described as shocking and no holds barred depicting an anaphylactic reaction from the point of view of the young woman having it at a party and ending with the young woman seeing her swollen and hivecovered face in the mirror before she collapses in response to criticism mylan increased financial assistance available for some patients to purchase epipens a gesture that was called a classic public relations move by harvard medical school professor aaron kesselheim the up to  saving cards can only be used by a small number of people who need the drug and no one on medicaid they do nothing about the high price which is still being paid by insurers who ultimately pass the cost onto consumers in september  the new york state attorney general began an investigation into mylans epipenschools program in new york to determine if the programs contracts violated antitrust law and the west virginia state attorney general opened an investigation into whether mylan had given the state the correct discount under the medicaid drug rebate program and subpoenaed the company when it refused to provide the documentation the state requested in october  the ceo of mylan testified to congress that pfizerking charged mylan about  for one device in september  a silicon valley engineering consultancy performed a teardown analysis of the epipen and estimated the manufacturing and packaging costs at about  for a twopack in october  mylan announced a settlement with the us department of justice over rebates paid by mylan to states under the medicaid drug rebate program questions had been raised by congress and others about why epipen had been classified as a generic rather a proprietary product in the program since  generic drugs have lower rebates  than proprietary drugs  and price hikes for generic drugs cannot be passed onto states and a common form of pharmaceutical fraud involves misclassifying proprietary drugs as generic under the program under the agreement mylan agreed to pay a  million payment and to a sign a corporate integrity agreement requiring it to perform better in the future the settlement also resolved cases brought by states related to the rebates simultaneously with the settlement mylan also announced it was being investigated by the securities and exchange commission related to the drug rebate program in june  the new york times published an article reporting on internal mylan discussions about price increases on the epipen between  and  in which the company chairman expressed disdain for people and agencies who might criticize the company the reporter wrote those top leaders’ responses are a far cry from the message on mylan’s website which says that we challenge every member of every team to challenge the status quo and that we put people and patients first trusting that profits will follow and also noted that the firm is a case study in the limits of what consumer and employee activism as well as government oversight can achieve  execution drugsedit mylan manufactures rocuronium bromide which is approved by the state of alabama for use in executions by lethal injection european manufacturers refuse to sell drugs which can be used for executions to the united states except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain in september  the londonbased human rights organization reprieve told mylan that they were the only fdaapproved manufacturer of rocuronium bromide without legal controls in place to prevent its use in executions and there was a very real risk that mylan may soon become the goto provider of execution drugs for states across the country the german asset manager dje kapital de divested itself of  million in mylan shares for that reason mylan said that their distribution was legally compliant referencesedit  a b public filings  form k mylan investors relations retrieved august     mylan nv k for the fiscal year ended december    mylan buys part of drug maker pittsburgh business times december     mylan laboratories to acquire generics business of merck kgaa for  billion euros medical news today may     pharmaceutical giants tracking mylans prosperity the pittsburgh tribunereview august     egan matt epipen maker faces revolt over execs  million pay package cnn money   transdermal patches  mylan mylantechcom   brand name medicines  mylan deycom   about us mylancom   a b about us mylancom   matrixlabsindiacom matrixlabsindiacom   whats new  arcana arzneimittelherstellung arcanade   httpwwwmantacomcomsdnbcompanywsklv  httpwwwidairelandcomsearchcompaniesxmlssid  httpwwwbioportfoliocomnewspdfusmylantowithdrawqualimedbrandfromfrenchmarketreportpdf  a b c dearment alaric october   milan puskar cofounder of mylan dies drug store news   mylan  years young and still making history mylan retrieved april     myl stock history  mylan retrieved august     a b c d e freudenheim milt september   exposing the fda new york times   lewis ralph a  the emerging effects of the drug price competition and patent term restoration act of  journal of contemporary health law  policy   –   a b ron wolf for the philadelphia inquirer august   smithkline loses exclusive rights to drug  a b boehm garth yao lixin han liang zheng qiang september  development of the generic drug industry in the us after the hatchwaxman act of  acta pharmaceutica sinica b   – doijapsb   a b john seaman and john t landry mylan  years of unconventional success mylan in association with university press of new england  isbn  page   a b strickland carol october   bolar a drug company under siege the new york times   shaw donna february   us charges bolar pharmaceutical with misrepresenting its products philadelphia inquirer   freudenheim milt february   bolar plans guilty plea on generics the new york times   a b c pink sheet october   mylans maxzide is approvable at fda lederle to market brand competition to smithklines no ranked dyazide final approval anticipated imminently  fda approval history nda  maxzide page accessed september    reid kenneth november   us judge to rule on drug marketing journal of commerce   andrews edmund l july   fda inquiry on generic drugs focuses on changes in ingredients the new york times   cimons marlene august   fda to lift ok of last dyazide generic version los angeles times   bolar and mylan team to purchase somerset labs pink sheet november     somerset eldepryl june  approval clears way for mylanbolar acquisition pink sheet june     a b ku mannching sherry december   recent trends in specialty pharma business model journal of food and drug analysis   – doijjfda   mylan form k annual report for the financial year ending march    filed june    a b labaton stephen december   a drug maker is said to face a suit on prices the new york times   press release ftc reaches record financial settlement to settle charges of pricefixing in generic drug market  federal trade commission ftc november     labaton stephen july   genericdrug maker agrees to settlement in pricefixing case the new york times   a b creswell julie march   icahn the spoiler fortune   pollack andrew november   icahn offers  billion for mylan drug maker the new york times   okeefe eric may   icahn slate wins seats on blockbuster board the new york times   lazo shirley a survival strategy barrons   icahn drops bid for mylan los angeles times bloomberg news july     mylan signs usmil takeover deal for indias matrix laboratories ihs august     mylans acquisition of matrix business strategy case study icrm   massey steve may   mylan buys merck generic drug unit for  billion pittsburgh postgazette   press release mylan completes acquisition of generics business of merck kgaa mylan october     a b c d e f g cynthia koons and robert langreth for bloomberg businessweek september   how marketing turned the epipen into a billiondollar business  johnson carolyn y ho catherine august   how mylan the epipen company maneuvered to create a virtual monopoly the washington post via the chicago tribune   adams russell october   mylan again sues pittsburgh postgazette wall street journal retrieved august     sabatini patricia boselovic len july   mylan workers overrode drug quality controls internal report detailed pervasive practice of ignoring safety procedures pittsburgh postgazette retrieved august     edwards jim july   its not mylans first quality control beef with fda money watch cbs news retrieved august     mylan pittsburgh postgazette settle lawsuits cbs news associated press february   retrieved august     us department of justice october   press release four pharmaceutical companies pay  million for submission of false claims to medicaid  mylan acquires rights to pfizers inhaler technology drugstorenewscom retrieved may     stanton dan june   gsk breathes freely as mylan launches seretide generic in uk inpharma technologist   helfand carly february   mylan joins the advaircopycat queue but approval could be a long slog fiercepharma   swetlitz ike silverman ed august   mylan may have violated antitrust law in its epipen sales to schools pbs newshour   a b odonnell jayne september   family matters epipens had highlevel help getting into schools usa today   thomas katie february   mylan buys drug maker of generic injectables new york times   palmer eric august   updated fda castigates three mylan sterile drug plants in warning letter fiercepharma   novak matt august   how congress the fda and sarah jessica parker helped epipen become a  billion business gizmodo   abc news business news personal finance and money news  abc news abc news retrieved july     us drugmaker mylan to acquire famy care for  million timesofindiaeconomictimes february     a b duhigg charles  june  outcry over epipen prices hasn’t made them lower the new york times   koons cynthia november   mylans hostile bid for perrigo fails bloomberg   rockoff jonathan d mattioli dana april   teva offers to buy mylan for  billion wall street journal   teva to buy allergans generic drug unit bloombergcom july     chitra somayaji july   teva snaps up allergans generics arm dumping mylan bloombergcom   mylan to codevelop pulmatrix copd candidate gen   mylan to acquire meda for b  gen news highlights  gen retrieved august     mylan snaps up dermatology biz from investors in b deal  fiercepharma retrieved august     a b c tara parkerpope and rachel rabkin peachman for the new york times august   epipen price rise sparks concern for allergy sufferers  bartolotta devin august   cost jumps nearly percent for lifesaving epipens cbs baltimore retrieved august     goldberg kenny people with food allergies say lifesaving drug too expensive kpbs public media retrieved june     walker joseph winslow ron steele anne august   mylan to launch cheaper generic epipen alternative wall street journal   a b c thomas katie october   mylan to settle epipen overpricing case for  million the new york times   thomas katie   states accuse generic drug companies of price fixing the new york times retrieved    a b erman michael may   mylan may have overcharged us for epipen by  billion hhs reuters new york retrieved may     king pharmaceuticals october   press release king pharmaceuticals to acquire meridian medical technologies  carly helfand for fiercepharma march   fda swats down tevas epipen copy putting mylan in cruise control  a b emily willingham for forbes august   why did mylan hike epipen prices  because they could  emma court for marketwatch august   mylan’s epipen price increases are valeantlike in size shkrelilike in approach  brad tuttle for time august    signs that epipen prices are completely out of control  michael hiltzik for the los angeles times august   another reason to hate mylan which jacked up the price of lifesaving epipens its a tax dodger  matt novak for gizmodo august   how congress the fda and sarah jessica parker helped epipen become a  billion business  beth snyder bulik for fiercepharma may   no holds barred in mylan’s ultrarealistic peanut allergy campaign  mylan to provide epipen cost assistance as ceo is asked to testify on price hike the guardian   a b carolyn y johnson august   why mylan’s ‘savings card’ won’t make epipen cheaper for all patients washington post washington post   larson erik hopkins jared s september   mylan’s epipen school sales trigger ny antitrust probe bloomberg retrieved september     feeley jef langreth robert september   mylan investigations mount as west virginia opens fraud probe bloomberg news   popken ben september   upgraded epipens torn apart tech firm its the same core device nbc news   tracy seipel silicon valley engineers figure real cost to make lifesaving autoinjector twopack the mercury news retrieved october     thomas katie september   is epipen a brandname or a generic drug mylan casts it both ways the new york times   mole beth october   for ripping off medicaid epipen maker mylan pays feds  million ars technica retrieved october     ztracer zachary tracer october   mylan agrees to  million epipen settlement with us bloombergcom   novak matt  june  drug company chairman to america go fuck yourself gizmodo   mole beth  june  mylan chairman drug pricing critics ought to go copulate with themselves ars technica   loew derek  june  mylan begins harvesting the crop its sown in the pipeline   a b owen dyer october   drug company is targeted for refusing to adopt ban on distribution of execution drug bmj   g doibmjg  external linksedit media related to mylan at wikimedia commons business data for mylan google finance yahoo finance reuters sec filings v t e pittsburgh history timeline culture dialect media neighborhoods notable people skyscrapers government airport conventions city hall courthouse mayor council events intergov police da sheriff fire libraries transit education port regional economy allegheny conference duquesne club chamber of commerce economic club hyp club stock exchange fortune  headquarters us steel pnc ppg heinz wesco consol dicks allegheny technologies forbes largest private companies  lumber giant eagle other headquarters american bridge american eagle ampco ansys armstrong black box calgon carbon compunetix dollar bank dqe eatn park education management corporation eqt federated gnc gurucom highmark igate iron city kennametal koppers laughlin marc usa millcraft msa nichecom oxford ptc renda rue upmc vocelli wabtec shared headquarters alcoa modcloth nova chemicals subsidiary headquarters allegheny energy bayer corporation fedex ground glaxosmithkline usa lanxess respironics vivisimo westinghouse regional operations aa bny mellon formerly mellon financial dreyfus eaton spreadshirt macys historic big wheel clark dravo fisher integra mesta murphy gulf oil jl ketchum rockwell sunbeam westinghouse sports dapper dan grand prix great race head of the ohio lore marathon mylan classic regatta wphl baseball pirates wild things panthers dukes chronicletelegraph cup allegheny burghers champions crawfords filipinos grays hardhats keystones stogies rebels basketball yellow jackets panthers m panthers w dukes m dukes w colonials m colonials w roundball classic condors ironmen loendi monticello phantoms pipers piranhas pirates rens xplosion football steelers panthers steeler nation heritage colts force passion renegades  allstars allegheny americans as duquesne gladiators homestead lyceum maulers power odds olympics quakers jp stars early pro football circuit hockey penguins colonials m colonials w three rivers classic as bankers cougars duquesne ft pitt hornets keystones lyceum panthers phantoms pirates pirates wphl pros shamrocks victorias winter garden yellow jackets soccer riverhounds beadling cannons hurricanes phantoms spirit other sledgehammers bulls harlequins pcc triangles wallabies studio wrestling dirty dozen venues ppg paints arena heinz field pnc park  lumber arena fitzgerald field house highmark stadium palumbo center petersen events center petersen sports complex rooney field sewall center trees hall central park civic arena duquesne gardens exposition park forbes field josh gibson field greenlee field motor square garden pitt stadium recreation park schenley gardens three rivers winter garden parks allegheny arsenal allegheny commons allegheny riverfront artgardens buhl community chatham university arboretum frank curto frick emerald view highland market square mellon mellon green mellon square north shore riverfront phillips point of view point state ppg place riverview roberto clemente memorial rodef shalom biblical botanical garden schenley schenley plaza south shore riverfront south side three rivers west end overlook westinghouse transportation inclines steps v t e port authority of allegheny county light rail list of stations blue line – library blue line – south hills village red line inclines historical list duquesne incline monongahela incline buses and busways list of routes martin luther king jr east busway south busway west busway former lines  drake brown line patrain skybus other north shore connector port authority  series pcc wabash tunnel v t e public transportation in greater pittsburgh bus services port authority of allegheny county list of bus routes beaver butler fayette indigo mid mon valley mountain line new castle town  country university of pittsburgh washington westmoreland bus rapid transit mlk jr east busway south busway west busway light rail red line blue line library south hills village inclines duquesne monongahela amtrak capitol limited pennsylvanian airports pittsburgh international arnold palmer allegheny county beaver butler eddie dew greensburg jeannette herron jefferson jimmy stewart joe hardy lakehill monroeville new castle rock rostraver washington wheeling zelienople discontinued broadway limited brown line list of streetcar routes in pittsburgh parkway limited patrain skybus v t e tunnels and bridges in pittsburgh tunnels allegheny river tunnel armstrong tunnel cork run tunnel corliss tunnel fort pitt tunnel jl tunnel liberty tunnel mount washington transit tunnel pittsburgh and castle shannon tunnel pittsburgh  steubenville extension railroad tunnel schenley tunnel squirrel hill tunnel wabash tunnel bridges th street bridge st street bridge rd street railroad bridge th street bridge bloomfield bridge birmingham bridge david mccullough bridge fort duquesne bridge fort pitt bridge fort wayne railroad bridge glenwood bridge glenwood bo railroad bridge highland park bridge homestead grays bridge hot metal bridge liberty bridge mckees rocks bridge panhandle bridge panther hollow bridge schenley bridge senator robert d fleming bridge smithfield street bridge south tenth street bridge three sisters roberto clemente bridge andy warhol bridge rachel carson bridge veterans bridge west end bridge attractions aviary baywood cathedral of learning chinatown conservatory dippy immaculate heart duquesne incline heinz chapel little italy mellon institute mon incline observatory pamelas penn station point of view sculpture primantis science center steps uss requin zoo kennywood luna park westinghouse sign landmarks national city national county state city phlf cultural museums art arts arts festival bible fort pitt and blockhouse clayton clemente childrens frick glass center history jazz jewish mattress factory dental miller miss pittsburgh nationality rooms national map natural history soldiers and sailors warhol wilson wsg venues heinz hall benedum byham harris kellystrayhorn new hazlett oreilly foster playhouse trib hunt stage ae syria mosque nixon theater festivals anthrocon arts blues comicon fashion film folk handmade new works tekko whiskey  fine spirits wine shopping and entertainment casino gateway clipper fleet station square strip downtown oakland south side macys market square southside works waterworks mount washington east liberty squirrel hill shadyside walnut street opera ballet symphony brass classical theatre dance ensemble caravan theatre folk light opera opera theater jewish theatre public theater playwrights musical theater stage right youth ballet youth symphony bricolage nnoc v t e shopping malls in pittsburgh enclosed beaver valley mall the block northway century iii mall the galleria of mt lebanon the mall at robinson monroeville mall pittsburgh mills ross park mall south hills village station square uniontown mall warner centre washington crown center westmoreland mall lifestyle  outdoor bakery square edgewood towne centre ellsworth avenue mccandless crossing northern lights robinson town centre settlers ridge southside works walnut street the waterfront waterworks mall outlet grove city premium outlets tanger outlets pittsburgh defunct allegheny center mall east hills shopping center eastgate commerce center eastland mall greengate mall parkway center mall village square mall washington mall colleges and universities pitt carnegie mellon duquesne robert morris chatham point park carlow art institute byzantine catholic seminary pittsburgh theological seminary saint paul seminary ccac culture of pittsburgh cookie table jewish history iron city brewing company jagoff joe magarac mister rogers neighborhood mr yuk parking chairs pittsburgh left pittsburgh toilet robot hall of fame steeler nation book category portal v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlemylanoldid categories companies in the nasdaq indexcompanies listed on nasdaqcorporate inversionspharmaceutical companies of the united statescompanies in the nasdaq biotechnology indexlife sciences industryhealth care companies based in pennsylvaniacompanies listed on tasecompanies formerly listed on the new york stock exchangehidden categories use mdy dates from october all articles with unsourced statementsarticles with unsourced statements from september interlanguage link template link number navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutschespañolفارسیfrançaisעבריתportuguêssuomi edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view mylan  wikipedia mylan from wikipedia the free encyclopedia jump to navigation search mylan trading name mylan nv formerly called milan type public under dutch law traded as nasdaq myl tase myl nasdaq biotechnology component nasdaq component sp  component isin us industry pharmaceuticals founded   years ago  in white sulphur springs west virginia united states founders milan puskar don panoz headquarters canonsburg pennsylvania united states of america area served worldwide key people heather bresch ceo products generic and specialty pharmaceuticals and active pharmaceutical ingredients revenue us billion  operating income us million  net income us billion  total assets us  billion  total equity us billion  number of employees   divisions see operations subsidiaries meda famy care website wwwmylancom mylan nv is an american global generic and specialty pharmaceuticals company registered in the netherlands with principal executive offices in hatfield hertfordshire uk and global headquarters in canonsburg pennsylvania us in  mylan acquired a controlling interest in indiabased matrix laboratories limited a top producer of active pharmaceutical ingredients apis for generic drugs and the generics business of germanybased merck kgaa through these acquisitions mylan grew from the thirdlargest generic and pharmaceuticals company in the united states to the secondlargest generic and specialty pharmaceuticals company in the world in  mylans pricing of the epipen an epinephrine autoinjector became controversial and was widely referred to as price gouging as a result investigations were opened into whether mylan had misclassified the epipen under the medicaid drug rebate program a common form of pharmaceutical fraud in october  mylan settled these investigations with the us department of justice agreeing to pay  million and enter into a corporate integrity agreement concerning the rebate program in a report published on june   the institutional shareholder services criticized mylan for the outsized compensation of mylans directors former ceo robert coury received a  million  pay package in spite of the harm to the company inflicted by the epipen controversies and steep shareholder losses the report urged mylans shareholders to oust all of mylans existing directors contents  operations  location  stock  history  acquisition history  criticism  epipen pricing  execution drugs  references  external links operationsedit mylan inc operates several divisions and subsidiaries in north america and south america mylan operates mylan pharmaceuticals based in morgantown west virginia mylan pharmaceuticals ulc mylan canada mylan technologies inc mti  transdermal drug delivery systems tdds and related technologies udl laboratories inc somerset pharmaceuticals inc a research and development company in tampa florida owned by mylan somerset develops emsam manufactured by mylan technologies and marketed in the united states by dey another mylan company mylan laboratories limited campos dos goytacazes brazil in oceania and central east south and southeast asia mylan operates mylan new zealand limited  new zealand mylan laboratories limited  headquartered in hyderabad india operates nine active pharmaceutical ingredient api and intermediate manufacturing facilities located in india and china mylan seiyaku ltd  japan alphapharm  australia agila specialties pvt ltd  india oncotherapies ltd  india in europe africa and west asia mylan operates operates under the mylan name in austria belgium the czech republic denmark finland france germany hungary italy the netherlands norway poland portugal slovakia slovenia spain sweden switzerland the united kingdom also operates in south africa arcana arzneimittel gmbh  germany generics pharma hellas  greece gerard laboratories  ireland qualimed  trademark in france but will stop being marketed under the brand name docpharma  generic pharmaceutical distribution company in belgium the netherlands and luxembourg locationedit founded in  the company was first located in white sulphur springs west virginia the company moved to morgantown west virginia in  and in  it relocated its corporate headquarters to the pittsburgh suburb canonsburg pennsylvania finally in  it moved to a new office center in nearby southpointe a suburban business park located in cecil township where it is still located stockedit on february   mylan had its initial public offering ipo becoming a publicly traded company on the otc market under the ticker symbol myln in  the stock moved to nasdaq their final stock move was in  when their stock became available for trade on the new york stock exchange under the ticker symbol myl currently the stock is traded on the nasdaq historyedit mylan pharmaceuticals was founded as a drug distributor in  by milan puskar and don panoz in  mylan began manufacturing penicillin g tablets as well as vitamins and other dietary supplements panoz left mylan in  and puskar quit the company in  as it grew and experienced financial difficulties the board hired roy mcknight as board chairman who convinced puskar to return in  mylan discontinued operating as a contract manufacturing organization in  and instead chose to market their products under their own mylanlabeled brandcitation needed with the passage of the hatchwaxman act in  mylan and other small generic companies gained value in the eighteen months following passage of the law mylans earnings grew  to  million and its stock value rose  in the s one of the most prescribed drugs in the us was dyazide a diuretic that was a combination drug containing triamterene and hydrochlorothiazide it had been on the market since  and its patents had expired in  complications arose with the introductions of generics versions because the formulation of dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent some generic companies committed fraud trying to bring a generic version of dyazide bolar pharmaceutical had the first generic version approved in  but it turned out that bolar had fraudulently substituted dyazide for its own version to conduct studies that were submitted to the fda by  the fda rescinded its approval based on its suspicions and filed criminal charges against bolar to which bolar eventually pled guilty in  mylan chose to develop a new version of a triamterenehydrochlorothiazide combination drug instead of going the generic route it developed a different more stable formulation and used different dosages of each active ingredient  mg hydrochlorothiazide and  mg triamterene compared with dyazides  mg hydrochlorothiazide and  mg triamterene this drug had to get approval as a new drug as opposed to a generic their product was called maxzide and was approved in  the higher dose allowed once per day dosing which mylan and its marketing partner lederle believed would help it compete against dyazide which had m in sales in  however mylans patents on the drug were declared invalid in court and its marketing exclusivity expired in  prompting a rush of generic competition mylan had concerns about the practices of its competitors and the fda in general and also with regard to companies seeking to bring generic versions of maxzide mylan hired private investigators to examine its competitors practices and when it found evidence of corruption it submitted it to the house oversight and investigations committee which investigated and found fraud and corruption within the food and drug administrations generic drugs division and at other generic companies two of the companies that had gotten approval to market generic versions of maxzide vitarine pharmaceutical and par pharmaceutical were targets of mylans initial investigation and were found to have used mylans maxzide to obtain their bioequivalence data leading both companies to withdraw its generic competitor to mylans product the corruption in the nascent generics industry and at the office in the fda regulating it was widely covered in the media and led to widespread concern among doctors and the public in the late s and early s that generic drugs were not really the same as the branded drugs they were meant to replace in  mylan agreed to enter into a joint venture with bolar to buy somerset pharmaceuticals mylan wanted access to somersets drug discovery capabilities as well as its new drug for parkinsons selegiline the deal was completed in  but its consummation was dependent on fda approval of selegiline which came in  mylan acquired bertek inc in  for its transdermal patch technologies and kept as a subsidiary in  mylan renamed the company mylan technologies inc mti mti eventually came to be the contract manufacturer for the selegiline transdermal patch and was the first company to market generic nitroglycerin estradiol clonidine and fentanyl transdermal patches mylan acquired udl laboratories a supplier of unit dose generic medications to institutional and longterm care facilities in  in  when it was the worlds second largest generics company mylan came under investigation from the federal trade commission after it raised the prices of its products tripling them in the case of lorazepam mylan had entered into an exclusive agreement with profarmica an italian company that supplied drug ingredients after which mylans competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs before the round of price increases the price of generic drugs had been    of the price of branded drugs and afterwards it was around  the ftc filed suit at the end of  and  states filed parallel actions the case was settled in  with mylan paying a total of m  m in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid  million in attorneys fees to the state attorneys general  million plus  million in attorneys fees to settle certain class actions with insurers and managed care organizations  and mylan and three ingredient suppliers cambrex corporation profarmaco srl and gyma laboratories also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future in  mylan and king pharmaceuticals began discussing a deal in which mylan would acquire king for about b mylan wanted to expand its presence in branded pharmaceuticals and to acquire kings sales force the deal became one of the business soap operas of the year and included an sec investigation into kings accounting and carl icahn obtaining a  interest in mylan and becoming its largest stakeholder in order to kill the deal the parties called off the deal in february  icahn offered to buy mylan for b and ran a slate of board members to change the direction of mylan he won three seats in may  in june mylan bought back  of its shares in order to fend off icahn and in july icahn gave up his bid and sold his shares in august  mylan announced that it had reached agreement to buy a controlling interest in matrix laboratories an indian supplier of active pharmaceutical ingredients the deal gave mylan access to markets in india and china and was completed in january the next year in may  mylan and merck kgaa agreed that mylan would acquire mercks generics arm for b the deal was completed that october and tripled the size of mylan mylan acquired the rights to market the epipen in the transaction at that time annual sales were around  million and the epipen had about  of the market in  the company filed two lawsuits against the pittsburgh postgazette after the newspaper ran an article that was critical of the quality control procedures used at the companys morgantown plant the company had earlier quality control issues involving the fda the lawsuits were dropped in  without any damages paid by the postgazette which stated the postgazette did not find and did not intend to report that mylan had manufactured or distributed any defective drugs the postgazette regrets if any reader of the article thought otherwise also in  mylan and its subsidiary udl agreed to pay a m to settle a suit filed under the false claims act in which mylanudl and two other companies were accused of underpaying states under the medicaid drug rebate program the program requires drug companies to give rebates to states under medicaid and the rebates are higher for new drugs than for generics the suit said that the companies sold new drugs but paid rebates as if they were generics in  mylan entered into an agreement with pfizer for the exclusive worldwide rights to develop manufacture and commercialize pfizers generic equivalent to glaxosmithklines advair usseretide uk diskus incorporating pfizers proprietary dry powder inhaler delivery platform mylan launched the product in the uk in  and in february  the fda accepted its anda putting it in line behind hikma and sandoz to launch a generic version in the us in  mylan launched a program called epipenschools to sell epipens in bulk and with discounts to schools to participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year in december  the national association of state boards of education launched a policy initiative designed to help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine autoinjector access and use and advocated for state laws protecting school from legal liability for stocking and using epinephrine autoinjectors gayle manchin the mother of mylans ceo heather bresch had become president of the association in  and shortly after had discussed donations from her daughters company to the association manchin had been appointed to the west virginia state school board by her husband thengovernor of the state joe manchin in  in  mylan acquired an indian generic injectable drugs company agila specialties private for  billion in cash in  three plants acquired in that deal were issued warning letters by the fda after successful lobbying from mylan in  the school access to emergency epinephrine act became law after passing congress with broad and bipartisan support it protected anyone from liability if they administered epinephrine to a child in a school previously only trained professionals or the affected person were allowed to administer the drug and were open to liability and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them joe manchin the father of mylans ceo was a senator at that time in july  mylan and abbott laboratories announced an agreement under which mylan would buy abbotts generic drugs business in developed markets for stock valued at about  billion mylan acquired mumbaibased famy care and expand its presence in the market for womens contraceptives at about  million starting in  according to a  report in the new york times midlevel executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the epipen and raising concerns that the price increases were unethical the times reported that when these concerns were brought to robert coury the chairman of the board coury replied that he was untroubled he raised both his middle fingers and explained using colorful language that anyone criticizing mylan including its employees ought to go copulate with themselves critics in congress and on wall street he said should do the same and regulators at the food and drug administration they too deserved a round of anatomically challenging selffulfillment  the times reported that bresch provided similarly dismissive responses in april  mylan tried negotiate with the management of irish pharmaceutical firm perrigo to acquire the company and when those negotiations failed mylan attempted a hostile takeover offering to buy b in shares directly from shareholders too few shareholders agreed to sell their stock by the deadline set in november  and the effort failed two weeks after mylan made its first offer for perrigo teva pharmaceutical offered to buy mylan for b the combined companies would have been the worlds largest generic company and the th biggest drug company in the world in july teva dropped its bid for mylan and instead acquired allergans generic drug business for about the same price in june  mylan agreed to work with pulmatrix a company with a proprietary inhaled drug delivery platform to codevelop a product to treat for chronic obstructive pulmonary disease the product was pur a generic drug in a pulmatrix device in february  the company announced it would acquire meda for  billion in may of the same year the company announced it would acquire renaissance acquisition holdings dermatology division for up to  billion in  mylan had about b in sales of epipens and those sales accounted for  of mylans profit mylan had maintained about a  market share since it had acquired the product and had continually raised the price of epipens starting in  in  the wholesale price of two epipens was about  by july  the price was about  in may  it was around  and in may  the price rose again to around  around a  jump from the price in  in the summer of  as parents prepared to send their children back to school and went to pharmacies to get new epipens people began to express outrage at the cost of the epipen and mylan was widely and harshly criticized the price hikes led to investigations by congress and states attorneys general in october  mylan agreed to pay a m fine related to incorrect rebates it paid under the medicaid drug rebate program in december  the attorneys general of  states filed a civil complaint accusing mylan of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug the complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings telephone calls and text messages according to the department of health and human services office of inspector general analysis the us government may have overpaid as much as  billion between  and  to drugmaker mylan nv for the epipen emergency allergy treatment this represents three times the proposed settlement of  million announced by mylan in october  republican senator chuck grassley chair of the senate judiciary committee that launched the probe of epipen pricing probe in  released the analysis on may   on the same day a group of mylan investment funds urged shareholders to vote against the reelection of the companys directors after it paid chairman robert coury over  million last year acquisition historyedit the following is an illustration of the companys major mergers and acquisitions and historical predecessors mylan   renaissance acquisition holdings dermatology div acq    meda acq    famy care acq    abbott laboratories generics div acq    merck kgaa generics div acq  renamed mylan laboratories inc   udl laboratories acq    bertek inc acq  renamed mylan technologies inc milan pharmaceuticals founded  criticismedit epipen pricingedit see also epinephrine autoinjector § cost see also heather bresch § business executive mylan acquired the right to market and distribute the epipen line of epinephrine autoinjector devices from merck kgaa as part of their  deal that right had formerly been held by dey lp a wholly owned subsidiary of merck the devices deliver about  worth of drug at that time annual sales were around m bresch the companys ceo saw an opportunity to increase sales through marketing and advocacy and the company launched a marketing campaign to increase awareness of the dangers of anaphylaxis for people with severe allergies that made the brand epipen as identified with its product as kleenex is with facial tissue the company also successfully lobbied the fda to broaden the label to include risk of anaphylaxis and in parallel successfully lobbied congress to generate legislation making epipens available in schools and in public places like defibrillators are and hired the same people that medtronic had worked with on defibrillator legislation to do so mylans efforts to gain market dominance were aided when sanofis competing product was recalled in november  and further when tevas generic competitor was rejected by the fda in march  by the first half of  mylan had an  market share of such devices in the us and in that year sales reached around b and accounted for  of mylans profit those profits were also due in part to mylans continually raising the price of epipens starting in  in  the wholesale price of two epipens was about  the price was about the same in  by july  the price about  in may  it was around  and in may  the price rose again to around  the last price increase sparked widespread outrage including criticism from martin shkreli poster boy for grasping pharma greed letters from two senators and initiation of congressional investigations and mylans pricing of the epipen was widely referred to as price gouging the last price increase coincided with a new line of tv commercials that were described as shocking and no holds barred depicting an anaphylactic reaction from the point of view of the young woman having it at a party and ending with the young woman seeing her swollen and hivecovered face in the mirror before she collapses in response to criticism mylan increased financial assistance available for some patients to purchase epipens a gesture that was called a classic public relations move by harvard medical school professor aaron kesselheim the up to  saving cards can only be used by a small number of people who need the drug and no one on medicaid they do nothing about the high price which is still being paid by insurers who ultimately pass the cost onto consumers in september  the new york state attorney general began an investigation into mylans epipenschools program in new york to determine if the programs contracts violated antitrust law and the west virginia state attorney general opened an investigation into whether mylan had given the state the correct discount under the medicaid drug rebate program and subpoenaed the company when it refused to provide the documentation the state requested in october  the ceo of mylan testified to congress that pfizerking charged mylan about  for one device in september  a silicon valley engineering consultancy performed a teardown analysis of the epipen and estimated the manufacturing and packaging costs at about  for a twopack in october  mylan announced a settlement with the us department of justice over rebates paid by mylan to states under the medicaid drug rebate program questions had been raised by congress and others about why epipen had been classified as a generic rather a proprietary product in the program since  generic drugs have lower rebates  than proprietary drugs  and price hikes for generic drugs cannot be passed onto states and a common form of pharmaceutical fraud involves misclassifying proprietary drugs as generic under the program under the agreement mylan agreed to pay a  million payment and to a sign a corporate integrity agreement requiring it to perform better in the future the settlement also resolved cases brought by states related to the rebates simultaneously with the settlement mylan also announced it was being investigated by the securities and exchange commission related to the drug rebate program in june  the new york times published an article reporting on internal mylan discussions about price increases on the epipen between  and  in which the company chairman expressed disdain for people and agencies who might criticize the company the reporter wrote those top leaders’ responses are a far cry from the message on mylan’s website which says that we challenge every member of every team to challenge the status quo and that we put people and patients first trusting that profits will follow and also noted that the firm is a case study in the limits of what consumer and employee activism as well as government oversight can achieve  execution drugsedit mylan manufactures rocuronium bromide which is approved by the state of alabama for use in executions by lethal injection european manufacturers refuse to sell drugs which can be used for executions to the united states except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain in september  the londonbased human rights organization reprieve told mylan that they were the only fdaapproved manufacturer of rocuronium bromide without legal controls in place to prevent its use in executions and there was a very real risk that mylan may soon become the goto provider of execution drugs for states across the country the german asset manager dje kapital de divested itself of  million in mylan shares for that reason mylan said that their distribution was legally compliant referencesedit  a b public filings  form k mylan investors relations retrieved august     mylan nv k for the fiscal year ended december    mylan buys part of drug maker pittsburgh business times december     mylan laboratories to acquire generics business of merck kgaa for  billion euros medical news today may     pharmaceutical giants tracking mylans prosperity the pittsburgh tribunereview august     egan matt epipen maker faces revolt over execs  million pay package cnn money   transdermal patches  mylan mylantechcom   brand name medicines  mylan deycom   about us mylancom   a b about us mylancom   matrixlabsindiacom matrixlabsindiacom   whats new  arcana arzneimittelherstellung arcanade   httpwwwmantacomcomsdnbcompanywsklv  httpwwwidairelandcomsearchcompaniesxmlssid  httpwwwbioportfoliocomnewspdfusmylantowithdrawqualimedbrandfromfrenchmarketreportpdf  a b c dearment alaric october   milan puskar cofounder of mylan dies drug store news   mylan  years young and still making history mylan retrieved april     myl stock history  mylan retrieved august     a b c d e freudenheim milt september   exposing the fda new york times   lewis ralph a  the emerging effects of the drug price competition and patent term restoration act of  journal of contemporary health law  policy   –   a b ron wolf for the philadelphia inquirer august   smithkline loses exclusive rights to drug  a b boehm garth yao lixin han liang zheng qiang september  development of the generic drug industry in the us after the hatchwaxman act of  acta pharmaceutica sinica b   – doijapsb   a b john seaman and john t landry mylan  years of unconventional success mylan in association with university press of new england  isbn  page   a b strickland carol october   bolar a drug company under siege the new york times   shaw donna february   us charges bolar pharmaceutical with misrepresenting its products philadelphia inquirer   freudenheim milt february   bolar plans guilty plea on generics the new york times   a b c pink sheet october   mylans maxzide is approvable at fda lederle to market brand competition to smithklines no ranked dyazide final approval anticipated imminently  fda approval history nda  maxzide page accessed september    reid kenneth november   us judge to rule on drug marketing journal of commerce   andrews edmund l july   fda inquiry on generic drugs focuses on changes in ingredients the new york times   cimons marlene august   fda to lift ok of last dyazide generic version los angeles times   bolar and mylan team to purchase somerset labs pink sheet november     somerset eldepryl june  approval clears way for mylanbolar acquisition pink sheet june     a b ku mannching sherry december   recent trends in specialty pharma business model journal of food and drug analysis   – doijjfda   mylan form k annual report for the financial year ending march    filed june    a b labaton stephen december   a drug maker is said to face a suit on prices the new york times   press release ftc reaches record financial settlement to settle charges of pricefixing in generic drug market  federal trade commission ftc november     labaton stephen july   genericdrug maker agrees to settlement in pricefixing case the new york times   a b creswell julie march   icahn the spoiler fortune   pollack andrew november   icahn offers  billion for mylan drug maker the new york times   okeefe eric may   icahn slate wins seats on blockbuster board the new york times   lazo shirley a survival strategy barrons   icahn drops bid for mylan los angeles times bloomberg news july     mylan signs usmil takeover deal for indias matrix laboratories ihs august     mylans acquisition of matrix business strategy case study icrm   massey steve may   mylan buys merck generic drug unit for  billion pittsburgh postgazette   press release mylan completes acquisition of generics business of merck kgaa mylan october     a b c d e f g cynthia koons and robert langreth for bloomberg businessweek september   how marketing turned the epipen into a billiondollar business  johnson carolyn y ho catherine august   how mylan the epipen company maneuvered to create a virtual monopoly the washington post via the chicago tribune   adams russell october   mylan again sues pittsburgh postgazette wall street journal retrieved august     sabatini patricia boselovic len july   mylan workers overrode drug quality controls internal report detailed pervasive practice of ignoring safety procedures pittsburgh postgazette retrieved august     edwards jim july   its not mylans first quality control beef with fda money watch cbs news retrieved august     mylan pittsburgh postgazette settle lawsuits cbs news associated press february   retrieved august     us department of justice october   press release four pharmaceutical companies pay  million for submission of false claims to medicaid  mylan acquires rights to pfizers inhaler technology drugstorenewscom retrieved may     stanton dan june   gsk breathes freely as mylan launches seretide generic in uk inpharma technologist   helfand carly february   mylan joins the advaircopycat queue but approval could be a long slog fiercepharma   swetlitz ike silverman ed august   mylan may have violated antitrust law in its epipen sales to schools pbs newshour   a b odonnell jayne september   family matters epipens had highlevel help getting into schools usa today   thomas katie february   mylan buys drug maker of generic injectables new york times   palmer eric august   updated fda castigates three mylan sterile drug plants in warning letter fiercepharma   novak matt august   how congress the fda and sarah jessica parker helped epipen become a  billion business gizmodo   abc news business news personal finance and money news  abc news abc news retrieved july     us drugmaker mylan to acquire famy care for  million timesofindiaeconomictimes february     a b duhigg charles  june  outcry over epipen prices hasn’t made them lower the new york times   koons cynthia november   mylans hostile bid for perrigo fails bloomberg   rockoff jonathan d mattioli dana april   teva offers to buy mylan for  billion wall street journal   teva to buy allergans generic drug unit bloombergcom july     chitra somayaji july   teva snaps up allergans generics arm dumping mylan bloombergcom   mylan to codevelop pulmatrix copd candidate gen   mylan to acquire meda for b  gen news highlights  gen retrieved august     mylan snaps up dermatology biz from investors in b deal  fiercepharma retrieved august     a b c tara parkerpope and rachel rabkin peachman for the new york times august   epipen price rise sparks concern for allergy sufferers  bartolotta devin august   cost jumps nearly percent for lifesaving epipens cbs baltimore retrieved august     goldberg kenny people with food allergies say lifesaving drug too expensive kpbs public media retrieved june     walker joseph winslow ron steele anne august   mylan to launch cheaper generic epipen alternative wall street journal   a b c thomas katie october   mylan to settle epipen overpricing case for  million the new york times   thomas katie   states accuse generic drug companies of price fixing the new york times retrieved    a b erman michael may   mylan may have overcharged us for epipen by  billion hhs reuters new york retrieved may     king pharmaceuticals october   press release king pharmaceuticals to acquire meridian medical technologies  carly helfand for fiercepharma march   fda swats down tevas epipen copy putting mylan in cruise control  a b emily willingham for forbes august   why did mylan hike epipen prices  because they could  emma court for marketwatch august   mylan’s epipen price increases are valeantlike in size shkrelilike in approach  brad tuttle for time august    signs that epipen prices are completely out of control  michael hiltzik for the los angeles times august   another reason to hate mylan which jacked up the price of lifesaving epipens its a tax dodger  matt novak for gizmodo august   how congress the fda and sarah jessica parker helped epipen become a  billion business  beth snyder bulik for fiercepharma may   no holds barred in mylan’s ultrarealistic peanut allergy campaign  mylan to provide epipen cost assistance as ceo is asked to testify on price hike the guardian   a b carolyn y johnson august   why mylan’s ‘savings card’ won’t make epipen cheaper for all patients washington post washington post   larson erik hopkins jared s september   mylan’s epipen school sales trigger ny antitrust probe bloomberg retrieved september     feeley jef langreth robert september   mylan investigations mount as west virginia opens fraud probe bloomberg news   popken ben september   upgraded epipens torn apart tech firm its the same core device nbc news   tracy seipel silicon valley engineers figure real cost to make lifesaving autoinjector twopack the mercury news retrieved october     thomas katie september   is epipen a brandname or a generic drug mylan casts it both ways the new york times   mole beth october   for ripping off medicaid epipen maker mylan pays feds  million ars technica retrieved october     ztracer zachary tracer october   mylan agrees to  million epipen settlement with us bloombergcom   novak matt  june  drug company chairman to america go fuck yourself gizmodo   mole beth  june  mylan chairman drug pricing critics ought to go copulate with themselves ars technica   loew derek  june  mylan begins harvesting the crop its sown in the pipeline   a b owen dyer october   drug company is targeted for refusing to adopt ban on distribution of execution drug bmj   g doibmjg  external linksedit media related to mylan at wikimedia commons business data for mylan google finance yahoo finance reuters sec filings v t e pittsburgh history timeline culture dialect media neighborhoods notable people skyscrapers government airport conventions city hall courthouse mayor council events intergov police da sheriff fire libraries transit education port regional economy allegheny conference duquesne club chamber of commerce economic club hyp club stock exchange fortune  headquarters us steel pnc ppg heinz wesco consol dicks allegheny technologies forbes largest private companies  lumber giant eagle other headquarters american bridge american eagle ampco ansys armstrong black box calgon carbon compunetix dollar bank dqe eatn park education management corporation eqt federated gnc gurucom highmark igate iron city kennametal koppers laughlin marc usa millcraft msa nichecom oxford ptc renda rue upmc vocelli wabtec shared headquarters alcoa modcloth nova chemicals subsidiary headquarters allegheny energy bayer corporation fedex ground glaxosmithkline usa lanxess respironics vivisimo westinghouse regional operations aa bny mellon formerly mellon financial dreyfus eaton spreadshirt macys historic big wheel clark dravo fisher integra mesta murphy gulf oil jl ketchum rockwell sunbeam westinghouse sports dapper dan grand prix great race head of the ohio lore marathon mylan classic regatta wphl baseball pirates wild things panthers dukes chronicletelegraph cup allegheny burghers champions crawfords filipinos grays hardhats keystones stogies rebels basketball yellow jackets panthers m panthers w dukes m dukes w colonials m colonials w roundball classic condors ironmen loendi monticello phantoms pipers piranhas pirates rens xplosion football steelers panthers steeler nation heritage colts force passion renegades  allstars allegheny americans as duquesne gladiators homestead lyceum maulers power odds olympics quakers jp stars early pro football circuit hockey penguins colonials m colonials w three rivers classic as bankers cougars duquesne ft pitt hornets keystones lyceum panthers phantoms pirates pirates wphl pros shamrocks victorias winter garden yellow jackets soccer riverhounds beadling cannons hurricanes phantoms spirit other sledgehammers bulls harlequins pcc triangles wallabies studio wrestling dirty dozen venues ppg paints arena heinz field pnc park  lumber arena fitzgerald field house highmark stadium palumbo center petersen events center petersen sports complex rooney field sewall center trees hall central park civic arena duquesne gardens exposition park forbes field josh gibson field greenlee field motor square garden pitt stadium recreation park schenley gardens three rivers winter garden parks allegheny arsenal allegheny commons allegheny riverfront artgardens buhl community chatham university arboretum frank curto frick emerald view highland market square mellon mellon green mellon square north shore riverfront phillips point of view point state ppg place riverview roberto clemente memorial rodef shalom biblical botanical garden schenley schenley plaza south shore riverfront south side three rivers west end overlook westinghouse transportation inclines steps v t e port authority of allegheny county light rail list of stations blue line – library blue line – south hills village red line inclines historical list duquesne incline monongahela incline buses and busways list of routes martin luther king jr east busway south busway west busway former lines  drake brown line patrain skybus other north shore connector port authority  series pcc wabash tunnel v t e public transportation in greater pittsburgh bus services port authority of allegheny county list of bus routes beaver butler fayette indigo mid mon valley mountain line new castle town  country university of pittsburgh washington westmoreland bus rapid transit mlk jr east busway south busway west busway light rail red line blue line library south hills village inclines duquesne monongahela amtrak capitol limited pennsylvanian airports pittsburgh international arnold palmer allegheny county beaver butler eddie dew greensburg jeannette herron jefferson jimmy stewart joe hardy lakehill monroeville new castle rock rostraver washington wheeling zelienople discontinued broadway limited brown line list of streetcar routes in pittsburgh parkway limited patrain skybus v t e tunnels and bridges in pittsburgh tunnels allegheny river tunnel armstrong tunnel cork run tunnel corliss tunnel fort pitt tunnel jl tunnel liberty tunnel mount washington transit tunnel pittsburgh and castle shannon tunnel pittsburgh  steubenville extension railroad tunnel schenley tunnel squirrel hill tunnel wabash tunnel bridges th street bridge st street bridge rd street railroad bridge th street bridge bloomfield bridge birmingham bridge david mccullough bridge fort duquesne bridge fort pitt bridge fort wayne railroad bridge glenwood bridge glenwood bo railroad bridge highland park bridge homestead grays bridge hot metal bridge liberty bridge mckees rocks bridge panhandle bridge panther hollow bridge schenley bridge senator robert d fleming bridge smithfield street bridge south tenth street bridge three sisters roberto clemente bridge andy warhol bridge rachel carson bridge veterans bridge west end bridge attractions aviary baywood cathedral of learning chinatown conservatory dippy immaculate heart duquesne incline heinz chapel little italy mellon institute mon incline observatory pamelas penn station point of view sculpture primantis science center steps uss requin zoo kennywood luna park westinghouse sign landmarks national city national county state city phlf cultural museums art arts arts festival bible fort pitt and blockhouse clayton clemente childrens frick glass center history jazz jewish mattress factory dental miller miss pittsburgh nationality rooms national map natural history soldiers and sailors warhol wilson wsg venues heinz hall benedum byham harris kellystrayhorn new hazlett oreilly foster playhouse trib hunt stage ae syria mosque nixon theater festivals anthrocon arts blues comicon fashion film folk handmade new works tekko whiskey  fine spirits wine shopping and entertainment casino gateway clipper fleet station square strip downtown oakland south side macys market square southside works waterworks mount washington east liberty squirrel hill shadyside walnut street opera ballet symphony brass classical theatre dance ensemble caravan theatre folk light opera opera theater jewish theatre public theater playwrights musical theater stage right youth ballet youth symphony bricolage nnoc v t e shopping malls in pittsburgh enclosed beaver valley mall the block northway century iii mall the galleria of mt lebanon the mall at robinson monroeville mall pittsburgh mills ross park mall south hills village station square uniontown mall warner centre washington crown center westmoreland mall lifestyle  outdoor bakery square edgewood towne centre ellsworth avenue mccandless crossing northern lights robinson town centre settlers ridge southside works walnut street the waterfront waterworks mall outlet grove city premium outlets tanger outlets pittsburgh defunct allegheny center mall east hills shopping center eastgate commerce center eastland mall greengate mall parkway center mall village square mall washington mall colleges and universities pitt carnegie mellon duquesne robert morris chatham point park carlow art institute byzantine catholic seminary pittsburgh theological seminary saint paul seminary ccac culture of pittsburgh cookie table jewish history iron city brewing company jagoff joe magarac mister rogers neighborhood mr yuk parking chairs pittsburgh left pittsburgh toilet robot hall of fame steeler nation book category portal v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlemylanoldid categories companies in the nasdaq indexcompanies listed on nasdaqcorporate inversionspharmaceutical companies of the united statescompanies in the nasdaq biotechnology indexlife sciences industryhealth care companies based in pennsylvaniacompanies listed on tasecompanies formerly listed on the new york stock exchangehidden categories use mdy dates from october all articles with unsourced statementsarticles with unsourced statements from september interlanguage link template link number navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutschespañolفارسیfrançaisעבריתportuguêssuomi edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view mylan inc products   brands products brands products mylan inc products mylan inc products mylan inc products information about mylan inc products upc mylan inc barcodes mylan inc gtin codes mylan inc gcp codes mylan inc product photosbsin  lsv brand name  mylan inc brand type  manufacturerbrand website  httpwwwmylancom× each mylan pharm  mg count gtin code    upc  gcp code    commercial name  × each mylan pharm  mg count× mfg mylan br  mg count gtin code    upc  gcp code    commercial name  × mfg mylan br  mg count× mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  × mfg mylan pharm  mg count× mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  × mfg mylan pharm  mg count× mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  × mfg mylan pharm  mg count× mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  × mfg mylan pharm  mg count× mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  × mfg mylan pharm  mg count× mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  × mfg mylan pharm  mg count× mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  × mfg mylan pharm  mg count× mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  × mfg mylan pharm  mg count × mfg mylan br  mg count gtin code    upc  gcp code    commercial name   × mfg mylan br  mg countadvanced healing bandages blister count gtin code    upc  gcp code    commercial name  advanced healing bandages blister countand × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  and × mfg mylan pharm  mg countand × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  and × mfg mylan pharm  mg countand × mfg mylan phar  mg count gtin code    upc  gcp code    commercial name  and × mfg mylan phar  mg countand bendroflumethiazide × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  and bendroflumethiazide × mfg mylan pharm  mg countaviance night musk perfume for women cologne spray gtin code    upc  gcp code    commercial name  aviance night musk perfume for women cologne spray weight   x  ozcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcaps × each  mg count gtin code    upc  gcp code    commercial name  caps × each  mg countcapsules × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  capsules × mfg mylan pharm  mg countcapsules × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  capsules × mfg mylan pharm  mg countcapsules × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  capsules × mfg mylan pharmaceuticals inc  mg countcapsules × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  capsules × mfg mylan pharmaceuticals inc  mg countcapsules × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  capsules × mfg mylan pharmaceuticals inc  mg countcapsules × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  capsules × mfg mylan pharmaceuticals inc  mg countcapsules × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  capsules × mfg mylan pharm  mg countcapsules × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  capsules × mfg mylan pharm  mg countcapsules × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  capsules × mfg mylan pharmaceuticals inc  mg countcetirizine hcl tab otc × tab  mg count gtin code    upc  gcp code    commercial name  cetirizine hcl tab otc × tab  mg countcimetidine tab  mg lb lb lb lb count gtin code    upc  gcp code    commercial name  cimetidine tab  mg lb lb lb lb countciprofloxacn tab  mg lb lb lb lb count gtin code    upc  gcp code    commercial name  ciprofloxacn tab  mg lb lb lb lb countdiltiazem hcl tablets × each  mg count gtin code    upc  gcp code    commercial name  diltiazem hcl tablets × each  mg countextended release tablets × each mylan pharmaceuticals in  mg count gtin code    upc  gcp code    commercial name  extended release tablets × each mylan pharmaceuticals in  mg countgeneric zyloprim tablets × mfg mylan pharmaceutical  mg count gtin code    upc  gcp code    commercial name  generic zyloprim tablets × mfg mylan pharmaceutical  mg counthcl and hydrochlorothiazide × mfg mylan p  mg count gtin code    upc  gcp code    commercial name  hcl and hydrochlorothiazide × mfg mylan p  mg counthcl extendedrelease pm capsules × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  hcl extendedrelease pm capsules × mfg mylan pharm  mg counthcl tablets × each  mg count gtin code    upc  gcp code    commercial name  hcl tablets × each  mg counthcl tablets × each  mg count gtin code    upc  gcp code    commercial name  hcl tablets × each  mg counthcl tablets × each  mg count gtin code    upc  gcp code    commercial name  hcl tablets × each  mg counthcl tablets × each  mg count gtin code    upc  gcp code    commercial name  hcl tablets × each  mg counthcl tablets × each  mg count gtin code    upc  gcp code    commercial name  hcl tablets × each  mg counthcl tablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  hcl tablets × mfg mylan pharmaceuticals inc  mg counthcl tablets × each  mg count gtin code    upc  gcp code    commercial name  hcl tablets × each  mg countinhalation saline solution  mylan xml gtin code    upc  gcp code    commercial name  inhalation saline solution  mylan xml volume   x  mlmethyclothiazide tablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  methyclothiazide tablets × mfg mylan pharmaceuticals inc  mg countmini edt for men gtin code    upc  gcp code    commercial name  mini edt for menml ampoules × unit dose package mylan  mg count gtin code    upc  gcp code    commercial name  ml ampoules × unit dose package mylan  mg countsulfate ml ampoules × ml unit dose mylan  mg count gtin code    upc  gcp code    commercial name  sulfate ml ampoules × ml unit dose mylan  mg countsulfate ml ampoules × ml unit dose mylan  mg count gtin code    upc  gcp code    commercial name  sulfate ml ampoules × ml unit dose mylan  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × each mylan pharmaceuticals inc  mg counttablets × each mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × each mylan pharmaceuticals inc  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each mfgby mylan pharmaceuticals inc us  mg count gtin code    upc  gcp code    commercial name  tablets × each mfgby mylan pharmaceuticals inc us  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharm  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharm  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × mfg mylan pharmaceuticals inc  mg count gtin code    upc  gcp code    commercial name  tablets × mfg mylan pharmaceuticals inc  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg counttablets × each  mg count gtin code    upc  gcp code    commercial name  tablets × each  mg count leave a reply cancel replyyou must be logged in to post a comment categoriesabcdefghijklmnopqrstuuncategorizedvwxyz recent posts composite antibacterial fibre its preparation method and application fixing device for thin sheet show window type wall pictures with movie effect in tunnel mancomputer interface device control method of automatic disc balancing system in cd machine feather heating – straightening method for badminton nanometer level transition metal oxide catalyst for transforming mercaptan and its prepn catalyst for converting mercaptan contained in hydrocarbon oil catalyst for converting thioalcohol contained in liquefied petroleum gas or light oil product dance match sysem for recreation eye medicine prepn for computer eyesight syndrome and xerophthalmia image sensor packing structure and its package method highiron sulfuric acid sludge cement telephonetelemechanical call signal dividing method and device multipling power generator with several intermittent electric machines iconic one theme  powered by wordpress mylan tries again to quell pricing outrage by offering generic epipen  the new york times nytimescom no longer supports internet explorer  or earlier please upgrade your browser learn more » sections home search skip to content skip to navigation view mobile version the new york times business daymylan tries again to quell pricing outrage by offering generic epipen search subscribe now log in  settings close search httpsnytimscdxo advertisement supported by business day mylan tries again to quell pricing outrage by offering generic epipen by andrew pollackaug   continue reading the main story share this page continue reading the main story video outrage over epipen pricing the huge increase of the list price for the severeallergy drug injector has led to backlash against mylan the latest in a string of pharmaceutical companies accused of price gouging by ainara tiefenthäler on publish date august   photo by karen kasmauski for the new york times watch in times video » embed in its latest move to quell outrage over its price increases the maker of the epipen has resorted to an unusual tactic — introducing a generic version of its own productthe company mylan said on monday that the generic epipen would be identical to the existing product which is used to treat severe allergic reactions but it will have a wholesale list price of  for a pack of two half the price of the brandname epipenthe raging debate over epipen pricing has offered a surprisingly wide window into the complicated world of prescription drug pricing in which powerful drug companies pharmacy benefit managers insurers and federal health programs all play major roles however the system remains opaquelast week the company announced steps to increase the financial assistance for the branded epipen for both commercially insured and uninsured patients those measures however did not stem the public furor in part because the company kept the list price the same so now the company will essentially sell the same product under two names at two price points in competition with each other advertisement continue reading the main story the new move did not mollify critics either some noted that even at  the generic would still be triple the price of the epipen in  when mylan acquired the product and began steadily raising its price the increases have accelerated in recent years even the generic expected to be available in several weeks should provide a nice profit to mylan because its manufacturing costs are believed to be far less than  continue reading the main story advertisement continue reading the main story several consumer advocacy groups unhappy with mylan’s handling of the drug’s pricing said that on tuesday they would deliver petitions signed by over  people to the company’s american corporate headquarters in canonsburg pa in addition the house committee on oversight and government reform said that it had started an investigation and had asked the company for information about the productrobert weissman president of the consumer group public citizen said mylan should just cut the price across the board“the weirdness of a generic drug company offering a generic version of its own branded but offpatent product is a signal that something is wrong” he said in a statement “in short today’s announcement is just one more convoluted mechanism to avoid plain talk admit to price gouging and just cut the price of epipen”while brandname drug companies sometimes start selling socalled authorized generic versions of their own products it is usually to undercut an outside generic competitor in this case mylan faces no immediate generic threatso why is it acting and why did it not announce the move last week with the other measuresthe company suggested in its news release that its action required an agreement from its manufacturing partner pfizer it also has said that merely reducing the list price of the drug would not necessarily lower the prices for patients because the outofpocket costs are set by pharmacy benefit managers and insurers the generic should mean savings for insurers and federal health programs like medicare and medicaid in addition to some patients“because of the complexity and opaqueness of today’s branded pharmaceutical supply chain and the increased shifting of costs to patients as a result of highdeductible health plans we determined that bypassing the brand system in this case and offering an additional alternative was the best option” heather bresch chief executive of mylan said in a statementmylan has repeatedly pointed to highdeductible health plans which leave patients with more outofpocket costs as the main reason patients are suddenly noticing higher prices for epipens video mylan chief on the  epipen heather bresch chief executive of mylan discusses the controversy surrounding the recent percent increase in her company’s lifesaving allergy injector by cnbc on publish date august   photo by cnbc watch in times video » embed adam j fein president of pembroke consulting who studies the drug distribution industry said that if mylan had simply lowered the price it would have risked angering all parties in the distribution network including pharmacy benefit managers wholesalers and pharmacies which take a piece of the total amount spent on the drug advertisement continue reading the main story introducing a generic “is a way to do it without making enemies with a bunch of fortune  companies who control your fate” he saidstill by selling both a generic and a branded version of the drug one mylan product is now battling another for sales newsletter sign up continue reading the main story please verify youre not a robot by clicking the box invalid email address please reenter you must select a newsletter to subscribe to sign up you agree to receive occasional updates and special offers for the new york timess products and services thank you for subscribing an error has occurred please try again later you are already subscribed to this email view all new york times newsletters see sample manage email preferences not you privacy policy opt out or contact us anytime ronny gal an analyst at sanford c bernstein  company estimated in a note on monday that mylan’s overall revenue per epinephrine autoinjector prescription would be reduced by around  percent to about  because of the introduction of the generica couple of factors are expected to limit that revenue decline the term epipen is so familiar that many doctors write prescriptions for it by name rather than for a generic epinephrine autoinjector while pharmacists in many states will be able to substitute the generic version some are almost sure to sell the branded version instead leaving mylan with higher revenuein addition mr fein said insurers might have negotiated deals with mylan that make the brandname version less expensive for them than the generic “it’s going to depend on your particular insurance plan and the kind of deal they have negotiated” he saidconsumers might also have incentives to use the brandname drug in some cases because most of them would have no copayments if they use a savings card being offered by mylan they might face a copayment albeit a relatively small one for the generic productdespite the lower revenue from releasing the generic mr gal said the move could be good for mylan shareholders by easing the downward pressure on the company’s stock after falling more than  percent last week mylan shares were up slightly on mondayit is not uncommon for brandname companies to introduce a generic version of their own product — known as an authorized generic in part to try to retain some sales once generic competition arrives but the generic industry and some other critics say the practice undermines the economics of the generic business and ultimately can lead to higher costs for consumers and insurers advertisement continue reading the main story a study by the federal trade commission several years ago found that some generic manufacturers agreed to delay the introduction of their generic product by years if the brandname company promised not to introduce an authorized genericmylan settled litigation with teva in  allowing teva to introduce a generic epipen in  it is not known if part of that agreement was for mylan to withhold any authorized generic if not then mylan might have been planning to introduce this authorized generic when teva introduced its own product but teva disclosed earlier this year that its application had been rejected by the food and drug administrationstill it might be only a matter of time before mylan faces new generic or nongeneric competition other companies sensing opportunities are looking at developing less expensive products that like epipen provide a rapid injection of epinephrine to counter anaphylaxis that can occur from a bee sting peanut allergy or other causeand pressure is mounting on the fda to be more accommodating in allowing alternatives on the marketepinephrine the drug is already generic the challenge has been developing an easytouse autoinjector that can reliably deliver the right amount of drug when used by the patient or caregiver under emergency circumstances sanofi removed a nongeneric competitor to epipen called auviq from the market last year because of dosing problems continue reading the main story we’re interested in your feedback on this page tell us what you think related coverage painted as epipen villain mylan’s chief says she’s no such thing aug   mylan to offer some patients aid on cost of epipens aug   mylan raised epipen’s price before the expected arrival of a generic aug   related coverage painted as epipen villain mylan’s chief says she’s no such thing aug   mylan to offer some patients aid on cost of epipens aug   mylan raised epipen’s price before the expected arrival of a generic aug   whats next loading go to home page » site index the new york times press releases  mylan en menu news select feature stories press releases fact sheets press releases all years               all categories advocacy career company events investor products uncategorized go advanced search search   search headlines only category all categories advocacy career company events investor products uncategorized from to  basic search jul   theravance biopharma and mylan announce positive results from month phase  safety study of revefenacin td in patients with chronic obstructive pulmonary disease copd these data combined with positive results from two phase  efficacy studies support nda filing planned for fourth quarter of  jul   mylan to report second quarter  financial results on aug   jul   fda oncologic drugs advisory committee unanimously recommends approval of mylan and biocons proposed biosimilar trastuzumab vote marks first proposed biosimilar trastuzumab to be recommended by the committee jun   mylan and biocon present clinical data on insulin glargine at the american diabetes associations th scientific sessions data show comparable efficacy safety and immunogenicity to lantus® in type  and type  diabetes patients jun   mylan to present at goldman sachs th annual global healthcare conference jun   mylan launches generic azilect® tablets jun   mylan launches generic reclast® injection may   theravance biopharma and mylan report additional phase  data for revefenacin td in several presentations at  ats presentations review detailed efficacy and safety data from two replicate pivotal phase  studies report prevalence of copd patients with low peak inspiratory flow rate in ongoing month phase  safety trial may   theravance biopharma and mylan to present additional data for revefenacin td in several presentations at  ats presentations will include detailed efficacy and safety data from two replicate pivotal phase  studies may   mylan to present at ubs global healthcare conference show  per page company about us business segments leadership corporate governance products quality our medicines and consumer products why generics therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms news feature stories press releases fact sheets investors stock performance investment calculator stock history public filings investor faqs careers life at mylan mylan benefits diversity  inclusion mylan near you resources and information to help prescribe dispense and take medicine with confidence pharmacists educational materials to help empower your customers patients what to know about our high quality generics physicians details about our brand name and generic medicines institutional customers resources that meet the specific needs of your institution explore you are leaving mylancom by clicking “continue” below you are leaving this mylan affiliate site to arrive on a thirdparty site that is solely responsible for its content continue go back contact mylan privacy shield policy privacy statement terms and conditions site map california supply chains act copyright   mylan nv all rights reserved for us audiences only ampampamplta hrefhttpwwwyoutubecomuserseeinsidemylan targetblank relnofollow datacategorysocialyoutube dataactionclicklink datalabelglobalfooterampampampgtyoutubeampampampltaampampampgt ampampamplta hrefhttptwittercommylannews targetblank relnofollow datacategorysocialtwitter dataactionclicklink datalabelglobalfooterampampampgttwitterampampampltaampampampgt ampampamplta hrefhttpfacebookcom targetblank relnofollow datacategorysocialfacebook dataactionclicklink datalabelglobalfooterampampampgtfacebookampampampltaampampampgt   en mylan worldwide close please select one of our websites from the list below africa south africa english americas canada english français united states english asia india english japan  europe austria deutsch belgium netherlands français czech republic čeština denmark dansk finland suomi france français germany deutsch greece greek hungary magyar ireland english italy italiano netherlands nederlands norway norsk poland polski portugal português slovakia slovenský spain español sweden svensk switzerland deutsch english united kingdom english pacific australia english new zealand english mylan also is proud to do business in these locations morocco luxembourg slovenia china singapore taiwan mylan inc pharmacovigilance officer in product safety and risk management team reviews  glassdoorglassdoor will not work properly unless browser cookie support is enabled learn how to enable cookiesmylan inc reviewskeywordlocation companiesjobscompaniessalariesinterviewssearchview allnum of numclose escsee all photossee all photos mylan inc engaged employeroverview overview  reviews  jobs  salaries  inter­views  benefits  photosfollowadd a reviewfollowadd a review mylan inc pharmacovigilance officer in product safety and risk management team reviews reviewfilterfilterpharmacovigilance officer in product safety and risk management teamjob titlelocationlocationworldwideus  all cities– albuquerque nm area– burlington vt area– cannonsburg oh– dallasfort worth tx area– greensboro nc area– greenville nc area– harrisburg pa area– houston tx area– jacksonville fl area– los angeles ca area– morgantown wv area– napa ca area– new york city ny area– pittsburgh pa area– savannah ga area– st louis mo area– washington dc area– waterloo ia areacanada  all cities– montreal qc area– ottawa on area– toronto on areafrance  all cities– châtillonsurchalaronne– lyon– paris area– saintpriest rhône rhonealpesgreece  all cities– athens areahungary  all cities– budapest areaindia  all cities– aurangabad maharashtra– banga– bangalore area– hyderabad area– indore area– nashikireland  all cities– dublin area– galway areaitaly  all cities– rome areaswitzerland  all cities– basel area– zurich areaunited arab emirates  all cities– dubai areauk  all cities– hemel hempstead area includes hq– london areaemployment statusparttimeinternfreelancecontractfulltimecurrent employeeclear allapply filtersclear allmylan incstarstarstarstarstarrecommend to a friendapprove of ceoheather bresch ratingclose your trust is our top concern so companies cant alter or remove reviews employee reviews sort popularratingdateprosgood benefits and working hours in  reviews senior executives are very bright and seem to know what they are doing as the company is growing in leaps and bounds in  reviewsgreat benefits and compensation in  reviews nice environment to work in challenging in  reviews good benefits career growth work life balance learning potential career opportunities in  reviewsconsworklife balance could be improved in  reviewsno work life balance and there are too many managers in  reviews with a salary position you can expect long hours in  reviewsupper management not effective in keeping innovations in  reviews lack of empowerment low speed on decision making and chaotic current enviroment due to several acquisitions in  reviewsmore pros and cons apr  working with mylan pharmaceuticlestarstarstarstarstarworklife balanceculture  valuescareer opportunitiescomp  benefitssenior managementcurrent employee  pharmacovigilance officer in product safety and risk management team in hyderabad indiacurrent employee  pharmacovigilance officer in product safety and risk management team in hyderabad indiarecommendspositive outlookapproves of ceoi have been working at mylan inc fulltime less than a yearprosbalanced worklife workknowledge knowledgeopportunity cultureconsi have not observed yetadvice to managementneed input and more support of it and automation to save crucial time as well as to work more efficiently and smoothlyshare on facebookshare on twittershare on whatsappshare via emailcopy linklink copiedflag as inappropriateflag as inappropriatehelpful  mylan inc response seconds agoedit • delete mylan inc   pdtreviews  pharmacovigilance officer in product safety and risk management team  mylan inc rss feedembed mylan inc careers there are a lot of great companies but not all give you the opportunity to work for a cause working together around the world to provide – more our values our culture join our team more resourcesthis is the employers chance to tell you why you should work for them the information provided is from their perspectivereviews by job titleintern  manager  chemist  intern  hourly  senior associate  trainee  scientist  senior chemist  senior analyst  qc chemist  pharmaceutical sales representative  supervisor  it director  officer  senior director  show moreshow lesscompany updates our interns had a great time giving back to their communities recently during their community service days we are so proud— hours ago mylan is excited to take part in the ias conference on hiv science to discuss the latest developments in hivrelated research— days agosee allsee allmylan inc photossee all photossee allview allnum of numclose esc company benefitsk planhealth insurancematernity  paternity leavevacation  paid time offretirement planadd benefitssee allsee allcompany videos loadingsee allsee all job seekers also viewedpnc financial services group reviewsstarstarstarstarstar  reviewsamgen reviewsstarstarstarstarstar  reviewsbny mellon reviewsstarstarstarstarstar  reviewsabbvie reviewsstarstarstarstarstar  reviewscrown castle reviewsstarstarstarstarstar  reviewswaters reviewsstarstarstarstarstar  reviewsthermo fisher scientific reviewsstarstarstarstarstar  reviewsmylan cellular reviewsstarstarstarstarstar  reviewsroche reviewsstarstarstarstarstar  reviewscardinal health reviewsstarstarstarstarstar  reviewswvu medicine reviewsstarstarstarstarstar  reviewshighmark health reviewsstarstarstarstarstar  reviews related job searchsales representative jobssales representative salaries kdirector jobsdirector salaries kpharmaceuticals sales representative jobspharmaceuticals sales representative salaries kscientist jobsscientist salaries kassociate director jobsassociate director salaries ksenior scientist jobssenior scientist salaries kproject manager jobsproject manager salaries kmanager jobsmanager salaries kintern jobsintern salaries ksenior manager jobssenior manager salaries kresearch associate jobsresearch associate salaries kpharmaceutical sales representative jobspharmaceutical sales representative salaries kinterested in a new jobupload a resume to mobile apply your response will be removed from the review – this cannot be undonedelete responsecancelthis will replace the current featured review for targeted profile are you sure you want to replace itcancelconfirmare you sure you want to remove this review from being featured for targeted profilecancelconfirm companies  reviews  glassdoorglassdoor will not work properly unless browser cookie support is enabled learn how to enable cookiessearch company reviews and ratingskeywordlocation companiesjobscompaniessalariesinterviewssearchupload your resumehiring post a job for freenewwho are the highest rated ceos in  see the winnershighest rated ceos  see the winnerscompany reviews and ratings get the whole storysearch ratings and reviews of over  companies worldwide get the inside scoop and find out what its really like from people whove actually worked therewrite a reviewwhats new at glassdoorare you paid fairly see your market worth in secondsreceive a custom salary estimate based on your title company location and experienceget your estimate companies hiring like crazy in july with positions spanning industries from tech to construction and beyond there’s something for everyoneread articleglassdoors employees choice awards glassdoors annual employees choice awards honor the best places to work acress north america and parts of europesee the  listrecently trendingbain  company reviewsfacebook reviewsboston consulting group reviewsgoogle reviewsibm reviewsmoreey reviewsoracle reviewsus air force reviewsdeloitte reviewsnordstrom reviewsverizon wireless reviewsus navy reviewskpmg reviewsjp morgan reviewshewlettpackard reviewspwc reviewscisco systems reviewssprint reviewsaccenture reviewsboeing reviewsdell reviewscomcast reviewsbooz allen hamilton reviewstmobile reviewsmore companieslesspopular companiesworking at targetworking at walmartworking at microsoftworking at wells fargoworking at bank of americamoreworking at searsworking at best buyworking at attworking at macysworking at enterpriseworking at the home depotworking at amazoncomworking at upsworking at lockheed martinworking at lowesworking at starbucksworking at appleworking at us armyworking at verizonworking at walgreensworking at citiworking at kohlsworking at cvs healthworking at mcdonaldscompanies near youlesscompany culturesmall vs large companieshow to find a mentortop  employee benefits  perkswhen is commuting for a job worth itplan to follow when starting a new jobmoredo you know your worthhow to become a managerthings to consider before walking out on your job best cities for jobshow to ask for flexible work scheduleadvantages inexperienced job seekers bringhow to handle a counter offernetworking etiquette for your careerhow to negotiate a job offerhow to double your salaryhow to deal with a bad bossworklife balance at the best places to workhow to boost moralethe best and worst industries for benefitshighest rated ceoshow to to improve your work performanceembed mentorship into your company culturethe pros and cons of transparent corporate culturesthings to not do when starting a new jobmore company culturelessgetting hiredcover letter opening lineshow to write a resumehow to answer interview questionshow to get a jobhow to negotiate your salarymorehow to prepare for an interviewhow to write a cover letterresume tipsskills to put on your resumeanswers for what is your greatest weaknesstell me about yourselfhow to find your passionhow to write a resume summarywhat to wear to an interviewsalary requirements dontsphone interview tips best interview answers what to bring to an interviewgood questions to ask in an interviewcommon interview questionshow to write a cover letterquestion to ask an employer at an interviewhow to pick the best people for your job referencetough questions and answersmore getting hired adviceless news  mylan en menu news select feature stories press releases fact sheets mylan to report second quarter  financial results on aug  fda oncologic drugs advisory committee unanimously recommends approval of mylan and biocons proposed biosimilar trastuzumabmylan and biocon present clinical data on insulin glargine at the american diabetes associations th scientific sessionsmylan launches generic reclast® injectionmylan launches generic azilect® tablets ‹ › latest news jul  theravance biopharma and mylan announce positive results from month phase  safety study of revefenacin td in patients with chronic obstructive pulmonary disease copd jul  mylan to report second quarter  financial results on aug   jul  fda oncologic drugs advisory committee unanimously recommends approval of mylan and biocons proposed biosimilar trastuzumab jun  mylan and biocon present clinical data on insulin glargine at the american diabetes associations th scientific sessions jun  mylan to present at goldman sachs th annual global healthcare conference view more search news releases contact mylan communications global communications communicationsmylancom epipen® autoinjector access resources stay connected email alerts follow us fact sheet download social responsibility at mylan  download   download company about us business segments leadership corporate governance products quality our medicines and consumer products why generics therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms news feature stories press releases fact sheets investors stock performance investment calculator stock history public filings investor faqs careers life at mylan mylan benefits diversity  inclusion mylan near you resources and information to help prescribe dispense and take medicine with confidence pharmacists educational materials to help empower your customers patients what to know about our high quality generics physicians details about our brand name and generic medicines institutional customers resources that meet the specific needs of your institution explore you are leaving mylancom by clicking “continue” below you are leaving this mylan affiliate site to arrive on a thirdparty site that is solely responsible for its content continue go back contact mylan privacy shield policy privacy statement terms and conditions site map california supply chains act copyright   mylan nv all rights reserved for us audiences only ampampamplta hrefhttpwwwyoutubecomuserseeinsidemylan targetblank relnofollow datacategorysocialyoutube dataactionclicklink datalabelglobalfooterampampampgtyoutubeampampampltaampampampgt ampampamplta hrefhttptwittercommylannews targetblank relnofollow datacategorysocialtwitter dataactionclicklink datalabelglobalfooterampampampgttwitterampampampltaampampampgt ampampamplta hrefhttpfacebookcom targetblank relnofollow datacategorysocialfacebook dataactionclicklink datalabelglobalfooterampampampgtfacebookampampampltaampampampgt   en mylan worldwide close please select one of our websites from the list below africa south africa english americas canada english français united states english asia india english japan  europe austria deutsch belgium netherlands français czech republic čeština denmark dansk finland suomi france français germany deutsch greece greek hungary magyar ireland english italy italiano netherlands nederlands norway norsk poland polski portugal português slovakia slovenský spain español sweden svensk switzerland deutsch english united kingdom english pacific australia english new zealand english mylan also is proud to do business in these locations morocco luxembourg slovenia china singapore taiwan mylan – seeing is believing en   en mylan worldwide close please select one of our websites from the list below africa south africa english americas brazil português brasileiro canada english français united states english asia india english japan  taiwan  europe austria deutsch belgium français nederlands bulgaria българия czech republic čeština denmark dansk finland suomi france français germany deutsch greece ελληνικά hungary magyar ireland english italy italiano netherlands nederlands norway norsk poland polski portugal português romania română serbia serbian latin slovakia slovenský slovenia slovenian spain español sweden svensk switzerland deutsch english united kingdom english pacific australia english new zealand english mylan also is proud to do business in these locations morocco luxembourg china singapore search company and product information menu savings our culture access generics and biosimilars drive access and savings for the us healthcare system the association for accessible medicines releases its  generic drug access  savings in the us report working at mylan learn about mylans culture as we work to provide  billion people access to high quality medicine mylan provides update on meridian medial technologies a pfizer company expanded voluntary worldwide recall of epipen autoinjector information and updates on recall and product replacement instructions for patients service mylans commitment learn what mylan has done to help patients access epinephrine learn what mylan has done to help patients access epinephrine innovation innovating today for a healthier tomorrow we are committed to advancing the future of generic and specialty medicines we are committed to advancing the future of generic and specialty medicines access learn about mylan epipen® autoinjector access programs learn about mylan epipen® autoinjector access programs quality providing access to quality injectables play video view how mylan upholds one global quality throughout its broad injectables portfolio view how mylan upholds one global quality throughout its broad injectables portfolio play video service innovation access quality resources and information to help prescribe dispense and take medicine with confidence explore pharmacists educational materials to help empower your customers patients what to know about our high quality products physicians details about our brandname and generic medicines institutional customers resources that meet the specific needs of your institution explore find a mylan product search our generic and brandname us pharmaceuticals by name   careers that can change the world every mylan employee works to impact the lives of  billion people around the world discover who we are global career opportunities select a location albania algeria australia austria belgium bosniaherzegovina brazil bulgaria canada china croatia czech republic denmark estonia finland france germany greece hungary india ireland italy japan latvia lithuania luxembourg morocco netherlands new zealand norway poland portugal puerto rico romania serbia slovakia slovenia south africa spain sweden switzerland taiwan united kingdom united states global executive leadership opportunities start here company about us business segments leadership global social responsibility corporate governance products product catalog quality our medicines and consumer products why generics therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms news feature stories press releases investors stock performance investment calculator stock history public filings investor faqs update on meridian’s voluntary worldwide recall of epipen® autoinjector careers life at mylan mylan benefits diversity  inclusion mylan near you resources and information to help prescribe dispense and take medicine with confidence pharmacists educational materials to help empower your customers patients what to know about our high quality products physicians details about our brandname and generic medicines health systems customers resources that meet the specific needs of your institution explore contact mylan privacy shield policy privacy statement terms and conditions site map california supply chains act copyright   mylan nv all rights reserved for us audiences only ampamplta hrefhttpwwwyoutubecomuserseeinsidemylan targetblank relnofollow datacategorysocialyoutube dataactionclicklink datalabelglobalfooterampampgtyoutubeampampltaampampgt ampamplta hrefhttptwittercommylannews targetblank relnofollow datacategorysocialtwitter dataactionclicklink datalabelglobalfooterampampgttwitterampampltaampampgt ampamplta hrefhttpfacebookcom targetblank relnofollow datacategorysocialfacebook dataactionclicklink datalabelglobalfooterampampgtfacebookampampltaampampgt you are leaving mylancom you are now leaving mylancom for a mylan affiliate site a mylan product site a third party site that mylan may contribute content to but does not have exclusive control over or a third party site that is solely responsible for its content and may not follow guidelines applicable in certain geographies continue go back mylan  wikipedia mylan from wikipedia the free encyclopedia jump to navigation search mylan trading name mylan nv formerly called milan type public under dutch law traded as nasdaq myl tase myl nasdaq biotechnology component nasdaq component sp  component isin us industry pharmaceuticals founded   years ago  in white sulphur springs west virginia united states founders milan puskar don panoz headquarters canonsburg pennsylvania united states of america area served worldwide key people heather bresch ceo products generic and specialty pharmaceuticals and active pharmaceutical ingredients revenue us billion  operating income us million  net income us billion  total assets us  billion  total equity us billion  number of employees   divisions see operations subsidiaries meda famy care website wwwmylancom mylan nv is an american global generic and specialty pharmaceuticals company registered in the netherlands with principal executive offices in hatfield hertfordshire uk and global headquarters in canonsburg pennsylvania us in  mylan acquired a controlling interest in indiabased matrix laboratories limited a top producer of active pharmaceutical ingredients apis for generic drugs and the generics business of germanybased merck kgaa through these acquisitions mylan grew from the thirdlargest generic and pharmaceuticals company in the united states to the secondlargest generic and specialty pharmaceuticals company in the world in  mylans pricing of the epipen an epinephrine autoinjector became controversial and was widely referred to as price gouging as a result investigations were opened into whether mylan had misclassified the epipen under the medicaid drug rebate program a common form of pharmaceutical fraud in october  mylan settled these investigations with the us department of justice agreeing to pay  million and enter into a corporate integrity agreement concerning the rebate program in a report published on june   the institutional shareholder services criticized mylan for the outsized compensation of mylans directors former ceo robert coury received a  million  pay package in spite of the harm to the company inflicted by the epipen controversies and steep shareholder losses the report urged mylans shareholders to oust all of mylans existing directors contents  operations  location  stock  history  acquisition history  criticism  epipen pricing  execution drugs  references  external links operationsedit mylan inc operates several divisions and subsidiaries in north america and south america mylan operates mylan pharmaceuticals based in morgantown west virginia mylan pharmaceuticals ulc mylan canada mylan technologies inc mti  transdermal drug delivery systems tdds and related technologies udl laboratories inc somerset pharmaceuticals inc a research and development company in tampa florida owned by mylan somerset develops emsam manufactured by mylan technologies and marketed in the united states by dey another mylan company mylan laboratories limited campos dos goytacazes brazil in oceania and central east south and southeast asia mylan operates mylan new zealand limited  new zealand mylan laboratories limited  headquartered in hyderabad india operates nine active pharmaceutical ingredient api and intermediate manufacturing facilities located in india and china mylan seiyaku ltd  japan alphapharm  australia agila specialties pvt ltd  india oncotherapies ltd  india in europe africa and west asia mylan operates operates under the mylan name in austria belgium the czech republic denmark finland france germany hungary italy the netherlands norway poland portugal slovakia slovenia spain sweden switzerland the united kingdom also operates in south africa arcana arzneimittel gmbh  germany generics pharma hellas  greece gerard laboratories  ireland qualimed  trademark in france but will stop being marketed under the brand name docpharma  generic pharmaceutical distribution company in belgium the netherlands and luxembourg locationedit founded in  the company was first located in white sulphur springs west virginia the company moved to morgantown west virginia in  and in  it relocated its corporate headquarters to the pittsburgh suburb canonsburg pennsylvania finally in  it moved to a new office center in nearby southpointe a suburban business park located in cecil township where it is still located stockedit on february   mylan had its initial public offering ipo becoming a publicly traded company on the otc market under the ticker symbol myln in  the stock moved to nasdaq their final stock move was in  when their stock became available for trade on the new york stock exchange under the ticker symbol myl currently the stock is traded on the nasdaq historyedit mylan pharmaceuticals was founded as a drug distributor in  by milan puskar and don panoz in  mylan began manufacturing penicillin g tablets as well as vitamins and other dietary supplements panoz left mylan in  and puskar quit the company in  as it grew and experienced financial difficulties the board hired roy mcknight as board chairman who convinced puskar to return in  mylan discontinued operating as a contract manufacturing organization in  and instead chose to market their products under their own mylanlabeled brandcitation needed with the passage of the hatchwaxman act in  mylan and other small generic companies gained value in the eighteen months following passage of the law mylans earnings grew  to  million and its stock value rose  in the s one of the most prescribed drugs in the us was dyazide a diuretic that was a combination drug containing triamterene and hydrochlorothiazide it had been on the market since  and its patents had expired in  complications arose with the introductions of generics versions because the formulation of dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent some generic companies committed fraud trying to bring a generic version of dyazide bolar pharmaceutical had the first generic version approved in  but it turned out that bolar had fraudulently substituted dyazide for its own version to conduct studies that were submitted to the fda by  the fda rescinded its approval based on its suspicions and filed criminal charges against bolar to which bolar eventually pled guilty in  mylan chose to develop a new version of a triamterenehydrochlorothiazide combination drug instead of going the generic route it developed a different more stable formulation and used different dosages of each active ingredient  mg hydrochlorothiazide and  mg triamterene compared with dyazides  mg hydrochlorothiazide and  mg triamterene this drug had to get approval as a new drug as opposed to a generic their product was called maxzide and was approved in  the higher dose allowed once per day dosing which mylan and its marketing partner lederle believed would help it compete against dyazide which had m in sales in  however mylans patents on the drug were declared invalid in court and its marketing exclusivity expired in  prompting a rush of generic competition mylan had concerns about the practices of its competitors and the fda in general and also with regard to companies seeking to bring generic versions of maxzide mylan hired private investigators to examine its competitors practices and when it found evidence of corruption it submitted it to the house oversight and investigations committee which investigated and found fraud and corruption within the food and drug administrations generic drugs division and at other generic companies two of the companies that had gotten approval to market generic versions of maxzide vitarine pharmaceutical and par pharmaceutical were targets of mylans initial investigation and were found to have used mylans maxzide to obtain their bioequivalence data leading both companies to withdraw its generic competitor to mylans product the corruption in the nascent generics industry and at the office in the fda regulating it was widely covered in the media and led to widespread concern among doctors and the public in the late s and early s that generic drugs were not really the same as the branded drugs they were meant to replace in  mylan agreed to enter into a joint venture with bolar to buy somerset pharmaceuticals mylan wanted access to somersets drug discovery capabilities as well as its new drug for parkinsons selegiline the deal was completed in  but its consummation was dependent on fda approval of selegiline which came in  mylan acquired bertek inc in  for its transdermal patch technologies and kept as a subsidiary in  mylan renamed the company mylan technologies inc mti mti eventually came to be the contract manufacturer for the selegiline transdermal patch and was the first company to market generic nitroglycerin estradiol clonidine and fentanyl transdermal patches mylan acquired udl laboratories a supplier of unit dose generic medications to institutional and longterm care facilities in  in  when it was the worlds second largest generics company mylan came under investigation from the federal trade commission after it raised the prices of its products tripling them in the case of lorazepam mylan had entered into an exclusive agreement with profarmica an italian company that supplied drug ingredients after which mylans competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs before the round of price increases the price of generic drugs had been    of the price of branded drugs and afterwards it was around  the ftc filed suit at the end of  and  states filed parallel actions the case was settled in  with mylan paying a total of m  m in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid  million in attorneys fees to the state attorneys general  million plus  million in attorneys fees to settle certain class actions with insurers and managed care organizations  and mylan and three ingredient suppliers cambrex corporation profarmaco srl and gyma laboratories also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future in  mylan and king pharmaceuticals began discussing a deal in which mylan would acquire king for about b mylan wanted to expand its presence in branded pharmaceuticals and to acquire kings sales force the deal became one of the business soap operas of the year and included an sec investigation into kings accounting and carl icahn obtaining a  interest in mylan and becoming its largest stakeholder in order to kill the deal the parties called off the deal in february  icahn offered to buy mylan for b and ran a slate of board members to change the direction of mylan he won three seats in may  in june mylan bought back  of its shares in order to fend off icahn and in july icahn gave up his bid and sold his shares in august  mylan announced that it had reached agreement to buy a controlling interest in matrix laboratories an indian supplier of active pharmaceutical ingredients the deal gave mylan access to markets in india and china and was completed in january the next year in may  mylan and merck kgaa agreed that mylan would acquire mercks generics arm for b the deal was completed that october and tripled the size of mylan mylan acquired the rights to market the epipen in the transaction at that time annual sales were around  million and the epipen had about  of the market in  the company filed two lawsuits against the pittsburgh postgazette after the newspaper ran an article that was critical of the quality control procedures used at the companys morgantown plant the company had earlier quality control issues involving the fda the lawsuits were dropped in  without any damages paid by the postgazette which stated the postgazette did not find and did not intend to report that mylan had manufactured or distributed any defective drugs the postgazette regrets if any reader of the article thought otherwise also in  mylan and its subsidiary udl agreed to pay a m to settle a suit filed under the false claims act in which mylanudl and two other companies were accused of underpaying states under the medicaid drug rebate program the program requires drug companies to give rebates to states under medicaid and the rebates are higher for new drugs than for generics the suit said that the companies sold new drugs but paid rebates as if they were generics in  mylan entered into an agreement with pfizer for the exclusive worldwide rights to develop manufacture and commercialize pfizers generic equivalent to glaxosmithklines advair usseretide uk diskus incorporating pfizers proprietary dry powder inhaler delivery platform mylan launched the product in the uk in  and in february  the fda accepted its anda putting it in line behind hikma and sandoz to launch a generic version in the us in  mylan launched a program called epipenschools to sell epipens in bulk and with discounts to schools to participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year in december  the national association of state boards of education launched a policy initiative designed to help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine autoinjector access and use and advocated for state laws protecting school from legal liability for stocking and using epinephrine autoinjectors gayle manchin the mother of mylans ceo heather bresch had become president of the association in  and shortly after had discussed donations from her daughters company to the association manchin had been appointed to the west virginia state school board by her husband thengovernor of the state joe manchin in  in  mylan acquired an indian generic injectable drugs company agila specialties private for  billion in cash in  three plants acquired in that deal were issued warning letters by the fda after successful lobbying from mylan in  the school access to emergency epinephrine act became law after passing congress with broad and bipartisan support it protected anyone from liability if they administered epinephrine to a child in a school previously only trained professionals or the affected person were allowed to administer the drug and were open to liability and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them joe manchin the father of mylans ceo was a senator at that time in july  mylan and abbott laboratories announced an agreement under which mylan would buy abbotts generic drugs business in developed markets for stock valued at about  billion mylan acquired mumbaibased famy care and expand its presence in the market for womens contraceptives at about  million starting in  according to a  report in the new york times midlevel executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the epipen and raising concerns that the price increases were unethical the times reported that when these concerns were brought to robert coury the chairman of the board coury replied that he was untroubled he raised both his middle fingers and explained using colorful language that anyone criticizing mylan including its employees ought to go copulate with themselves critics in congress and on wall street he said should do the same and regulators at the food and drug administration they too deserved a round of anatomically challenging selffulfillment  the times reported that bresch provided similarly dismissive responses in april  mylan tried negotiate with the management of irish pharmaceutical firm perrigo to acquire the company and when those negotiations failed mylan attempted a hostile takeover offering to buy b in shares directly from shareholders too few shareholders agreed to sell their stock by the deadline set in november  and the effort failed two weeks after mylan made its first offer for perrigo teva pharmaceutical offered to buy mylan for b the combined companies would have been the worlds largest generic company and the th biggest drug company in the world in july teva dropped its bid for mylan and instead acquired allergans generic drug business for about the same price in june  mylan agreed to work with pulmatrix a company with a proprietary inhaled drug delivery platform to codevelop a product to treat for chronic obstructive pulmonary disease the product was pur a generic drug in a pulmatrix device in february  the company announced it would acquire meda for  billion in may of the same year the company announced it would acquire renaissance acquisition holdings dermatology division for up to  billion in  mylan had about b in sales of epipens and those sales accounted for  of mylans profit mylan had maintained about a  market share since it had acquired the product and had continually raised the price of epipens starting in  in  the wholesale price of two epipens was about  by july  the price was about  in may  it was around  and in may  the price rose again to around  around a  jump from the price in  in the summer of  as parents prepared to send their children back to school and went to pharmacies to get new epipens people began to express outrage at the cost of the epipen and mylan was widely and harshly criticized the price hikes led to investigations by congress and states attorneys general in october  mylan agreed to pay a m fine related to incorrect rebates it paid under the medicaid drug rebate program in december  the attorneys general of  states filed a civil complaint accusing mylan of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug the complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings telephone calls and text messages according to the department of health and human services office of inspector general analysis the us government may have overpaid as much as  billion between  and  to drugmaker mylan nv for the epipen emergency allergy treatment this represents three times the proposed settlement of  million announced by mylan in october  republican senator chuck grassley chair of the senate judiciary committee that launched the probe of epipen pricing probe in  released the analysis on may   on the same day a group of mylan investment funds urged shareholders to vote against the reelection of the companys directors after it paid chairman robert coury over  million last year acquisition historyedit the following is an illustration of the companys major mergers and acquisitions and historical predecessors mylan   renaissance acquisition holdings dermatology div acq    meda acq    famy care acq    abbott laboratories generics div acq    merck kgaa generics div acq  renamed mylan laboratories inc   udl laboratories acq    bertek inc acq  renamed mylan technologies inc milan pharmaceuticals founded  criticismedit epipen pricingedit see also epinephrine autoinjector § cost see also heather bresch § business executive mylan acquired the right to market and distribute the epipen line of epinephrine autoinjector devices from merck kgaa as part of their  deal that right had formerly been held by dey lp a wholly owned subsidiary of merck the devices deliver about  worth of drug at that time annual sales were around m bresch the companys ceo saw an opportunity to increase sales through marketing and advocacy and the company launched a marketing campaign to increase awareness of the dangers of anaphylaxis for people with severe allergies that made the brand epipen as identified with its product as kleenex is with facial tissue the company also successfully lobbied the fda to broaden the label to include risk of anaphylaxis and in parallel successfully lobbied congress to generate legislation making epipens available in schools and in public places like defibrillators are and hired the same people that medtronic had worked with on defibrillator legislation to do so mylans efforts to gain market dominance were aided when sanofis competing product was recalled in november  and further when tevas generic competitor was rejected by the fda in march  by the first half of  mylan had an  market share of such devices in the us and in that year sales reached around b and accounted for  of mylans profit those profits were also due in part to mylans continually raising the price of epipens starting in  in  the wholesale price of two epipens was about  the price was about the same in  by july  the price about  in may  it was around  and in may  the price rose again to around  the last price increase sparked widespread outrage including criticism from martin shkreli poster boy for grasping pharma greed letters from two senators and initiation of congressional investigations and mylans pricing of the epipen was widely referred to as price gouging the last price increase coincided with a new line of tv commercials that were described as shocking and no holds barred depicting an anaphylactic reaction from the point of view of the young woman having it at a party and ending with the young woman seeing her swollen and hivecovered face in the mirror before she collapses in response to criticism mylan increased financial assistance available for some patients to purchase epipens a gesture that was called a classic public relations move by harvard medical school professor aaron kesselheim the up to  saving cards can only be used by a small number of people who need the drug and no one on medicaid they do nothing about the high price which is still being paid by insurers who ultimately pass the cost onto consumers in september  the new york state attorney general began an investigation into mylans epipenschools program in new york to determine if the programs contracts violated antitrust law and the west virginia state attorney general opened an investigation into whether mylan had given the state the correct discount under the medicaid drug rebate program and subpoenaed the company when it refused to provide the documentation the state requested in october  the ceo of mylan testified to congress that pfizerking charged mylan about  for one device in september  a silicon valley engineering consultancy performed a teardown analysis of the epipen and estimated the manufacturing and packaging costs at about  for a twopack in october  mylan announced a settlement with the us department of justice over rebates paid by mylan to states under the medicaid drug rebate program questions had been raised by congress and others about why epipen had been classified as a generic rather a proprietary product in the program since  generic drugs have lower rebates  than proprietary drugs  and price hikes for generic drugs cannot be passed onto states and a common form of pharmaceutical fraud involves misclassifying proprietary drugs as generic under the program under the agreement mylan agreed to pay a  million payment and to a sign a corporate integrity agreement requiring it to perform better in the future the settlement also resolved cases brought by states related to the rebates simultaneously with the settlement mylan also announced it was being investigated by the securities and exchange commission related to the drug rebate program in june  the new york times published an article reporting on internal mylan discussions about price increases on the epipen between  and  in which the company chairman expressed disdain for people and agencies who might criticize the company the reporter wrote those top leaders’ responses are a far cry from the message on mylan’s website which says that we challenge every member of every team to challenge the status quo and that we put people and patients first trusting that profits will follow and also noted that the firm is a case study in the limits of what consumer and employee activism as well as government oversight can achieve  execution drugsedit mylan manufactures rocuronium bromide which is approved by the state of alabama for use in executions by lethal injection european manufacturers refuse to sell drugs which can be used for executions to the united states except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain in september  the londonbased human rights organization reprieve told mylan that they were the only fdaapproved manufacturer of rocuronium bromide without legal controls in place to prevent its use in executions and there was a very real risk that mylan may soon become the goto provider of execution drugs for states across the country the german asset manager dje kapital de divested itself of  million in mylan shares for that reason mylan said that their distribution was legally compliant referencesedit  a b public filings  form k mylan investors relations retrieved august     mylan nv k for the fiscal year ended december    mylan buys part of drug maker pittsburgh business times december     mylan laboratories to acquire generics business of merck kgaa for  billion euros medical news today may     pharmaceutical giants tracking mylans prosperity the pittsburgh tribunereview august     egan matt epipen maker faces revolt over execs  million pay package cnn money   transdermal patches  mylan mylantechcom   brand name medicines  mylan deycom   about us mylancom   a b about us mylancom   matrixlabsindiacom matrixlabsindiacom   whats new  arcana arzneimittelherstellung arcanade   httpwwwmantacomcomsdnbcompanywsklv  httpwwwidairelandcomsearchcompaniesxmlssid  httpwwwbioportfoliocomnewspdfusmylantowithdrawqualimedbrandfromfrenchmarketreportpdf  a b c dearment alaric october   milan puskar cofounder of mylan dies drug store news   mylan  years young and still making history mylan retrieved april     myl stock history  mylan retrieved august     a b c d e freudenheim milt september   exposing the fda new york times   lewis ralph a  the emerging effects of the drug price competition and patent term restoration act of  journal of contemporary health law  policy   –   a b ron wolf for the philadelphia inquirer august   smithkline loses exclusive rights to drug  a b boehm garth yao lixin han liang zheng qiang september  development of the generic drug industry in the us after the hatchwaxman act of  acta pharmaceutica sinica b   – doijapsb   a b john seaman and john t landry mylan  years of unconventional success mylan in association with university press of new england  isbn  page   a b strickland carol october   bolar a drug company under siege the new york times   shaw donna february   us charges bolar pharmaceutical with misrepresenting its products philadelphia inquirer   freudenheim milt february   bolar plans guilty plea on generics the new york times   a b c pink sheet october   mylans maxzide is approvable at fda lederle to market brand competition to smithklines no ranked dyazide final approval anticipated imminently  fda approval history nda  maxzide page accessed september    reid kenneth november   us judge to rule on drug marketing journal of commerce   andrews edmund l july   fda inquiry on generic drugs focuses on changes in ingredients the new york times   cimons marlene august   fda to lift ok of last dyazide generic version los angeles times   bolar and mylan team to purchase somerset labs pink sheet november     somerset eldepryl june  approval clears way for mylanbolar acquisition pink sheet june     a b ku mannching sherry december   recent trends in specialty pharma business model journal of food and drug analysis   – doijjfda   mylan form k annual report for the financial year ending march    filed june    a b labaton stephen december   a drug maker is said to face a suit on prices the new york times   press release ftc reaches record financial settlement to settle charges of pricefixing in generic drug market  federal trade commission ftc november     labaton stephen july   genericdrug maker agrees to settlement in pricefixing case the new york times   a b creswell julie march   icahn the spoiler fortune   pollack andrew november   icahn offers  billion for mylan drug maker the new york times   okeefe eric may   icahn slate wins seats on blockbuster board the new york times   lazo shirley a survival strategy barrons   icahn drops bid for mylan los angeles times bloomberg news july     mylan signs usmil takeover deal for indias matrix laboratories ihs august     mylans acquisition of matrix business strategy case study icrm   massey steve may   mylan buys merck generic drug unit for  billion pittsburgh postgazette   press release mylan completes acquisition of generics business of merck kgaa mylan october     a b c d e f g cynthia koons and robert langreth for bloomberg businessweek september   how marketing turned the epipen into a billiondollar business  johnson carolyn y ho catherine august   how mylan the epipen company maneuvered to create a virtual monopoly the washington post via the chicago tribune   adams russell october   mylan again sues pittsburgh postgazette wall street journal retrieved august     sabatini patricia boselovic len july   mylan workers overrode drug quality controls internal report detailed pervasive practice of ignoring safety procedures pittsburgh postgazette retrieved august     edwards jim july   its not mylans first quality control beef with fda money watch cbs news retrieved august     mylan pittsburgh postgazette settle lawsuits cbs news associated press february   retrieved august     us department of justice october   press release four pharmaceutical companies pay  million for submission of false claims to medicaid  mylan acquires rights to pfizers inhaler technology drugstorenewscom retrieved may     stanton dan june   gsk breathes freely as mylan launches seretide generic in uk inpharma technologist   helfand carly february   mylan joins the advaircopycat queue but approval could be a long slog fiercepharma   swetlitz ike silverman ed august   mylan may have violated antitrust law in its epipen sales to schools pbs newshour   a b odonnell jayne september   family matters epipens had highlevel help getting into schools usa today   thomas katie february   mylan buys drug maker of generic injectables new york times   palmer eric august   updated fda castigates three mylan sterile drug plants in warning letter fiercepharma   novak matt august   how congress the fda and sarah jessica parker helped epipen become a  billion business gizmodo   abc news business news personal finance and money news  abc news abc news retrieved july     us drugmaker mylan to acquire famy care for  million timesofindiaeconomictimes february     a b duhigg charles  june  outcry over epipen prices hasn’t made them lower the new york times   koons cynthia november   mylans hostile bid for perrigo fails bloomberg   rockoff jonathan d mattioli dana april   teva offers to buy mylan for  billion wall street journal   teva to buy allergans generic drug unit bloombergcom july     chitra somayaji july   teva snaps up allergans generics arm dumping mylan bloombergcom   mylan to codevelop pulmatrix copd candidate gen   mylan to acquire meda for b  gen news highlights  gen retrieved august     mylan snaps up dermatology biz from investors in b deal  fiercepharma retrieved august     a b c tara parkerpope and rachel rabkin peachman for the new york times august   epipen price rise sparks concern for allergy sufferers  bartolotta devin august   cost jumps nearly percent for lifesaving epipens cbs baltimore retrieved august     goldberg kenny people with food allergies say lifesaving drug too expensive kpbs public media retrieved june     walker joseph winslow ron steele anne august   mylan to launch cheaper generic epipen alternative wall street journal   a b c thomas katie october   mylan to settle epipen overpricing case for  million the new york times   thomas katie   states accuse generic drug companies of price fixing the new york times retrieved    a b erman michael may   mylan may have overcharged us for epipen by  billion hhs reuters new york retrieved may     king pharmaceuticals october   press release king pharmaceuticals to acquire meridian medical technologies  carly helfand for fiercepharma march   fda swats down tevas epipen copy putting mylan in cruise control  a b emily willingham for forbes august   why did mylan hike epipen prices  because they could  emma court for marketwatch august   mylan’s epipen price increases are valeantlike in size shkrelilike in approach  brad tuttle for time august    signs that epipen prices are completely out of control  michael hiltzik for the los angeles times august   another reason to hate mylan which jacked up the price of lifesaving epipens its a tax dodger  matt novak for gizmodo august   how congress the fda and sarah jessica parker helped epipen become a  billion business  beth snyder bulik for fiercepharma may   no holds barred in mylan’s ultrarealistic peanut allergy campaign  mylan to provide epipen cost assistance as ceo is asked to testify on price hike the guardian   a b carolyn y johnson august   why mylan’s ‘savings card’ won’t make epipen cheaper for all patients washington post washington post   larson erik hopkins jared s september   mylan’s epipen school sales trigger ny antitrust probe bloomberg retrieved september     feeley jef langreth robert september   mylan investigations mount as west virginia opens fraud probe bloomberg news   popken ben september   upgraded epipens torn apart tech firm its the same core device nbc news   tracy seipel silicon valley engineers figure real cost to make lifesaving autoinjector twopack the mercury news retrieved october     thomas katie september   is epipen a brandname or a generic drug mylan casts it both ways the new york times   mole beth october   for ripping off medicaid epipen maker mylan pays feds  million ars technica retrieved october     ztracer zachary tracer october   mylan agrees to  million epipen settlement with us bloombergcom   novak matt  june  drug company chairman to america go fuck yourself gizmodo   mole beth  june  mylan chairman drug pricing critics ought to go copulate with themselves ars technica   loew derek  june  mylan begins harvesting the crop its sown in the pipeline   a b owen dyer october   drug company is targeted for refusing to adopt ban on distribution of execution drug bmj   g doibmjg  external linksedit media related to mylan at wikimedia commons business data for mylan google finance yahoo finance reuters sec filings v t e pittsburgh history timeline culture dialect media neighborhoods notable people skyscrapers government airport conventions city hall courthouse mayor council events intergov police da sheriff fire libraries transit education port regional economy allegheny conference duquesne club chamber of commerce economic club hyp club stock exchange fortune  headquarters us steel pnc ppg heinz wesco consol dicks allegheny technologies forbes largest private companies  lumber giant eagle other headquarters american bridge american eagle ampco ansys armstrong black box calgon carbon compunetix dollar bank dqe eatn park education management corporation eqt federated gnc gurucom highmark igate iron city kennametal koppers laughlin marc usa millcraft msa nichecom oxford ptc renda rue upmc vocelli wabtec shared headquarters alcoa modcloth nova chemicals subsidiary headquarters allegheny energy bayer corporation fedex ground glaxosmithkline usa lanxess respironics vivisimo westinghouse regional operations aa bny mellon formerly mellon financial dreyfus eaton spreadshirt macys historic big wheel clark dravo fisher integra mesta murphy gulf oil jl ketchum rockwell sunbeam westinghouse sports dapper dan grand prix great race head of the ohio lore marathon mylan classic regatta wphl baseball pirates wild things panthers dukes chronicletelegraph cup allegheny burghers champions crawfords filipinos grays hardhats keystones stogies rebels basketball yellow jackets panthers m panthers w dukes m dukes w colonials m colonials w roundball classic condors ironmen loendi monticello phantoms pipers piranhas pirates rens xplosion football steelers panthers steeler nation heritage colts force passion renegades  allstars allegheny americans as duquesne gladiators homestead lyceum maulers power odds olympics quakers jp stars early pro football circuit hockey penguins colonials m colonials w three rivers classic as bankers cougars duquesne ft pitt hornets keystones lyceum panthers phantoms pirates pirates wphl pros shamrocks victorias winter garden yellow jackets soccer riverhounds beadling cannons hurricanes phantoms spirit other sledgehammers bulls harlequins pcc triangles wallabies studio wrestling dirty dozen venues ppg paints arena heinz field pnc park  lumber arena fitzgerald field house highmark stadium palumbo center petersen events center petersen sports complex rooney field sewall center trees hall central park civic arena duquesne gardens exposition park forbes field josh gibson field greenlee field motor square garden pitt stadium recreation park schenley gardens three rivers winter garden parks allegheny arsenal allegheny commons allegheny riverfront artgardens buhl community chatham university arboretum frank curto frick emerald view highland market square mellon mellon green mellon square north shore riverfront phillips point of view point state ppg place riverview roberto clemente memorial rodef shalom biblical botanical garden schenley schenley plaza south shore riverfront south side three rivers west end overlook westinghouse transportation inclines steps v t e port authority of allegheny county light rail list of stations blue line – library blue line – south hills village red line inclines historical list duquesne incline monongahela incline buses and busways list of routes martin luther king jr east busway south busway west busway former lines  drake brown line patrain skybus other north shore connector port authority  series pcc wabash tunnel v t e public transportation in greater pittsburgh bus services port authority of allegheny county list of bus routes beaver butler fayette indigo mid mon valley mountain line new castle town  country university of pittsburgh washington westmoreland bus rapid transit mlk jr east busway south busway west busway light rail red line blue line library south hills village inclines duquesne monongahela amtrak capitol limited pennsylvanian airports pittsburgh international arnold palmer allegheny county beaver butler eddie dew greensburg jeannette herron jefferson jimmy stewart joe hardy lakehill monroeville new castle rock rostraver washington wheeling zelienople discontinued broadway limited brown line list of streetcar routes in pittsburgh parkway limited patrain skybus v t e tunnels and bridges in pittsburgh tunnels allegheny river tunnel armstrong tunnel cork run tunnel corliss tunnel fort pitt tunnel jl tunnel liberty tunnel mount washington transit tunnel pittsburgh and castle shannon tunnel pittsburgh  steubenville extension railroad tunnel schenley tunnel squirrel hill tunnel wabash tunnel bridges th street bridge st street bridge rd street railroad bridge th street bridge bloomfield bridge birmingham bridge david mccullough bridge fort duquesne bridge fort pitt bridge fort wayne railroad bridge glenwood bridge glenwood bo railroad bridge highland park bridge homestead grays bridge hot metal bridge liberty bridge mckees rocks bridge panhandle bridge panther hollow bridge schenley bridge senator robert d fleming bridge smithfield street bridge south tenth street bridge three sisters roberto clemente bridge andy warhol bridge rachel carson bridge veterans bridge west end bridge attractions aviary baywood cathedral of learning chinatown conservatory dippy immaculate heart duquesne incline heinz chapel little italy mellon institute mon incline observatory pamelas penn station point of view sculpture primantis science center steps uss requin zoo kennywood luna park westinghouse sign landmarks national city national county state city phlf cultural museums art arts arts festival bible fort pitt and blockhouse clayton clemente childrens frick glass center history jazz jewish mattress factory dental miller miss pittsburgh nationality rooms national map natural history soldiers and sailors warhol wilson wsg venues heinz hall benedum byham harris kellystrayhorn new hazlett oreilly foster playhouse trib hunt stage ae syria mosque nixon theater festivals anthrocon arts blues comicon fashion film folk handmade new works tekko whiskey  fine spirits wine shopping and entertainment casino gateway clipper fleet station square strip downtown oakland south side macys market square southside works waterworks mount washington east liberty squirrel hill shadyside walnut street opera ballet symphony brass classical theatre dance ensemble caravan theatre folk light opera opera theater jewish theatre public theater playwrights musical theater stage right youth ballet youth symphony bricolage nnoc v t e shopping malls in pittsburgh enclosed beaver valley mall the block northway century iii mall the galleria of mt lebanon the mall at robinson monroeville mall pittsburgh mills ross park mall south hills village station square uniontown mall warner centre washington crown center westmoreland mall lifestyle  outdoor bakery square edgewood towne centre ellsworth avenue mccandless crossing northern lights robinson town centre settlers ridge southside works walnut street the waterfront waterworks mall outlet grove city premium outlets tanger outlets pittsburgh defunct allegheny center mall east hills shopping center eastgate commerce center eastland mall greengate mall parkway center mall village square mall washington mall colleges and universities pitt carnegie mellon duquesne robert morris chatham point park carlow art institute byzantine catholic seminary pittsburgh theological seminary saint paul seminary ccac culture of pittsburgh cookie table jewish history iron city brewing company jagoff joe magarac mister rogers neighborhood mr yuk parking chairs pittsburgh left pittsburgh toilet robot hall of fame steeler nation book category portal v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlemylanoldid categories companies in the nasdaq indexcompanies listed on nasdaqcorporate inversionspharmaceutical companies of the united statescompanies in the nasdaq biotechnology indexlife sciences industryhealth care companies based in pennsylvaniacompanies listed on tasecompanies formerly listed on the new york stock exchangehidden categories use mdy dates from october all articles with unsourced statementsarticles with unsourced statements from september interlanguage link template link number navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutschespañolفارسیfrançaisעבריתportuguêssuomi edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view creative commons — attributionsharealike  unported — cc bysa  skip to content menu help us build a vibrant collaborative global commons donate now creative commons creative commons license deed attributionsharealike  unported cc bysa  this is a humanreadable summary of and not a substitute for the license disclaimer you are free to share — copy and redistribute the material in any medium or format adapt — remix transform and build upon the material for any purpose even commercially the licensor cannot revoke these freedoms as long as you follow the license terms under the following terms attribution — you must give appropriate credit provide a link to the license and indicate if changes were made you may do so in any reasonable manner but not in any way that suggests the licensor endorses you or your use attribute this work sharealike — if you remix transform or build upon the material you must distribute your contributions under the same license as the original no additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits notices you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation no warranties are given the license may not give you all of the permissions necessary for your intended use for example other rights such as publicity privacy or moral rights may limit how you use the material learn more about cc licensing or use the license for your own material this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work make a donation this page is available in the following languages castellano castellano españa català dansk deutsch english esperanto français galego hrvatski indonesia italiano latviski lietuvių melayu nederlands norsk polski português português br română slovenščina suomeksi svenska türkçe íslenska česky ελληνικά беларуская русский українська العربية پارسی     한국어 this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work when you share everyone wins contribute today to creative commons     disclaimer this deed highlights only some of the key features and terms of the actual license it is not a license and has no legal value you should carefully review all of the terms and conditions of the actual license before using the licensed material creative commons is not a law firm and does not provide legal services distributing displaying or linking to this deed or the license that it summarizes does not create a lawyerclient or any other relationship what does attribute this work mean the page you came from contained embedded licensing metadata including how the creator wishes to be attributed for reuse you can use the html here to cite the work doing so will also include metadata on your page so that others can find the original work as well the applicable mediation rules will be designated in the copyright notice published with the work or if none then in the request for mediation unless otherwise designated in a copyright notice attached to the work the uncitral arbitration rules apply to any arbitration more info if supplied you must provide the name of the creator and attribution parties a copyright notice a license notice a disclaimer notice and a link to the material cc licenses prior to version  also require you to provide the title of the material if supplied and may have other slight differences more info in  you must indicate if you modified the material and retain an indication of previous modifications in  and earlier license versions the indication of changes is only required if you create a derivative marking guide more info you may also use a license listed as compatible at httpscreativecommonsorgcompatiblelicenses more info a commercial use is one primarily intended for commercial advantage or monetary compensation more info merely changing the format never creates a derivative more info the license prohibits application of effective technological measures defined with reference to article  of the wipo copyright treaty more info the rights of users under exceptions and limitations such as fair use and fair dealing are not affected by the cc licenses more info you may need to get additional permissions before using the material as you intend more info mylan – seeing is believing en   en mylan worldwide close please select one of our websites from the list below africa south africa english americas brazil português brasileiro canada english français united states english asia india english japan  taiwan  europe austria deutsch belgium français nederlands bulgaria българия czech republic čeština denmark dansk finland suomi france français germany deutsch greece ελληνικά hungary magyar ireland english italy italiano netherlands nederlands norway norsk poland polski portugal português romania română serbia serbian latin slovakia slovenský slovenia slovenian spain español sweden svensk switzerland deutsch english united kingdom english pacific australia english new zealand english mylan also is proud to do business in these locations morocco luxembourg china singapore search company and product information menu savings our culture access generics and biosimilars drive access and savings for the us healthcare system the association for accessible medicines releases its  generic drug access  savings in the us report working at mylan learn about mylans culture as we work to provide  billion people access to high quality medicine mylan provides update on meridian medial technologies a pfizer company expanded voluntary worldwide recall of epipen autoinjector information and updates on recall and product replacement instructions for patients service mylans commitment learn what mylan has done to help patients access epinephrine learn what mylan has done to help patients access epinephrine innovation innovating today for a healthier tomorrow we are committed to advancing the future of generic and specialty medicines we are committed to advancing the future of generic and specialty medicines access learn about mylan epipen® autoinjector access programs learn about mylan epipen® autoinjector access programs quality providing access to quality injectables play video view how mylan upholds one global quality throughout its broad injectables portfolio view how mylan upholds one global quality throughout its broad injectables portfolio play video service innovation access quality resources and information to help prescribe dispense and take medicine with confidence explore pharmacists educational materials to help empower your customers patients what to know about our high quality products physicians details about our brandname and generic medicines institutional customers resources that meet the specific needs of your institution explore find a mylan product search our generic and brandname us pharmaceuticals by name   careers that can change the world every mylan employee works to impact the lives of  billion people around the world discover who we are global career opportunities select a location albania algeria australia austria belgium bosniaherzegovina brazil bulgaria canada china croatia czech republic denmark estonia finland france germany greece hungary india ireland italy japan latvia lithuania luxembourg morocco netherlands new zealand norway poland portugal puerto rico romania serbia slovakia slovenia south africa spain sweden switzerland taiwan united kingdom united states global executive leadership opportunities start here company about us business segments leadership global social responsibility corporate governance products product catalog quality our medicines and consumer products why generics therapeutic innovation active pharmaceutical ingredients packaging and finished dosage forms news feature stories press releases investors stock performance investment calculator stock history public filings investor faqs update on meridian’s voluntary worldwide recall of epipen® autoinjector careers life at mylan mylan benefits diversity  inclusion mylan near you resources and information to help prescribe dispense and take medicine with confidence pharmacists educational materials to help empower your customers patients what to know about our high quality products physicians details about our brandname and generic medicines health systems customers resources that meet the specific needs of your institution explore contact mylan privacy shield policy privacy statement terms and conditions site map california supply chains act copyright   mylan nv all rights reserved for us audiences only ampamplta hrefhttpwwwyoutubecomuserseeinsidemylan targetblank relnofollow datacategorysocialyoutube dataactionclicklink datalabelglobalfooterampampgtyoutubeampampltaampampgt ampamplta hrefhttptwittercommylannews targetblank relnofollow datacategorysocialtwitter dataactionclicklink datalabelglobalfooterampampgttwitterampampltaampampgt ampamplta hrefhttpfacebookcom targetblank relnofollow datacategorysocialfacebook dataactionclicklink datalabelglobalfooterampampgtfacebookampampltaampampgt you are leaving mylancom you are now leaving mylancom for a mylan affiliate site a mylan product site a third party site that mylan may contribute content to but does not have exclusive control over or a third party site that is solely responsible for its content and may not follow guidelines applicable in certain geographies continue go back mylan  wikipedia mylan from wikipedia the free encyclopedia jump to navigation search mylan trading name mylan nv formerly called milan type public under dutch law traded as nasdaq myl tase myl nasdaq biotechnology component nasdaq component sp  component isin us industry pharmaceuticals founded   years ago  in white sulphur springs west virginia united states founders milan puskar don panoz headquarters canonsburg pennsylvania united states of america area served worldwide key people heather bresch ceo products generic and specialty pharmaceuticals and active pharmaceutical ingredients revenue us billion  operating income us million  net income us billion  total assets us  billion  total equity us billion  number of employees   divisions see operations subsidiaries meda famy care website wwwmylancom mylan nv is an american global generic and specialty pharmaceuticals company registered in the netherlands with principal executive offices in hatfield hertfordshire uk and global headquarters in canonsburg pennsylvania us in  mylan acquired a controlling interest in indiabased matrix laboratories limited a top producer of active pharmaceutical ingredients apis for generic drugs and the generics business of germanybased merck kgaa through these acquisitions mylan grew from the thirdlargest generic and pharmaceuticals company in the united states to the secondlargest generic and specialty pharmaceuticals company in the world in  mylans pricing of the epipen an epinephrine autoinjector became controversial and was widely referred to as price gouging as a result investigations were opened into whether mylan had misclassified the epipen under the medicaid drug rebate program a common form of pharmaceutical fraud in october  mylan settled these investigations with the us department of justice agreeing to pay  million and enter into a corporate integrity agreement concerning the rebate program in a report published on june   the institutional shareholder services criticized mylan for the outsized compensation of mylans directors former ceo robert coury received a  million  pay package in spite of the harm to the company inflicted by the epipen controversies and steep shareholder losses the report urged mylans shareholders to oust all of mylans existing directors contents  operations  location  stock  history  acquisition history  criticism  epipen pricing  execution drugs  references  external links operationsedit mylan inc operates several divisions and subsidiaries in north america and south america mylan operates mylan pharmaceuticals based in morgantown west virginia mylan pharmaceuticals ulc mylan canada mylan technologies inc mti  transdermal drug delivery systems tdds and related technologies udl laboratories inc somerset pharmaceuticals inc a research and development company in tampa florida owned by mylan somerset develops emsam manufactured by mylan technologies and marketed in the united states by dey another mylan company mylan laboratories limited campos dos goytacazes brazil in oceania and central east south and southeast asia mylan operates mylan new zealand limited  new zealand mylan laboratories limited  headquartered in hyderabad india operates nine active pharmaceutical ingredient api and intermediate manufacturing facilities located in india and china mylan seiyaku ltd  japan alphapharm  australia agila specialties pvt ltd  india oncotherapies ltd  india in europe africa and west asia mylan operates operates under the mylan name in austria belgium the czech republic denmark finland france germany hungary italy the netherlands norway poland portugal slovakia slovenia spain sweden switzerland the united kingdom also operates in south africa arcana arzneimittel gmbh  germany generics pharma hellas  greece gerard laboratories  ireland qualimed  trademark in france but will stop being marketed under the brand name docpharma  generic pharmaceutical distribution company in belgium the netherlands and luxembourg locationedit founded in  the company was first located in white sulphur springs west virginia the company moved to morgantown west virginia in  and in  it relocated its corporate headquarters to the pittsburgh suburb canonsburg pennsylvania finally in  it moved to a new office center in nearby southpointe a suburban business park located in cecil township where it is still located stockedit on february   mylan had its initial public offering ipo becoming a publicly traded company on the otc market under the ticker symbol myln in  the stock moved to nasdaq their final stock move was in  when their stock became available for trade on the new york stock exchange under the ticker symbol myl currently the stock is traded on the nasdaq historyedit mylan pharmaceuticals was founded as a drug distributor in  by milan puskar and don panoz in  mylan began manufacturing penicillin g tablets as well as vitamins and other dietary supplements panoz left mylan in  and puskar quit the company in  as it grew and experienced financial difficulties the board hired roy mcknight as board chairman who convinced puskar to return in  mylan discontinued operating as a contract manufacturing organization in  and instead chose to market their products under their own mylanlabeled brandcitation needed with the passage of the hatchwaxman act in  mylan and other small generic companies gained value in the eighteen months following passage of the law mylans earnings grew  to  million and its stock value rose  in the s one of the most prescribed drugs in the us was dyazide a diuretic that was a combination drug containing triamterene and hydrochlorothiazide it had been on the market since  and its patents had expired in  complications arose with the introductions of generics versions because the formulation of dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent some generic companies committed fraud trying to bring a generic version of dyazide bolar pharmaceutical had the first generic version approved in  but it turned out that bolar had fraudulently substituted dyazide for its own version to conduct studies that were submitted to the fda by  the fda rescinded its approval based on its suspicions and filed criminal charges against bolar to which bolar eventually pled guilty in  mylan chose to develop a new version of a triamterenehydrochlorothiazide combination drug instead of going the generic route it developed a different more stable formulation and used different dosages of each active ingredient  mg hydrochlorothiazide and  mg triamterene compared with dyazides  mg hydrochlorothiazide and  mg triamterene this drug had to get approval as a new drug as opposed to a generic their product was called maxzide and was approved in  the higher dose allowed once per day dosing which mylan and its marketing partner lederle believed would help it compete against dyazide which had m in sales in  however mylans patents on the drug were declared invalid in court and its marketing exclusivity expired in  prompting a rush of generic competition mylan had concerns about the practices of its competitors and the fda in general and also with regard to companies seeking to bring generic versions of maxzide mylan hired private investigators to examine its competitors practices and when it found evidence of corruption it submitted it to the house oversight and investigations committee which investigated and found fraud and corruption within the food and drug administrations generic drugs division and at other generic companies two of the companies that had gotten approval to market generic versions of maxzide vitarine pharmaceutical and par pharmaceutical were targets of mylans initial investigation and were found to have used mylans maxzide to obtain their bioequivalence data leading both companies to withdraw its generic competitor to mylans product the corruption in the nascent generics industry and at the office in the fda regulating it was widely covered in the media and led to widespread concern among doctors and the public in the late s and early s that generic drugs were not really the same as the branded drugs they were meant to replace in  mylan agreed to enter into a joint venture with bolar to buy somerset pharmaceuticals mylan wanted access to somersets drug discovery capabilities as well as its new drug for parkinsons selegiline the deal was completed in  but its consummation was dependent on fda approval of selegiline which came in  mylan acquired bertek inc in  for its transdermal patch technologies and kept as a subsidiary in  mylan renamed the company mylan technologies inc mti mti eventually came to be the contract manufacturer for the selegiline transdermal patch and was the first company to market generic nitroglycerin estradiol clonidine and fentanyl transdermal patches mylan acquired udl laboratories a supplier of unit dose generic medications to institutional and longterm care facilities in  in  when it was the worlds second largest generics company mylan came under investigation from the federal trade commission after it raised the prices of its products tripling them in the case of lorazepam mylan had entered into an exclusive agreement with profarmica an italian company that supplied drug ingredients after which mylans competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs before the round of price increases the price of generic drugs had been    of the price of branded drugs and afterwards it was around  the ftc filed suit at the end of  and  states filed parallel actions the case was settled in  with mylan paying a total of m  m in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid  million in attorneys fees to the state attorneys general  million plus  million in attorneys fees to settle certain class actions with insurers and managed care organizations  and mylan and three ingredient suppliers cambrex corporation profarmaco srl and gyma laboratories also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future in  mylan and king pharmaceuticals began discussing a deal in which mylan would acquire king for about b mylan wanted to expand its presence in branded pharmaceuticals and to acquire kings sales force the deal became one of the business soap operas of the year and included an sec investigation into kings accounting and carl icahn obtaining a  interest in mylan and becoming its largest stakeholder in order to kill the deal the parties called off the deal in february  icahn offered to buy mylan for b and ran a slate of board members to change the direction of mylan he won three seats in may  in june mylan bought back  of its shares in order to fend off icahn and in july icahn gave up his bid and sold his shares in august  mylan announced that it had reached agreement to buy a controlling interest in matrix laboratories an indian supplier of active pharmaceutical ingredients the deal gave mylan access to markets in india and china and was completed in january the next year in may  mylan and merck kgaa agreed that mylan would acquire mercks generics arm for b the deal was completed that october and tripled the size of mylan mylan acquired the rights to market the epipen in the transaction at that time annual sales were around  million and the epipen had about  of the market in  the company filed two lawsuits against the pittsburgh postgazette after the newspaper ran an article that was critical of the quality control procedures used at the companys morgantown plant the company had earlier quality control issues involving the fda the lawsuits were dropped in  without any damages paid by the postgazette which stated the postgazette did not find and did not intend to report that mylan had manufactured or distributed any defective drugs the postgazette regrets if any reader of the article thought otherwise also in  mylan and its subsidiary udl agreed to pay a m to settle a suit filed under the false claims act in which mylanudl and two other companies were accused of underpaying states under the medicaid drug rebate program the program requires drug companies to give rebates to states under medicaid and the rebates are higher for new drugs than for generics the suit said that the companies sold new drugs but paid rebates as if they were generics in  mylan entered into an agreement with pfizer for the exclusive worldwide rights to develop manufacture and commercialize pfizers generic equivalent to glaxosmithklines advair usseretide uk diskus incorporating pfizers proprietary dry powder inhaler delivery platform mylan launched the product in the uk in  and in february  the fda accepted its anda putting it in line behind hikma and sandoz to launch a generic version in the us in  mylan launched a program called epipenschools to sell epipens in bulk and with discounts to schools to participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year in december  the national association of state boards of education launched a policy initiative designed to help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine autoinjector access and use and advocated for state laws protecting school from legal liability for stocking and using epinephrine autoinjectors gayle manchin the mother of mylans ceo heather bresch had become president of the association in  and shortly after had discussed donations from her daughters company to the association manchin had been appointed to the west virginia state school board by her husband thengovernor of the state joe manchin in  in  mylan acquired an indian generic injectable drugs company agila specialties private for  billion in cash in  three plants acquired in that deal were issued warning letters by the fda after successful lobbying from mylan in  the school access to emergency epinephrine act became law after passing congress with broad and bipartisan support it protected anyone from liability if they administered epinephrine to a child in a school previously only trained professionals or the affected person were allowed to administer the drug and were open to liability and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them joe manchin the father of mylans ceo was a senator at that time in july  mylan and abbott laboratories announced an agreement under which mylan would buy abbotts generic drugs business in developed markets for stock valued at about  billion mylan acquired mumbaibased famy care and expand its presence in the market for womens contraceptives at about  million starting in  according to a  report in the new york times midlevel executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the epipen and raising concerns that the price increases were unethical the times reported that when these concerns were brought to robert coury the chairman of the board coury replied that he was untroubled he raised both his middle fingers and explained using colorful language that anyone criticizing mylan including its employees ought to go copulate with themselves critics in congress and on wall street he said should do the same and regulators at the food and drug administration they too deserved a round of anatomically challenging selffulfillment  the times reported that bresch provided similarly dismissive responses in april  mylan tried negotiate with the management of irish pharmaceutical firm perrigo to acquire the company and when those negotiations failed mylan attempted a hostile takeover offering to buy b in shares directly from shareholders too few shareholders agreed to sell their stock by the deadline set in november  and the effort failed two weeks after mylan made its first offer for perrigo teva pharmaceutical offered to buy mylan for b the combined companies would have been the worlds largest generic company and the th biggest drug company in the world in july teva dropped its bid for mylan and instead acquired allergans generic drug business for about the same price in june  mylan agreed to work with pulmatrix a company with a proprietary inhaled drug delivery platform to codevelop a product to treat for chronic obstructive pulmonary disease the product was pur a generic drug in a pulmatrix device in february  the company announced it would acquire meda for  billion in may of the same year the company announced it would acquire renaissance acquisition holdings dermatology division for up to  billion in  mylan had about b in sales of epipens and those sales accounted for  of mylans profit mylan had maintained about a  market share since it had acquired the product and had continually raised the price of epipens starting in  in  the wholesale price of two epipens was about  by july  the price was about  in may  it was around  and in may  the price rose again to around  around a  jump from the price in  in the summer of  as parents prepared to send their children back to school and went to pharmacies to get new epipens people began to express outrage at the cost of the epipen and mylan was widely and harshly criticized the price hikes led to investigations by congress and states attorneys general in october  mylan agreed to pay a m fine related to incorrect rebates it paid under the medicaid drug rebate program in december  the attorneys general of  states filed a civil complaint accusing mylan of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug the complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings telephone calls and text messages according to the department of health and human services office of inspector general analysis the us government may have overpaid as much as  billion between  and  to drugmaker mylan nv for the epipen emergency allergy treatment this represents three times the proposed settlement of  million announced by mylan in october  republican senator chuck grassley chair of the senate judiciary committee that launched the probe of epipen pricing probe in  released the analysis on may   on the same day a group of mylan investment funds urged shareholders to vote against the reelection of the companys directors after it paid chairman robert coury over  million last year acquisition historyedit the following is an illustration of the companys major mergers and acquisitions and historical predecessors mylan   renaissance acquisition holdings dermatology div acq    meda acq    famy care acq    abbott laboratories generics div acq    merck kgaa generics div acq  renamed mylan laboratories inc   udl laboratories acq    bertek inc acq  renamed mylan technologies inc milan pharmaceuticals founded  criticismedit epipen pricingedit see also epinephrine autoinjector § cost see also heather bresch § business executive mylan acquired the right to market and distribute the epipen line of epinephrine autoinjector devices from merck kgaa as part of their  deal that right had formerly been held by dey lp a wholly owned subsidiary of merck the devices deliver about  worth of drug at that time annual sales were around m bresch the companys ceo saw an opportunity to increase sales through marketing and advocacy and the company launched a marketing campaign to increase awareness of the dangers of anaphylaxis for people with severe allergies that made the brand epipen as identified with its product as kleenex is with facial tissue the company also successfully lobbied the fda to broaden the label to include risk of anaphylaxis and in parallel successfully lobbied congress to generate legislation making epipens available in schools and in public places like defibrillators are and hired the same people that medtronic had worked with on defibrillator legislation to do so mylans efforts to gain market dominance were aided when sanofis competing product was recalled in november  and further when tevas generic competitor was rejected by the fda in march  by the first half of  mylan had an  market share of such devices in the us and in that year sales reached around b and accounted for  of mylans profit those profits were also due in part to mylans continually raising the price of epipens starting in  in  the wholesale price of two epipens was about  the price was about the same in  by july  the price about  in may  it was around  and in may  the price rose again to around  the last price increase sparked widespread outrage including criticism from martin shkreli poster boy for grasping pharma greed letters from two senators and initiation of congressional investigations and mylans pricing of the epipen was widely referred to as price gouging the last price increase coincided with a new line of tv commercials that were described as shocking and no holds barred depicting an anaphylactic reaction from the point of view of the young woman having it at a party and ending with the young woman seeing her swollen and hivecovered face in the mirror before she collapses in response to criticism mylan increased financial assistance available for some patients to purchase epipens a gesture that was called a classic public relations move by harvard medical school professor aaron kesselheim the up to  saving cards can only be used by a small number of people who need the drug and no one on medicaid they do nothing about the high price which is still being paid by insurers who ultimately pass the cost onto consumers in september  the new york state attorney general began an investigation into mylans epipenschools program in new york to determine if the programs contracts violated antitrust law and the west virginia state attorney general opened an investigation into whether mylan had given the state the correct discount under the medicaid drug rebate program and subpoenaed the company when it refused to provide the documentation the state requested in october  the ceo of mylan testified to congress that pfizerking charged mylan about  for one device in september  a silicon valley engineering consultancy performed a teardown analysis of the epipen and estimated the manufacturing and packaging costs at about  for a twopack in october  mylan announced a settlement with the us department of justice over rebates paid by mylan to states under the medicaid drug rebate program questions had been raised by congress and others about why epipen had been classified as a generic rather a proprietary product in the program since  generic drugs have lower rebates  than proprietary drugs  and price hikes for generic drugs cannot be passed onto states and a common form of pharmaceutical fraud involves misclassifying proprietary drugs as generic under the program under the agreement mylan agreed to pay a  million payment and to a sign a corporate integrity agreement requiring it to perform better in the future the settlement also resolved cases brought by states related to the rebates simultaneously with the settlement mylan also announced it was being investigated by the securities and exchange commission related to the drug rebate program in june  the new york times published an article reporting on internal mylan discussions about price increases on the epipen between  and  in which the company chairman expressed disdain for people and agencies who might criticize the company the reporter wrote those top leaders’ responses are a far cry from the message on mylan’s website which says that we challenge every member of every team to challenge the status quo and that we put people and patients first trusting that profits will follow and also noted that the firm is a case study in the limits of what consumer and employee activism as well as government oversight can achieve  execution drugsedit mylan manufactures rocuronium bromide which is approved by the state of alabama for use in executions by lethal injection european manufacturers refuse to sell drugs which can be used for executions to the united states except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain in september  the londonbased human rights organization reprieve told mylan that they were the only fdaapproved manufacturer of rocuronium bromide without legal controls in place to prevent its use in executions and there was a very real risk that mylan may soon become the goto provider of execution drugs for states across the country the german asset manager dje kapital de divested itself of  million in mylan shares for that reason mylan said that their distribution was legally compliant referencesedit  a b public filings  form k mylan investors relations retrieved august     mylan nv k for the fiscal year ended december    mylan buys part of drug maker pittsburgh business times december     mylan laboratories to acquire generics business of merck kgaa for  billion euros medical news today may     pharmaceutical giants tracking mylans prosperity the pittsburgh tribunereview august     egan matt epipen maker faces revolt over execs  million pay package cnn money   transdermal patches  mylan mylantechcom   brand name medicines  mylan deycom   about us mylancom   a b about us mylancom   matrixlabsindiacom matrixlabsindiacom   whats new  arcana arzneimittelherstellung arcanade   httpwwwmantacomcomsdnbcompanywsklv  httpwwwidairelandcomsearchcompaniesxmlssid  httpwwwbioportfoliocomnewspdfusmylantowithdrawqualimedbrandfromfrenchmarketreportpdf  a b c dearment alaric october   milan puskar cofounder of mylan dies drug store news   mylan  years young and still making history mylan retrieved april     myl stock history  mylan retrieved august     a b c d e freudenheim milt september   exposing the fda new york times   lewis ralph a  the emerging effects of the drug price competition and patent term restoration act of  journal of contemporary health law  policy   –   a b ron wolf for the philadelphia inquirer august   smithkline loses exclusive rights to drug  a b boehm garth yao lixin han liang zheng qiang september  development of the generic drug industry in the us after the hatchwaxman act of  acta pharmaceutica sinica b   – doijapsb   a b john seaman and john t landry mylan  years of unconventional success mylan in association with university press of new england  isbn  page   a b strickland carol october   bolar a drug company under siege the new york times   shaw donna february   us charges bolar pharmaceutical with misrepresenting its products philadelphia inquirer   freudenheim milt february   bolar plans guilty plea on generics the new york times   a b c pink sheet october   mylans maxzide is approvable at fda lederle to market brand competition to smithklines no ranked dyazide final approval anticipated imminently  fda approval history nda  maxzide page accessed september    reid kenneth november   us judge to rule on drug marketing journal of commerce   andrews edmund l july   fda inquiry on generic drugs focuses on changes in ingredients the new york times   cimons marlene august   fda to lift ok of last dyazide generic version los angeles times   bolar and mylan team to purchase somerset labs pink sheet november     somerset eldepryl june  approval clears way for mylanbolar acquisition pink sheet june     a b ku mannching sherry december   recent trends in specialty pharma business model journal of food and drug analysis   – doijjfda   mylan form k annual report for the financial year ending march    filed june    a b labaton stephen december   a drug maker is said to face a suit on prices the new york times   press release ftc reaches record financial settlement to settle charges of pricefixing in generic drug market  federal trade commission ftc november     labaton stephen july   genericdrug maker agrees to settlement in pricefixing case the new york times   a b creswell julie march   icahn the spoiler fortune   pollack andrew november   icahn offers  billion for mylan drug maker the new york times   okeefe eric may   icahn slate wins seats on blockbuster board the new york times   lazo shirley a survival strategy barrons   icahn drops bid for mylan los angeles times bloomberg news july     mylan signs usmil takeover deal for indias matrix laboratories ihs august     mylans acquisition of matrix business strategy case study icrm   massey steve may   mylan buys merck generic drug unit for  billion pittsburgh postgazette   press release mylan completes acquisition of generics business of merck kgaa mylan october     a b c d e f g cynthia koons and robert langreth for bloomberg businessweek september   how marketing turned the epipen into a billiondollar business  johnson carolyn y ho catherine august   how mylan the epipen company maneuvered to create a virtual monopoly the washington post via the chicago tribune   adams russell october   mylan again sues pittsburgh postgazette wall street journal retrieved august     sabatini patricia boselovic len july   mylan workers overrode drug quality controls internal report detailed pervasive practice of ignoring safety procedures pittsburgh postgazette retrieved august     edwards jim july   its not mylans first quality control beef with fda money watch cbs news retrieved august     mylan pittsburgh postgazette settle lawsuits cbs news associated press february   retrieved august     us department of justice october   press release four pharmaceutical companies pay  million for submission of false claims to medicaid  mylan acquires rights to pfizers inhaler technology drugstorenewscom retrieved may     stanton dan june   gsk breathes freely as mylan launches seretide generic in uk inpharma technologist   helfand carly february   mylan joins the advaircopycat queue but approval could be a long slog fiercepharma   swetlitz ike silverman ed august   mylan may have violated antitrust law in its epipen sales to schools pbs newshour   a b odonnell jayne september   family matters epipens had highlevel help getting into schools usa today   thomas katie february   mylan buys drug maker of generic injectables new york times   palmer eric august   updated fda castigates three mylan sterile drug plants in warning letter fiercepharma   novak matt august   how congress the fda and sarah jessica parker helped epipen become a  billion business gizmodo   abc news business news personal finance and money news  abc news abc news retrieved july     us drugmaker mylan to acquire famy care for  million timesofindiaeconomictimes february     a b duhigg charles  june  outcry over epipen prices hasn’t made them lower the new york times   koons cynthia november   mylans hostile bid for perrigo fails bloomberg   rockoff jonathan d mattioli dana april   teva offers to buy mylan for  billion wall street journal   teva to buy allergans generic drug unit bloombergcom july     chitra somayaji july   teva snaps up allergans generics arm dumping mylan bloombergcom   mylan to codevelop pulmatrix copd candidate gen   mylan to acquire meda for b  gen news highlights  gen retrieved august     mylan snaps up dermatology biz from investors in b deal  fiercepharma retrieved august     a b c tara parkerpope and rachel rabkin peachman for the new york times august   epipen price rise sparks concern for allergy sufferers  bartolotta devin august   cost jumps nearly percent for lifesaving epipens cbs baltimore retrieved august     goldberg kenny people with food allergies say lifesaving drug too expensive kpbs public media retrieved june     walker joseph winslow ron steele anne august   mylan to launch cheaper generic epipen alternative wall street journal   a b c thomas katie october   mylan to settle epipen overpricing case for  million the new york times   thomas katie   states accuse generic drug companies of price fixing the new york times retrieved    a b erman michael may   mylan may have overcharged us for epipen by  billion hhs reuters new york retrieved may     king pharmaceuticals october   press release king pharmaceuticals to acquire meridian medical technologies  carly helfand for fiercepharma march   fda swats down tevas epipen copy putting mylan in cruise control  a b emily willingham for forbes august   why did mylan hike epipen prices  because they could  emma court for marketwatch august   mylan’s epipen price increases are valeantlike in size shkrelilike in approach  brad tuttle for time august    signs that epipen prices are completely out of control  michael hiltzik for the los angeles times august   another reason to hate mylan which jacked up the price of lifesaving epipens its a tax dodger  matt novak for gizmodo august   how congress the fda and sarah jessica parker helped epipen become a  billion business  beth snyder bulik for fiercepharma may   no holds barred in mylan’s ultrarealistic peanut allergy campaign  mylan to provide epipen cost assistance as ceo is asked to testify on price hike the guardian   a b carolyn y johnson august   why mylan’s ‘savings card’ won’t make epipen cheaper for all patients washington post washington post   larson erik hopkins jared s september   mylan’s epipen school sales trigger ny antitrust probe bloomberg retrieved september     feeley jef langreth robert september   mylan investigations mount as west virginia opens fraud probe bloomberg news   popken ben september   upgraded epipens torn apart tech firm its the same core device nbc news   tracy seipel silicon valley engineers figure real cost to make lifesaving autoinjector twopack the mercury news retrieved october     thomas katie september   is epipen a brandname or a generic drug mylan casts it both ways the new york times   mole beth october   for ripping off medicaid epipen maker mylan pays feds  million ars technica retrieved october     ztracer zachary tracer october   mylan agrees to  million epipen settlement with us bloombergcom   novak matt  june  drug company chairman to america go fuck yourself gizmodo   mole beth  june  mylan chairman drug pricing critics ought to go copulate with themselves ars technica   loew derek  june  mylan begins harvesting the crop its sown in the pipeline   a b owen dyer october   drug company is targeted for refusing to adopt ban on distribution of execution drug bmj   g doibmjg  external linksedit media related to mylan at wikimedia commons business data for mylan google finance yahoo finance reuters sec filings v t e pittsburgh history timeline culture dialect media neighborhoods notable people skyscrapers government airport conventions city hall courthouse mayor council events intergov police da sheriff fire libraries transit education port regional economy allegheny conference duquesne club chamber of commerce economic club hyp club stock exchange fortune  headquarters us steel pnc ppg heinz wesco consol dicks allegheny technologies forbes largest private companies  lumber giant eagle other headquarters american bridge american eagle ampco ansys armstrong black box calgon carbon compunetix dollar bank dqe eatn park education management corporation eqt federated gnc gurucom highmark igate iron city kennametal koppers laughlin marc usa millcraft msa nichecom oxford ptc renda rue upmc vocelli wabtec shared headquarters alcoa modcloth nova chemicals subsidiary headquarters allegheny energy bayer corporation fedex ground glaxosmithkline usa lanxess respironics vivisimo westinghouse regional operations aa bny mellon formerly mellon financial dreyfus eaton spreadshirt macys historic big wheel clark dravo fisher integra mesta murphy gulf oil jl ketchum rockwell sunbeam westinghouse sports dapper dan grand prix great race head of the ohio lore marathon mylan classic regatta wphl baseball pirates wild things panthers dukes chronicletelegraph cup allegheny burghers champions crawfords filipinos grays hardhats keystones stogies rebels basketball yellow jackets panthers m panthers w dukes m dukes w colonials m colonials w roundball classic condors ironmen loendi monticello phantoms pipers piranhas pirates rens xplosion football steelers panthers steeler nation heritage colts force passion renegades  allstars allegheny americans as duquesne gladiators homestead lyceum maulers power odds olympics quakers jp stars early pro football circuit hockey penguins colonials m colonials w three rivers classic as bankers cougars duquesne ft pitt hornets keystones lyceum panthers phantoms pirates pirates wphl pros shamrocks victorias winter garden yellow jackets soccer riverhounds beadling cannons hurricanes phantoms spirit other sledgehammers bulls harlequins pcc triangles wallabies studio wrestling dirty dozen venues ppg paints arena heinz field pnc park  lumber arena fitzgerald field house highmark stadium palumbo center petersen events center petersen sports complex rooney field sewall center trees hall central park civic arena duquesne gardens exposition park forbes field josh gibson field greenlee field motor square garden pitt stadium recreation park schenley gardens three rivers winter garden parks allegheny arsenal allegheny commons allegheny riverfront artgardens buhl community chatham university arboretum frank curto frick emerald view highland market square mellon mellon green mellon square north shore riverfront phillips point of view point state ppg place riverview roberto clemente memorial rodef shalom biblical botanical garden schenley schenley plaza south shore riverfront south side three rivers west end overlook westinghouse transportation inclines steps v t e port authority of allegheny county light rail list of stations blue line – library blue line – south hills village red line inclines historical list duquesne incline monongahela incline buses and busways list of routes martin luther king jr east busway south busway west busway former lines  drake brown line patrain skybus other north shore connector port authority  series pcc wabash tunnel v t e public transportation in greater pittsburgh bus services port authority of allegheny county list of bus routes beaver butler fayette indigo mid mon valley mountain line new castle town  country university of pittsburgh washington westmoreland bus rapid transit mlk jr east busway south busway west busway light rail red line blue line library south hills village inclines duquesne monongahela amtrak capitol limited pennsylvanian airports pittsburgh international arnold palmer allegheny county beaver butler eddie dew greensburg jeannette herron jefferson jimmy stewart joe hardy lakehill monroeville new castle rock rostraver washington wheeling zelienople discontinued broadway limited brown line list of streetcar routes in pittsburgh parkway limited patrain skybus v t e tunnels and bridges in pittsburgh tunnels allegheny river tunnel armstrong tunnel cork run tunnel corliss tunnel fort pitt tunnel jl tunnel liberty tunnel mount washington transit tunnel pittsburgh and castle shannon tunnel pittsburgh  steubenville extension railroad tunnel schenley tunnel squirrel hill tunnel wabash tunnel bridges th street bridge st street bridge rd street railroad bridge th street bridge bloomfield bridge birmingham bridge david mccullough bridge fort duquesne bridge fort pitt bridge fort wayne railroad bridge glenwood bridge glenwood bo railroad bridge highland park bridge homestead grays bridge hot metal bridge liberty bridge mckees rocks bridge panhandle bridge panther hollow bridge schenley bridge senator robert d fleming bridge smithfield street bridge south tenth street bridge three sisters roberto clemente bridge andy warhol bridge rachel carson bridge veterans bridge west end bridge attractions aviary baywood cathedral of learning chinatown conservatory dippy immaculate heart duquesne incline heinz chapel little italy mellon institute mon incline observatory pamelas penn station point of view sculpture primantis science center steps uss requin zoo kennywood luna park westinghouse sign landmarks national city national county state city phlf cultural museums art arts arts festival bible fort pitt and blockhouse clayton clemente childrens frick glass center history jazz jewish mattress factory dental miller miss pittsburgh nationality rooms national map natural history soldiers and sailors warhol wilson wsg venues heinz hall benedum byham harris kellystrayhorn new hazlett oreilly foster playhouse trib hunt stage ae syria mosque nixon theater festivals anthrocon arts blues comicon fashion film folk handmade new works tekko whiskey  fine spirits wine shopping and entertainment casino gateway clipper fleet station square strip downtown oakland south side macys market square southside works waterworks mount washington east liberty squirrel hill shadyside walnut street opera ballet symphony brass classical theatre dance ensemble caravan theatre folk light opera opera theater jewish theatre public theater playwrights musical theater stage right youth ballet youth symphony bricolage nnoc v t e shopping malls in pittsburgh enclosed beaver valley mall the block northway century iii mall the galleria of mt lebanon the mall at robinson monroeville mall pittsburgh mills ross park mall south hills village station square uniontown mall warner centre washington crown center westmoreland mall lifestyle  outdoor bakery square edgewood towne centre ellsworth avenue mccandless crossing northern lights robinson town centre settlers ridge southside works walnut street the waterfront waterworks mall outlet grove city premium outlets tanger outlets pittsburgh defunct allegheny center mall east hills shopping center eastgate commerce center eastland mall greengate mall parkway center mall village square mall washington mall colleges and universities pitt carnegie mellon duquesne robert morris chatham point park carlow art institute byzantine catholic seminary pittsburgh theological seminary saint paul seminary ccac culture of pittsburgh cookie table jewish history iron city brewing company jagoff joe magarac mister rogers neighborhood mr yuk parking chairs pittsburgh left pittsburgh toilet robot hall of fame steeler nation book category portal v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlemylanoldid categories companies in the nasdaq indexcompanies listed on nasdaqcorporate inversionspharmaceutical companies of the united statescompanies in the nasdaq biotechnology indexlife sciences industryhealth care companies based in pennsylvaniacompanies listed on tasecompanies formerly listed on the new york stock exchangehidden categories use mdy dates from october all articles with unsourced statementsarticles with unsourced statements from september interlanguage link template link number navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutschespañolفارسیfrançaisעבריתportuguêssuomi edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view mylan mylannews  twitter skip to content home home home current page moments moments moments current page search query search twitter searches you follow follow following unfollow saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  language english bahasa indonesia bahasa melayu català čeština dansk deutsch english uk español filipino français hrvatski italiano magyar nederlands norsk polski português română slovenčina suomi svenska tiếng việt türkçe ελληνικά български език русский српски українська мова עִבְרִית العربية فارسی मराठी हिन्दी বাংলা ગુજરાતી தமிழ் ಕನ್ನಡ ภาษาไทย 한국어  简体 繁體 have an account log in have an account remember me · forgot password new to twitter sign up mylan mylannews tweets tweets current page  following following  followers followers  likes likes  lists lists    more likes lists unmute mylannews mute mylannews follow following unfollow blocked unblock pending cancel mylan mylannews official page for mylan where we work around the clock and around the globe to help provide  billion people access to high quality medicine mylancom joined may   photos and videos photos and videos tweets tweets tweets current page tweets  replies media you blocked mylannews are you sure you want to view these tweets viewing tweets wont unblock mylannews yes view profile close mylan followed mylan retweeted maria sharapova‏verified account mariasharapova h hours ago more copy link to tweet embed tweet last night was so much fun and a great team win thank you worldteamtennis for having me this yearpictwittercomjcpwr  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo mylan retweeted mylan wtt‏verified account worldteamtennis h hours ago more copy link to tweet embed tweet embed video dessert for t harolds worst habit venuseswilliams washkastles answers  s wnickmccarvel in honor of her th mylanwtt seasonpictwittercomzthyqxh  questions with venus williams from what she ate for breakfast to how she would allocate  minutes for just herself venus williams answers a dozen questions with nick mccarvel in honor of playing her th season of mylan wtt  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jul  more copy link to tweet embed tweet fastfactfriday mylan is replacing waterbased dustremoval systems with dryfiltration setups at our wv osd plant httpbitlyqserhc pictwittercomlqpvi  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jul  more copy link to tweet embed tweet theravance biopharma and mylan announce positive results from month phase  safety study of revefenacin tdhttpbitlyglrwmq   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jul  more copy link to tweet embed tweet mylan to report second quarter  financial results on aug  httpbitlyvbelss   reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jul  more copy link to tweet embed tweet mylan retweeted womenscongpolicyinst mylan is proud to take part in the wcpisteamfair best of luck gulfoahttpstwittercomwcpinststatus … mylan added womenscongpolicyinst wcpinst just a few hours away from the wcpisteamfair we hope to see you there httpbitlyvumlp   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jul  more copy link to tweet embed tweet proud of the mylan and bioconlimited teams for reaching this important milestone httpbitlyuetcpd pictwittercomcrhnomulk  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jul  more copy link to tweet embed tweet fda odac unanimously recommends approval of mylan and biocons proposed biosimilar trastuzumabhttpbitlyuetcpd   reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan retweeted fda oncology‏verified account fdaoncology jul  more copy link to tweet embed tweet odac votes  in favor of trastuzumab biosimilar for herpositive metastatic or adjuvant breast cancer bcsm  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jun  more copy link to tweet embed tweet proud to once again attend schoolnurses annual meeting attendees learn about our school epinephrine access program booth  nasnpictwittercomvjdhgz  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jun  more copy link to tweet embed tweet generics account for  of prescriptions dispensed but only  of drug costs read the accessiblemeds report httpbitlyrxaccessreport pictwittercomqqhut  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jun  more copy link to tweet embed tweet genericdrugs lower healthcare costs the us saved  billion in  and  trillion in the last decade httpbitlyrxaccessreport pictwittercomgaoigopx  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jun  more copy link to tweet embed tweet genericdrugs and biosimilars drive access and savings for the us healthcare system more from ceo heather bresch httpbitlyrujwk pictwittercomccffnycrh  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan retweeted aam‏ accessiblemeds jun  more copy link to tweet embed tweet just released  generic drug access and savings in the us report httpsgooglyjrknm  generics biosimilars quintilesimspictwittercomovatlbvt  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jun  more copy link to tweet embed tweet mylan  biocon present clinical data on insulin glargine at the american diabetes associations scientific sessionshttpbitlyrmgcvo   reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jun  more copy link to tweet embed tweet mylan to present at goldman sachs th annual global healthcare conferencehttpbitlyrwxtm   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jun  more copy link to tweet embed tweet mylan launches generic azilect® tabletshttpbitlyrihpum   replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan‏ mylannews jun  more copy link to tweet embed tweet mylan launches generic reclast® injectionhttpbitlyrsuipq   replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan retweeted mylan careers‏ mylancareers may  more copy link to tweet embed tweet ceo heather bresch talks about sustaining a culture at mylan to deliver better health for a better world httpbitlyqxgsvh  mylanproudpictwittercomuxxgdfry  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylan retweeted map international‏ mapintl may  more copy link to tweet embed tweet we are thankful for the lifechanging gifts our pharmaceutical partners send us we are so honored to partner with mylannews  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo mylannews hasnt tweeted yet back to top ↑ loading seems to be taking a while twitter may be over capacity or experiencing a momentary hiccup try again or visit twitter status for more information new to twitter sign up now to get your own personalized timeline sign up you may also like · refresh false   twitter about help center terms privacy policy cookies ads info close choose a trend location dismiss close previous next close go to a persons profile searches you follow follow following unfollow saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  close promote this tweet close block cancel block add a location to your tweets when you tweet with a location twitter stores that location you can switch location onoff before each tweet and always have the option to delete your location history learn more turn location on not now close share location results from send close your lists close create a new list list name description under  characters optional privacy public · anyone can follow this list private · only you can access this list save list close close copy link to tweet heres the url for this tweet copy it to easily share with friends close embed this tweet embed this video add this tweet to your website by copying the code below learn more add this video to your website by copying the code below learn more hmm there was a problem reaching the server try again include parent tweet include media by embedding twitter content in your website or app you are agreeing to the twitter developer agreement and developer policy preview close why youre seeing this ad close log in to twitter remember me · forgot password dont have an account sign up » close sign up for twitter not on twitter sign up tune into the things you care about and get updates as they happen sign up have an account log in » close twoway sending and receiving short codes country code for customers of united states  any canada  any united kingdom  vodafone orange  o brazil  nextel tim haiti  digicel voila ireland  vodafone o india  bharti airtel videocon reliance indonesia  axis  telkomsel indosat xl axiata italy  wind  vodafone » see sms short codes for other countries close confirmation close   close skip all welcome home this timeline is where you’ll spend most of your time getting instant updates about what matters to you tweets not working for you hover over the profile pic and click the following button to unfollow any account say a lot with a little when you see a tweet you love tap the heart — it lets the person who wrote it know you shared the love spread the word the fastest way to share someone else’s tweet with your followers is with a retweet tap the icon to send it instantly join the conversation add your thoughts about any tweet with a reply find a topic you’re passionate about and jump right in learn the latest get instant insight into what people are talking about now get more of what you love follow more accounts to get instant updates about topics you care about find whats happening see the latest conversations about any topic instantly never miss a moment catch up instantly on the best stories happening as they unfold back next next tweet from user mylan  wikipedia mylan from wikipedia the free encyclopedia jump to navigation search mylan trading name mylan nv formerly called milan type public under dutch law traded as nasdaq myl tase myl nasdaq biotechnology component nasdaq component sp  component isin us industry pharmaceuticals founded   years ago  in white sulphur springs west virginia united states founders milan puskar don panoz headquarters canonsburg pennsylvania united states of america area served worldwide key people heather bresch ceo products generic and specialty pharmaceuticals and active pharmaceutical ingredients revenue us billion  operating income us million  net income us billion  total assets us  billion  total equity us billion  number of employees   divisions see operations subsidiaries meda famy care website wwwmylancom mylan nv is an american global generic and specialty pharmaceuticals company registered in the netherlands with principal executive offices in hatfield hertfordshire uk and global headquarters in canonsburg pennsylvania us in  mylan acquired a controlling interest in indiabased matrix laboratories limited a top producer of active pharmaceutical ingredients apis for generic drugs and the generics business of germanybased merck kgaa through these acquisitions mylan grew from the thirdlargest generic and pharmaceuticals company in the united states to the secondlargest generic and specialty pharmaceuticals company in the world in  mylans pricing of the epipen an epinephrine autoinjector became controversial and was widely referred to as price gouging as a result investigations were opened into whether mylan had misclassified the epipen under the medicaid drug rebate program a common form of pharmaceutical fraud in october  mylan settled these investigations with the us department of justice agreeing to pay  million and enter into a corporate integrity agreement concerning the rebate program in a report published on june   the institutional shareholder services criticized mylan for the outsized compensation of mylans directors former ceo robert coury received a  million  pay package in spite of the harm to the company inflicted by the epipen controversies and steep shareholder losses the report urged mylans shareholders to oust all of mylans existing directors contents  operations  location  stock  history  acquisition history  criticism  epipen pricing  execution drugs  references  external links operationsedit mylan inc operates several divisions and subsidiaries in north america and south america mylan operates mylan pharmaceuticals based in morgantown west virginia mylan pharmaceuticals ulc mylan canada mylan technologies inc mti  transdermal drug delivery systems tdds and related technologies udl laboratories inc somerset pharmaceuticals inc a research and development company in tampa florida owned by mylan somerset develops emsam manufactured by mylan technologies and marketed in the united states by dey another mylan company mylan laboratories limited campos dos goytacazes brazil in oceania and central east south and southeast asia mylan operates mylan new zealand limited  new zealand mylan laboratories limited  headquartered in hyderabad india operates nine active pharmaceutical ingredient api and intermediate manufacturing facilities located in india and china mylan seiyaku ltd  japan alphapharm  australia agila specialties pvt ltd  india oncotherapies ltd  india in europe africa and west asia mylan operates operates under the mylan name in austria belgium the czech republic denmark finland france germany hungary italy the netherlands norway poland portugal slovakia slovenia spain sweden switzerland the united kingdom also operates in south africa arcana arzneimittel gmbh  germany generics pharma hellas  greece gerard laboratories  ireland qualimed  trademark in france but will stop being marketed under the brand name docpharma  generic pharmaceutical distribution company in belgium the netherlands and luxembourg locationedit founded in  the company was first located in white sulphur springs west virginia the company moved to morgantown west virginia in  and in  it relocated its corporate headquarters to the pittsburgh suburb canonsburg pennsylvania finally in  it moved to a new office center in nearby southpointe a suburban business park located in cecil township where it is still located stockedit on february   mylan had its initial public offering ipo becoming a publicly traded company on the otc market under the ticker symbol myln in  the stock moved to nasdaq their final stock move was in  when their stock became available for trade on the new york stock exchange under the ticker symbol myl currently the stock is traded on the nasdaq historyedit mylan pharmaceuticals was founded as a drug distributor in  by milan puskar and don panoz in  mylan began manufacturing penicillin g tablets as well as vitamins and other dietary supplements panoz left mylan in  and puskar quit the company in  as it grew and experienced financial difficulties the board hired roy mcknight as board chairman who convinced puskar to return in  mylan discontinued operating as a contract manufacturing organization in  and instead chose to market their products under their own mylanlabeled brandcitation needed with the passage of the hatchwaxman act in  mylan and other small generic companies gained value in the eighteen months following passage of the law mylans earnings grew  to  million and its stock value rose  in the s one of the most prescribed drugs in the us was dyazide a diuretic that was a combination drug containing triamterene and hydrochlorothiazide it had been on the market since  and its patents had expired in  complications arose with the introductions of generics versions because the formulation of dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent some generic companies committed fraud trying to bring a generic version of dyazide bolar pharmaceutical had the first generic version approved in  but it turned out that bolar had fraudulently substituted dyazide for its own version to conduct studies that were submitted to the fda by  the fda rescinded its approval based on its suspicions and filed criminal charges against bolar to which bolar eventually pled guilty in  mylan chose to develop a new version of a triamterenehydrochlorothiazide combination drug instead of going the generic route it developed a different more stable formulation and used different dosages of each active ingredient  mg hydrochlorothiazide and  mg triamterene compared with dyazides  mg hydrochlorothiazide and  mg triamterene this drug had to get approval as a new drug as opposed to a generic their product was called maxzide and was approved in  the higher dose allowed once per day dosing which mylan and its marketing partner lederle believed would help it compete against dyazide which had m in sales in  however mylans patents on the drug were declared invalid in court and its marketing exclusivity expired in  prompting a rush of generic competition mylan had concerns about the practices of its competitors and the fda in general and also with regard to companies seeking to bring generic versions of maxzide mylan hired private investigators to examine its competitors practices and when it found evidence of corruption it submitted it to the house oversight and investigations committee which investigated and found fraud and corruption within the food and drug administrations generic drugs division and at other generic companies two of the companies that had gotten approval to market generic versions of maxzide vitarine pharmaceutical and par pharmaceutical were targets of mylans initial investigation and were found to have used mylans maxzide to obtain their bioequivalence data leading both companies to withdraw its generic competitor to mylans product the corruption in the nascent generics industry and at the office in the fda regulating it was widely covered in the media and led to widespread concern among doctors and the public in the late s and early s that generic drugs were not really the same as the branded drugs they were meant to replace in  mylan agreed to enter into a joint venture with bolar to buy somerset pharmaceuticals mylan wanted access to somersets drug discovery capabilities as well as its new drug for parkinsons selegiline the deal was completed in  but its consummation was dependent on fda approval of selegiline which came in  mylan acquired bertek inc in  for its transdermal patch technologies and kept as a subsidiary in  mylan renamed the company mylan technologies inc mti mti eventually came to be the contract manufacturer for the selegiline transdermal patch and was the first company to market generic nitroglycerin estradiol clonidine and fentanyl transdermal patches mylan acquired udl laboratories a supplier of unit dose generic medications to institutional and longterm care facilities in  in  when it was the worlds second largest generics company mylan came under investigation from the federal trade commission after it raised the prices of its products tripling them in the case of lorazepam mylan had entered into an exclusive agreement with profarmica an italian company that supplied drug ingredients after which mylans competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs before the round of price increases the price of generic drugs had been    of the price of branded drugs and afterwards it was around  the ftc filed suit at the end of  and  states filed parallel actions the case was settled in  with mylan paying a total of m  m in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid  million in attorneys fees to the state attorneys general  million plus  million in attorneys fees to settle certain class actions with insurers and managed care organizations  and mylan and three ingredient suppliers cambrex corporation profarmaco srl and gyma laboratories also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future in  mylan and king pharmaceuticals began discussing a deal in which mylan would acquire king for about b mylan wanted to expand its presence in branded pharmaceuticals and to acquire kings sales force the deal became one of the business soap operas of the year and included an sec investigation into kings accounting and carl icahn obtaining a  interest in mylan and becoming its largest stakeholder in order to kill the deal the parties called off the deal in february  icahn offered to buy mylan for b and ran a slate of board members to change the direction of mylan he won three seats in may  in june mylan bought back  of its shares in order to fend off icahn and in july icahn gave up his bid and sold his shares in august  mylan announced that it had reached agreement to buy a controlling interest in matrix laboratories an indian supplier of active pharmaceutical ingredients the deal gave mylan access to markets in india and china and was completed in january the next year in may  mylan and merck kgaa agreed that mylan would acquire mercks generics arm for b the deal was completed that october and tripled the size of mylan mylan acquired the rights to market the epipen in the transaction at that time annual sales were around  million and the epipen had about  of the market in  the company filed two lawsuits against the pittsburgh postgazette after the newspaper ran an article that was critical of the quality control procedures used at the companys morgantown plant the company had earlier quality control issues involving the fda the lawsuits were dropped in  without any damages paid by the postgazette which stated the postgazette did not find and did not intend to report that mylan had manufactured or distributed any defective drugs the postgazette regrets if any reader of the article thought otherwise also in  mylan and its subsidiary udl agreed to pay a m to settle a suit filed under the false claims act in which mylanudl and two other companies were accused of underpaying states under the medicaid drug rebate program the program requires drug companies to give rebates to states under medicaid and the rebates are higher for new drugs than for generics the suit said that the companies sold new drugs but paid rebates as if they were generics in  mylan entered into an agreement with pfizer for the exclusive worldwide rights to develop manufacture and commercialize pfizers generic equivalent to glaxosmithklines advair usseretide uk diskus incorporating pfizers proprietary dry powder inhaler delivery platform mylan launched the product in the uk in  and in february  the fda accepted its anda putting it in line behind hikma and sandoz to launch a generic version in the us in  mylan launched a program called epipenschools to sell epipens in bulk and with discounts to schools to participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year in december  the national association of state boards of education launched a policy initiative designed to help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine autoinjector access and use and advocated for state laws protecting school from legal liability for stocking and using epinephrine autoinjectors gayle manchin the mother of mylans ceo heather bresch had become president of the association in  and shortly after had discussed donations from her daughters company to the association manchin had been appointed to the west virginia state school board by her husband thengovernor of the state joe manchin in  in  mylan acquired an indian generic injectable drugs company agila specialties private for  billion in cash in  three plants acquired in that deal were issued warning letters by the fda after successful lobbying from mylan in  the school access to emergency epinephrine act became law after passing congress with broad and bipartisan support it protected anyone from liability if they administered epinephrine to a child in a school previously only trained professionals or the affected person were allowed to administer the drug and were open to liability and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them joe manchin the father of mylans ceo was a senator at that time in july  mylan and abbott laboratories announced an agreement under which mylan would buy abbotts generic drugs business in developed markets for stock valued at about  billion mylan acquired mumbaibased famy care and expand its presence in the market for womens contraceptives at about  million starting in  according to a  report in the new york times midlevel executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the epipen and raising concerns that the price increases were unethical the times reported that when these concerns were brought to robert coury the chairman of the board coury replied that he was untroubled he raised both his middle fingers and explained using colorful language that anyone criticizing mylan including its employees ought to go copulate with themselves critics in congress and on wall street he said should do the same and regulators at the food and drug administration they too deserved a round of anatomically challenging selffulfillment  the times reported that bresch provided similarly dismissive responses in april  mylan tried negotiate with the management of irish pharmaceutical firm perrigo to acquire the company and when those negotiations failed mylan attempted a hostile takeover offering to buy b in shares directly from shareholders too few shareholders agreed to sell their stock by the deadline set in november  and the effort failed two weeks after mylan made its first offer for perrigo teva pharmaceutical offered to buy mylan for b the combined companies would have been the worlds largest generic company and the th biggest drug company in the world in july teva dropped its bid for mylan and instead acquired allergans generic drug business for about the same price in june  mylan agreed to work with pulmatrix a company with a proprietary inhaled drug delivery platform to codevelop a product to treat for chronic obstructive pulmonary disease the product was pur a generic drug in a pulmatrix device in february  the company announced it would acquire meda for  billion in may of the same year the company announced it would acquire renaissance acquisition holdings dermatology division for up to  billion in  mylan had about b in sales of epipens and those sales accounted for  of mylans profit mylan had maintained about a  market share since it had acquired the product and had continually raised the price of epipens starting in  in  the wholesale price of two epipens was about  by july  the price was about  in may  it was around  and in may  the price rose again to around  around a  jump from the price in  in the summer of  as parents prepared to send their children back to school and went to pharmacies to get new epipens people began to express outrage at the cost of the epipen and mylan was widely and harshly criticized the price hikes led to investigations by congress and states attorneys general in october  mylan agreed to pay a m fine related to incorrect rebates it paid under the medicaid drug rebate program in december  the attorneys general of  states filed a civil complaint accusing mylan of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug the complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings telephone calls and text messages according to the department of health and human services office of inspector general analysis the us government may have overpaid as much as  billion between  and  to drugmaker mylan nv for the epipen emergency allergy treatment this represents three times the proposed settlement of  million announced by mylan in october  republican senator chuck grassley chair of the senate judiciary committee that launched the probe of epipen pricing probe in  released the analysis on may   on the same day a group of mylan investment funds urged shareholders to vote against the reelection of the companys directors after it paid chairman robert coury over  million last year acquisition historyedit the following is an illustration of the companys major mergers and acquisitions and historical predecessors mylan   renaissance acquisition holdings dermatology div acq    meda acq    famy care acq    abbott laboratories generics div acq    merck kgaa generics div acq  renamed mylan laboratories inc   udl laboratories acq    bertek inc acq  renamed mylan technologies inc milan pharmaceuticals founded  criticismedit epipen pricingedit see also epinephrine autoinjector § cost see also heather bresch § business executive mylan acquired the right to market and distribute the epipen line of epinephrine autoinjector devices from merck kgaa as part of their  deal that right had formerly been held by dey lp a wholly owned subsidiary of merck the devices deliver about  worth of drug at that time annual sales were around m bresch the companys ceo saw an opportunity to increase sales through marketing and advocacy and the company launched a marketing campaign to increase awareness of the dangers of anaphylaxis for people with severe allergies that made the brand epipen as identified with its product as kleenex is with facial tissue the company also successfully lobbied the fda to broaden the label to include risk of anaphylaxis and in parallel successfully lobbied congress to generate legislation making epipens available in schools and in public places like defibrillators are and hired the same people that medtronic had worked with on defibrillator legislation to do so mylans efforts to gain market dominance were aided when sanofis competing product was recalled in november  and further when tevas generic competitor was rejected by the fda in march  by the first half of  mylan had an  market share of such devices in the us and in that year sales reached around b and accounted for  of mylans profit those profits were also due in part to mylans continually raising the price of epipens starting in  in  the wholesale price of two epipens was about  the price was about the same in  by july  the price about  in may  it was around  and in may  the price rose again to around  the last price increase sparked widespread outrage including criticism from martin shkreli poster boy for grasping pharma greed letters from two senators and initiation of congressional investigations and mylans pricing of the epipen was widely referred to as price gouging the last price increase coincided with a new line of tv commercials that were described as shocking and no holds barred depicting an anaphylactic reaction from the point of view of the young woman having it at a party and ending with the young woman seeing her swollen and hivecovered face in the mirror before she collapses in response to criticism mylan increased financial assistance available for some patients to purchase epipens a gesture that was called a classic public relations move by harvard medical school professor aaron kesselheim the up to  saving cards can only be used by a small number of people who need the drug and no one on medicaid they do nothing about the high price which is still being paid by insurers who ultimately pass the cost onto consumers in september  the new york state attorney general began an investigation into mylans epipenschools program in new york to determine if the programs contracts violated antitrust law and the west virginia state attorney general opened an investigation into whether mylan had given the state the correct discount under the medicaid drug rebate program and subpoenaed the company when it refused to provide the documentation the state requested in october  the ceo of mylan testified to congress that pfizerking charged mylan about  for one device in september  a silicon valley engineering consultancy performed a teardown analysis of the epipen and estimated the manufacturing and packaging costs at about  for a twopack in october  mylan announced a settlement with the us department of justice over rebates paid by mylan to states under the medicaid drug rebate program questions had been raised by congress and others about why epipen had been classified as a generic rather a proprietary product in the program since  generic drugs have lower rebates  than proprietary drugs  and price hikes for generic drugs cannot be passed onto states and a common form of pharmaceutical fraud involves misclassifying proprietary drugs as generic under the program under the agreement mylan agreed to pay a  million payment and to a sign a corporate integrity agreement requiring it to perform better in the future the settlement also resolved cases brought by states related to the rebates simultaneously with the settlement mylan also announced it was being investigated by the securities and exchange commission related to the drug rebate program in june  the new york times published an article reporting on internal mylan discussions about price increases on the epipen between  and  in which the company chairman expressed disdain for people and agencies who might criticize the company the reporter wrote those top leaders’ responses are a far cry from the message on mylan’s website which says that we challenge every member of every team to challenge the status quo and that we put people and patients first trusting that profits will follow and also noted that the firm is a case study in the limits of what consumer and employee activism as well as government oversight can achieve  execution drugsedit mylan manufactures rocuronium bromide which is approved by the state of alabama for use in executions by lethal injection european manufacturers refuse to sell drugs which can be used for executions to the united states except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain in september  the londonbased human rights organization reprieve told mylan that they were the only fdaapproved manufacturer of rocuronium bromide without legal controls in place to prevent its use in executions and there was a very real risk that mylan may soon become the goto provider of execution drugs for states across the country the german asset manager dje kapital de divested itself of  million in mylan shares for that reason mylan said that their distribution was legally compliant referencesedit  a b public filings  form k mylan investors relations retrieved august     mylan nv k for the fiscal year ended december    mylan buys part of drug maker pittsburgh business times december     mylan laboratories to acquire generics business of merck kgaa for  billion euros medical news today may     pharmaceutical giants tracking mylans prosperity the pittsburgh tribunereview august     egan matt epipen maker faces revolt over execs  million pay package cnn money   transdermal patches  mylan mylantechcom   brand name medicines  mylan deycom   about us mylancom   a b about us mylancom   matrixlabsindiacom matrixlabsindiacom   whats new  arcana arzneimittelherstellung arcanade   httpwwwmantacomcomsdnbcompanywsklv  httpwwwidairelandcomsearchcompaniesxmlssid  httpwwwbioportfoliocomnewspdfusmylantowithdrawqualimedbrandfromfrenchmarketreportpdf  a b c dearment alaric october   milan puskar cofounder of mylan dies drug store news   mylan  years young and still making history mylan retrieved april     myl stock history  mylan retrieved august     a b c d e freudenheim milt september   exposing the fda new york times   lewis ralph a  the emerging effects of the drug price competition and patent term restoration act of  journal of contemporary health law  policy   –   a b ron wolf for the philadelphia inquirer august   smithkline loses exclusive rights to drug  a b boehm garth yao lixin han liang zheng qiang september  development of the generic drug industry in the us after the hatchwaxman act of  acta pharmaceutica sinica b   – doijapsb   a b john seaman and john t landry mylan  years of unconventional success mylan in association with university press of new england  isbn  page   a b strickland carol october   bolar a drug company under siege the new york times   shaw donna february   us charges bolar pharmaceutical with misrepresenting its products philadelphia inquirer   freudenheim milt february   bolar plans guilty plea on generics the new york times   a b c pink sheet october   mylans maxzide is approvable at fda lederle to market brand competition to smithklines no ranked dyazide final approval anticipated imminently  fda approval history nda  maxzide page accessed september    reid kenneth november   us judge to rule on drug marketing journal of commerce   andrews edmund l july   fda inquiry on generic drugs focuses on changes in ingredients the new york times   cimons marlene august   fda to lift ok of last dyazide generic version los angeles times   bolar and mylan team to purchase somerset labs pink sheet november     somerset eldepryl june  approval clears way for mylanbolar acquisition pink sheet june     a b ku mannching sherry december   recent trends in specialty pharma business model journal of food and drug analysis   – doijjfda   mylan form k annual report for the financial year ending march    filed june    a b labaton stephen december   a drug maker is said to face a suit on prices the new york times   press release ftc reaches record financial settlement to settle charges of pricefixing in generic drug market  federal trade commission ftc november     labaton stephen july   genericdrug maker agrees to settlement in pricefixing case the new york times   a b creswell julie march   icahn the spoiler fortune   pollack andrew november   icahn offers  billion for mylan drug maker the new york times   okeefe eric may   icahn slate wins seats on blockbuster board the new york times   lazo shirley a survival strategy barrons   icahn drops bid for mylan los angeles times bloomberg news july     mylan signs usmil takeover deal for indias matrix laboratories ihs august     mylans acquisition of matrix business strategy case study icrm   massey steve may   mylan buys merck generic drug unit for  billion pittsburgh postgazette   press release mylan completes acquisition of generics business of merck kgaa mylan october     a b c d e f g cynthia koons and robert langreth for bloomberg businessweek september   how marketing turned the epipen into a billiondollar business  johnson carolyn y ho catherine august   how mylan the epipen company maneuvered to create a virtual monopoly the washington post via the chicago tribune   adams russell october   mylan again sues pittsburgh postgazette wall street journal retrieved august     sabatini patricia boselovic len july   mylan workers overrode drug quality controls internal report detailed pervasive practice of ignoring safety procedures pittsburgh postgazette retrieved august     edwards jim july   its not mylans first quality control beef with fda money watch cbs news retrieved august     mylan pittsburgh postgazette settle lawsuits cbs news associated press february   retrieved august     us department of justice october   press release four pharmaceutical companies pay  million for submission of false claims to medicaid  mylan acquires rights to pfizers inhaler technology drugstorenewscom retrieved may     stanton dan june   gsk breathes freely as mylan launches seretide generic in uk inpharma technologist   helfand carly february   mylan joins the advaircopycat queue but approval could be a long slog fiercepharma   swetlitz ike silverman ed august   mylan may have violated antitrust law in its epipen sales to schools pbs newshour   a b odonnell jayne september   family matters epipens had highlevel help getting into schools usa today   thomas katie february   mylan buys drug maker of generic injectables new york times   palmer eric august   updated fda castigates three mylan sterile drug plants in warning letter fiercepharma   novak matt august   how congress the fda and sarah jessica parker helped epipen become a  billion business gizmodo   abc news business news personal finance and money news  abc news abc news retrieved july     us drugmaker mylan to acquire famy care for  million timesofindiaeconomictimes february     a b duhigg charles  june  outcry over epipen prices hasn’t made them lower the new york times   koons cynthia november   mylans hostile bid for perrigo fails bloomberg   rockoff jonathan d mattioli dana april   teva offers to buy mylan for  billion wall street journal   teva to buy allergans generic drug unit bloombergcom july     chitra somayaji july   teva snaps up allergans generics arm dumping mylan bloombergcom   mylan to codevelop pulmatrix copd candidate gen   mylan to acquire meda for b  gen news highlights  gen retrieved august     mylan snaps up dermatology biz from investors in b deal  fiercepharma retrieved august     a b c tara parkerpope and rachel rabkin peachman for the new york times august   epipen price rise sparks concern for allergy sufferers  bartolotta devin august   cost jumps nearly percent for lifesaving epipens cbs baltimore retrieved august     goldberg kenny people with food allergies say lifesaving drug too expensive kpbs public media retrieved june     walker joseph winslow ron steele anne august   mylan to launch cheaper generic epipen alternative wall street journal   a b c thomas katie october   mylan to settle epipen overpricing case for  million the new york times   thomas katie   states accuse generic drug companies of price fixing the new york times retrieved    a b erman michael may   mylan may have overcharged us for epipen by  billion hhs reuters new york retrieved may     king pharmaceuticals october   press release king pharmaceuticals to acquire meridian medical technologies  carly helfand for fiercepharma march   fda swats down tevas epipen copy putting mylan in cruise control  a b emily willingham for forbes august   why did mylan hike epipen prices  because they could  emma court for marketwatch august   mylan’s epipen price increases are valeantlike in size shkrelilike in approach  brad tuttle for time august    signs that epipen prices are completely out of control  michael hiltzik for the los angeles times august   another reason to hate mylan which jacked up the price of lifesaving epipens its a tax dodger  matt novak for gizmodo august   how congress the fda and sarah jessica parker helped epipen become a  billion business  beth snyder bulik for fiercepharma may   no holds barred in mylan’s ultrarealistic peanut allergy campaign  mylan to provide epipen cost assistance as ceo is asked to testify on price hike the guardian   a b carolyn y johnson august   why mylan’s ‘savings card’ won’t make epipen cheaper for all patients washington post washington post   larson erik hopkins jared s september   mylan’s epipen school sales trigger ny antitrust probe bloomberg retrieved september     feeley jef langreth robert september   mylan investigations mount as west virginia opens fraud probe bloomberg news   popken ben september   upgraded epipens torn apart tech firm its the same core device nbc news   tracy seipel silicon valley engineers figure real cost to make lifesaving autoinjector twopack the mercury news retrieved october     thomas katie september   is epipen a brandname or a generic drug mylan casts it both ways the new york times   mole beth october   for ripping off medicaid epipen maker mylan pays feds  million ars technica retrieved october     ztracer zachary tracer october   mylan agrees to  million epipen settlement with us bloombergcom   novak matt  june  drug company chairman to america go fuck yourself gizmodo   mole beth  june  mylan chairman drug pricing critics ought to go copulate with themselves ars technica   loew derek  june  mylan begins harvesting the crop its sown in the pipeline   a b owen dyer october   drug company is targeted for refusing to adopt ban on distribution of execution drug bmj   g doibmjg  external linksedit media related to mylan at wikimedia commons business data for mylan google finance yahoo finance reuters sec filings v t e pittsburgh history timeline culture dialect media neighborhoods notable people skyscrapers government airport conventions city hall courthouse mayor council events intergov police da sheriff fire libraries transit education port regional economy allegheny conference duquesne club chamber of commerce economic club hyp club stock exchange fortune  headquarters us steel pnc ppg heinz wesco consol dicks allegheny technologies forbes largest private companies  lumber giant eagle other headquarters american bridge american eagle ampco ansys armstrong black box calgon carbon compunetix dollar bank dqe eatn park education management corporation eqt federated gnc gurucom highmark igate iron city kennametal koppers laughlin marc usa millcraft msa nichecom oxford ptc renda rue upmc vocelli wabtec shared headquarters alcoa modcloth nova chemicals subsidiary headquarters allegheny energy bayer corporation fedex ground glaxosmithkline usa lanxess respironics vivisimo westinghouse regional operations aa bny mellon formerly mellon financial dreyfus eaton spreadshirt macys historic big wheel clark dravo fisher integra mesta murphy gulf oil jl ketchum rockwell sunbeam westinghouse sports dapper dan grand prix great race head of the ohio lore marathon mylan classic regatta wphl baseball pirates wild things panthers dukes chronicletelegraph cup allegheny burghers champions crawfords filipinos grays hardhats keystones stogies rebels basketball yellow jackets panthers m panthers w dukes m dukes w colonials m colonials w roundball classic condors ironmen loendi monticello phantoms pipers piranhas pirates rens xplosion football steelers panthers steeler nation heritage colts force passion renegades  allstars allegheny americans as duquesne gladiators homestead lyceum maulers power odds olympics quakers jp stars early pro football circuit hockey penguins colonials m colonials w three rivers classic as bankers cougars duquesne ft pitt hornets keystones lyceum panthers phantoms pirates pirates wphl pros shamrocks victorias winter garden yellow jackets soccer riverhounds beadling cannons hurricanes phantoms spirit other sledgehammers bulls harlequins pcc triangles wallabies studio wrestling dirty dozen venues ppg paints arena heinz field pnc park  lumber arena fitzgerald field house highmark stadium palumbo center petersen events center petersen sports complex rooney field sewall center trees hall central park civic arena duquesne gardens exposition park forbes field josh gibson field greenlee field motor square garden pitt stadium recreation park schenley gardens three rivers winter garden parks allegheny arsenal allegheny commons allegheny riverfront artgardens buhl community chatham university arboretum frank curto frick emerald view highland market square mellon mellon green mellon square north shore riverfront phillips point of view point state ppg place riverview roberto clemente memorial rodef shalom biblical botanical garden schenley schenley plaza south shore riverfront south side three rivers west end overlook westinghouse transportation inclines steps v t e port authority of allegheny county light rail list of stations blue line – library blue line – south hills village red line inclines historical list duquesne incline monongahela incline buses and busways list of routes martin luther king jr east busway south busway west busway former lines  drake brown line patrain skybus other north shore connector port authority  series pcc wabash tunnel v t e public transportation in greater pittsburgh bus services port authority of allegheny county list of bus routes beaver butler fayette indigo mid mon valley mountain line new castle town  country university of pittsburgh washington westmoreland bus rapid transit mlk jr east busway south busway west busway light rail red line blue line library south hills village inclines duquesne monongahela amtrak capitol limited pennsylvanian airports pittsburgh international arnold palmer allegheny county beaver butler eddie dew greensburg jeannette herron jefferson jimmy stewart joe hardy lakehill monroeville new castle rock rostraver washington wheeling zelienople discontinued broadway limited brown line list of streetcar routes in pittsburgh parkway limited patrain skybus v t e tunnels and bridges in pittsburgh tunnels allegheny river tunnel armstrong tunnel cork run tunnel corliss tunnel fort pitt tunnel jl tunnel liberty tunnel mount washington transit tunnel pittsburgh and castle shannon tunnel pittsburgh  steubenville extension railroad tunnel schenley tunnel squirrel hill tunnel wabash tunnel bridges th street bridge st street bridge rd street railroad bridge th street bridge bloomfield bridge birmingham bridge david mccullough bridge fort duquesne bridge fort pitt bridge fort wayne railroad bridge glenwood bridge glenwood bo railroad bridge highland park bridge homestead grays bridge hot metal bridge liberty bridge mckees rocks bridge panhandle bridge panther hollow bridge schenley bridge senator robert d fleming bridge smithfield street bridge south tenth street bridge three sisters roberto clemente bridge andy warhol bridge rachel carson bridge veterans bridge west end bridge attractions aviary baywood cathedral of learning chinatown conservatory dippy immaculate heart duquesne incline heinz chapel little italy mellon institute mon incline observatory pamelas penn station point of view sculpture primantis science center steps uss requin zoo kennywood luna park westinghouse sign landmarks national city national county state city phlf cultural museums art arts arts festival bible fort pitt and blockhouse clayton clemente childrens frick glass center history jazz jewish mattress factory dental miller miss pittsburgh nationality rooms national map natural history soldiers and sailors warhol wilson wsg venues heinz hall benedum byham harris kellystrayhorn new hazlett oreilly foster playhouse trib hunt stage ae syria mosque nixon theater festivals anthrocon arts blues comicon fashion film folk handmade new works tekko whiskey  fine spirits wine shopping and entertainment casino gateway clipper fleet station square strip downtown oakland south side macys market square southside works waterworks mount washington east liberty squirrel hill shadyside walnut street opera ballet symphony brass classical theatre dance ensemble caravan theatre folk light opera opera theater jewish theatre public theater playwrights musical theater stage right youth ballet youth symphony bricolage nnoc v t e shopping malls in pittsburgh enclosed beaver valley mall the block northway century iii mall the galleria of mt lebanon the mall at robinson monroeville mall pittsburgh mills ross park mall south hills village station square uniontown mall warner centre washington crown center westmoreland mall lifestyle  outdoor bakery square edgewood towne centre ellsworth avenue mccandless crossing northern lights robinson town centre settlers ridge southside works walnut street the waterfront waterworks mall outlet grove city premium outlets tanger outlets pittsburgh defunct allegheny center mall east hills shopping center eastgate commerce center eastland mall greengate mall parkway center mall village square mall washington mall colleges and universities pitt carnegie mellon duquesne robert morris chatham point park carlow art institute byzantine catholic seminary pittsburgh theological seminary saint paul seminary ccac culture of pittsburgh cookie table jewish history iron city brewing company jagoff joe magarac mister rogers neighborhood mr yuk parking chairs pittsburgh left pittsburgh toilet robot hall of fame steeler nation book category portal v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlemylanoldid categories companies in the nasdaq indexcompanies listed on nasdaqcorporate inversionspharmaceutical companies of the united statescompanies in the nasdaq biotechnology indexlife sciences industryhealth care companies based in pennsylvaniacompanies listed on tasecompanies formerly listed on the new york stock exchangehidden categories use mdy dates from october all articles with unsourced statementsarticles with unsourced statements from september interlanguage link template link number navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutschespañolفارسیfrançaisעבריתportuguêssuomi edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view data dumps    freebase api deprecated    google developers freebase api deprecated all products sign in send feedback hey there are you maybe looking for firebase instead data dumps the freebase api will be completely shutdown on aug   this page provides access to the last available data dump read more data dumps are a downloadable version of the data in freebase they constitute a snapshot of the data stored in freebase and the schema that structures it and are provided under the same ccby license the freebasewikidata mappings are provided under the cc license freebase triples freebase deleted triples freebasewikidata mappings license citing freebase triples this dataset contains every fact currently in freebase total triples  billion updated weekly data format ntriples rdf license ccby  gb gzip gb uncompressed download the rdf data is serialized using the ntriples format encoded as utf text and compressed with gzip rdf httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagedate httpwwwworgxmlschemagyearmonth  httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagesource httprdffreebasecomnsgxgfm  httprdffreebasecomnsgvjzynm httprdffreebasecomnstypeobjecttype httprdffreebasecomnsmeasurementunitdatedpercentage  httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagerate   httprdffreebasecomnsgvjzynm httpwwwworgrdfsyntaxnstype httprdffreebasecomnsmeasurementunitdatedpercentage  if youre writing your own code to parse the rdf dumps its often more efficient to read directly from gzip file rather than extracting the data first and then processing the uncompressed data subject predicate object  note in freebase objects have mids that look like mrkqx in rdf those mids become mrkqx likewise freebase schema like commontopic are written as commontopic the subject is the id of a freebase object it can be a freebase mid ex mrkqx for topics and cvts or a humanreadable id ex commontopic for schema the predicate is always a humanreadable id for a freebase property or a property from a standard rdf vocabulary like rdfs freebase foreign key namespaces are also used as predicates to make it easier to look up keys by namespace the object field may contain a freebase mid for an object or a humanreadable id for schema from freebase or other rdf vocabularies it may also include literal values like strings booleans and numeric values topic descriptions often contain newlines in order to make each triple fit on one line we have escaped newlines with n freebase deleted triples we also provide a dump of triples that have been deleted from freebase over time this is a onetime dump through march  in the future we might consider providing periodic updates of recently deleted triples but at the moment we have no specific timeframe for doing so and are only providing this onetime dump the dump is distributed as a targz file gb compressed gb uncompressed it contains  deleted triples in  files there is no particular meaning to the individual files it is just easier to manipulate several smaller files than one huge file thanks to chun how tan and john giannandrea for making this data release possible total triples  million updated june   data format csv license ccby  gb gzip gb uncompressed download the data format is essentially csv with one important caveat the object field may contain any characters including commas as well as any other reasonable delimiters you could think of however all the other fields are guaranteed not to contain commas so the data can still be parsed unambiguously the columns in the dataset are defined as creationtimestamp unix epoch time in milliseconds creator deletiontimestamp unix epoch time in milliseconds deletor subject mid predicate mid object midliteral languagecode csv usermwclwikipediaenusermwclwikipediaenmrtypeobjectkeywikipediaenben usermwclmusicbrainzuserturtlewaxbotmnncpzmusicrecordingartistmvbfmen usermwclimagesusergardeningbotmwmcommonimagesizemklyen usermwclmusicbrainzusermbzpipelinemergebotmfvvltypeobjecttypecommontopicen usermwclimagesusergardeningbotmxsczcommonlicensedobjectlicensemxben usercontentadministratorusergardeningbotmgkbytypeobjecttypetypecontenten usermwclimagesusergardeningbotmhcommontopicimagemcsen usermwclchefmozuserdeletebotmzcztypeobjectnamela casa rosa mexican restauranten freebasewikidata mappings the data has been created based on the wikidatadump of october   and contains only those links that have at least two common wikipedialinks and not a single disagreeing wikipedialink furthermore the lines are sorted by the number of common wikipedialinks although in turtle this does not really matter total triples m updated october   data format ntriples rdf license cc  mb gzip mb uncompressed download the rdf data is serialized using the ntriples format encoded as utf text and compressed with gzip rdf httprdffreebasecomnsmj httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmnrg httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmjgd httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmd httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmgd httpwwwworgowlsameas httpwwwwikidataorgentityq  license freebase data dumps are provided free of charge for any purpose with regular updates by google they are distributed like freebase itself under the creative commons attribution aka ccby and use is subject to the terms of service the freebasewikidata id mappings are provided under cc and can be used without restrictions citing if youd like to cite these data dumps in a publication you may use google freebase data dumps httpsdevelopersgooglecomfreebasedata month day year or as bibtex bibtex misc except as otherwise noted the content of this page is licensed under the creative commons attribution  license and code samples are licensed under the apache  license for details see our site policies java is a registered trademark of oracle andor its affiliates last updated february   send feedback about this page documentation feedback freebase api deprecated product feedback cancel